PT J
AU Mercadante, S
   Lazzari, M
   Reale, C
   Cuomo, A
   Fusco, F
   Marchetti, P
   Mediati, RD
   Chiurazzi, B
   Ciuffedra, L
   Caraceni, A
   Iaffaioli, V
   Luzzani, M
   Micheletto, G
   Papa, A
   Raffaeli, W
   Valle, A
   Caruso, M
   Di Costanzo, F
   Pinato, G
   Nardi, F
   Barni, S
   Natoli, S
   Mammucari, M
   Sabato, AF
   Dauri, M
AF Mercadante, Sebastiano
   Lazzari, Marzia
   Reale, Carlo
   Cuomo, Arturo
   Fusco, Flavio
   Marchetti, Paolo
   Mediati, Rocco D.
   Chiurazzi, Bruno
   Ciuffedra, Libero
   Caraceni, Augusto
   Iaffaioli, Vincenzo
   Luzzani, Massimo
   Micheletto, Giuseppe
   Papa, Alfonso
   Raffaeli, William
   Valle, Alessandro
   Caruso, Michele
   Di Costanzo, Francesco
   Pinato, Gianpaolo
   Nardi, Filippo
   Barni, Sandro
   Natoli, Silvia
   Mammucari, Massimo
   Sabato, Alessandro F.
   Dauri, Mario
TI Italian Oncological Pain Survey (IOPS) A Multicentre Italian Study of Breakthrough Pain Performed in Different Settings
SO CLINICAL JOURNAL OF PAIN
LA English
DT Article
DE breakthrough pain; cancer pain; rapid-onset opioids; palliative care; epidemiology
ID chronic cancer pain; episodic pain; prevalence; management; admission; hospice
AB Objective: A survey of breakthrough pain (BTP) was performed in five palliative care units (PCU), seven oncology departments (ONC), and nine pain clinics (OPC). Methods: A standard algorithm was used to confirm the diagnosis of BTP of patients refereed to different settings. Results: 1,412 evaluable cancer patients were enrolled. 53.9% were males and the mean age was 63.7 +/- 13.1 years. The mean intensity of background pain was 2.8 +/- 0.73. Patients reported 2.4 +/- 1.1 BTP episodes/ day with a mean intensity of 7.37 +/- 1.28. 80.6% patients reported that the BTP had a significant negative impact in everyday life. The majority of patients reported a fast onset of BTP, which was predictable in 50.7% of cases, while BTP with a gradual onset (> 10 min) was less predictable (29%) (P=0.001). PCU patients were older, had lower Karnofsky levels, a lower number of BTP episodes/ day, a slow onset of BTP onset, and a less predictable BTP. Cancer diagnosis was performed a mean of 23.5 months (SD +/- 32.8) before the assessment. The mean duration of background pain was 3.5 months (SD +/- 3.5), and the mean duration of any analgesic treatment was 2.5 months (SD +/- 3). BTP started a mean of 2.2 months (SD +/- 1.9) before the assessment. Characteristics of BTP were influenced by the course of disease, as well as the duration of background pain and initiation of BTP. Most patients took rapid onset opioids and were satisfied with the treatment. BTP diagnosis was prevalently made by ONC and OPC physicians, and rarely by GPs. Conclusion: This survey performed by an Italian observatory expert review group, has confirmed that the BTP represents a clinically relevant condition with a negative impact on the patient's quality of life. BTP was detected in all settings involved. A number of factors are associated with the BTP. Also factors regarding the course of disease and setting of care have been assessed. This information may help in stratifying patients or predicting the risk of development of BTP with specific characteristics.
C1 [Mercadante, Sebastiano] La Maddalena Canc Ctr, Palermo, Italy.
   [Lazzari, Marzia; Natoli, Silvia; Sabato, Alessandro F.; Dauri, Mario] Univ Roma Tor Vergata, Emergency Care Crit Care Med Pain Med & Anesthesi, Rome, Italy.
   [Reale, Carlo] Umberto I Hosp, Anesthesiol Resuscitat & Pain Therapy Dept, Rome, Italy.
   [Marchetti, Paolo] Univ Roma La Sapienza, Rome, Italy.
   [Marchetti, Paolo] IDI IRCCS, Rome, Italy.
   [Mammucari, Massimo] ASL RM F, Rome, Italy.
   [Marchetti, Paolo] IRCCS Fdn Pascale, Natl Canc Inst, Naples, Italy.
   [Chiurazzi, Bruno] AORN A Cardarelli Hosp, Naples, Italy.
   [Papa, Alfonso] Monaldi Hosp, AO Dei Colli, Naples, Italy.
   [Fusco, Flavio] Palliat Care ASL3, Genoa, Italy.
   [Luzzani, Massimo] EO Galliera Hosp, Palliat Care Gerontol & Phys Educ Dept, Genoa, Italy.
   [Mediati, Rocco D.] Careggi Hosp, Dept Oncol, Florence, Italy.
   [Ciuffedra, Libero] AO City Hlth & Sci, Hematol Oncol Ctr Subalpine COES, Molinette, Italy.
   [Valle, Alessandro] FARO Fdn, Turin, Italy.
   [Caraceni, Augusto] IRCCS Fdn Natl Canc Inst Milan, Milan, Italy.
   [Raffaeli, William] Infermi Hosp, Rimini, Italy.
   [Caruso, Michele] Humanitas Oncol Ctr Catania, Catania, Italy.
   [Di Costanzo, Francesco] Careggi Hosp, Florence, Italy.
   [Pinato, Gianpaolo] IRCCS Veneto Oncol Inst, Padua, Italy.
   [Nardi, Filippo] AV3 Macerata Hosp, Macerata, Italy.
   [Barni, Sandro] AO Treviglio, Bergamo, Italy.
   [Caraceni, Augusto] Norwegian Univ Sci & Technol, European Palliat Care Res Ctr, N-7034 Trondheim, Norway.
C3 University of Rome Tor Vergata; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Fondazione Pascale; Antonio Cardarelli Hospital; Ente Ospedaliero Ospedali Galliera; University of Florence; Azienda Ospedaliero Universitaria Careggi; Hospital of Rimini; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Istituto Oncologico Veneto (IOV); Norwegian University of Science & Technology (NTNU)
RP Mercadante, S (corresponding author), La Maddalena Canc Ctr, Palermo, Italy.
EM terapiadeldolore@lamaddalenanet.it
CR Brunelli C, 2010, HEALTH QUAL LIFE OUT, V8, P0, DOI 10.1186/1477-7525-8-42
   Caraceni A, 2004, PALLIATIVE MED, V18, P177, DOI 10.1191/0269216304pm890oa
   Caraceni A, 2012, J PAIN SYMPTOM MANAG, V43, P833, DOI 10.1016/j.jpainsymman.2011.05.018
   Davies A, 2013, J PAIN SYMPTOM MANAG, V46, P619, DOI 10.1016/j.jpainsymman.2012.12.009
   Davies A, 2011, EUR J PAIN, V15, P756, DOI 10.1016/j.ejpain.2010.12.004
   Davies AN, 2008, J PAIN SYMPTOM MANAG, V35, P406, DOI 10.1016/j.jpainsymman.2007.05.010
   Gatti A, 2012, ADV THER, V29, P464, DOI 10.1007/s12325-012-0022-z
   Gómez-Batiste X, 2002, J PAIN SYMPTOM MANAG, V24, P45, DOI 10.1016/S0885-3924(02)00421-9
   Greco MT, 2011, CLIN J PAIN, V27, P9, DOI 10.1097/AJP.0b013e3181edc250
   Haugen DF, 2010, PAIN, V149, P476, DOI 10.1016/j.pain.2010.02.035
   Mercadante S, 2010, J PAIN SYMPTOM MANAG, V40, P183, DOI 10.1016/j.jpainsymman.2010.01.010
   Mercadante S, 2007, DRUG AGING, V24, P761, DOI 10.2165/00002512-200724090-00004
   Mercadante S, 2013, CURR MED RES OPIN, V29, P667, DOI 10.1185/03007995.2013.792247
   Mercadante S, 2013, CURR OPIN SUPPORT PA, V7, P139, DOI 10.1097/SPC.0b013e3283610433
   Mercadante S, 2013, CURR MED RES OPIN, V29, P93, DOI 10.1185/03007995.2012.755120
   Mercadante S, 2012, DRUGS, V72, P181, DOI 10.2165/11597260-000000000-00000
   Petzke F, 1999, J PAIN SYMPTOM MANAG, V17, P391, DOI 10.1016/S0885-3924(99)00023-8
   PORTENOY RK, 1990, PAIN, V41, P273, DOI 10.1016/0304-3959(90)90004-W
   Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8
   Portenoy RK, 2011, LANCET, V377, P2236, DOI 10.1016/S0140-6736(11)60236-5
   Swanwick M, 2001, PALLIATIVE MED, V15, P9, DOI 10.1191/026921601668030190
   Webber K, 2011, SUPPORT CARE CANCER, V19, P2041, DOI 10.1007/s00520-010-1062-z
   Zeppetella G, 2000, J PAIN SYMPTOM MANAG, V20, P87, DOI 10.1016/S0885-3924(00)00161-5
   Zeppetella G, 2014, J PAIN SYMPTOM MANAG, V47, P772, DOI 10.1016/j.jpainsymman.2013.05.020
NR 24
TC 57
Z9 62
U1 0
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0749-8047
EI 1536-5409
J9 CLIN J PAIN
JI Clin. J. Pain
PD MAR 15
PY 2015
VL 31
IS 3
BP 214
EP 221
DI 10.1097/AJP.0000000000000161
PG 8
WC Anesthesiology; Clinical Neurology
SC Anesthesiology; Neurosciences & Neurology
GA CB2RS
UT WOS:000349476300004
PM 25654429
DA 2026-01-16
ER

PT J
AU Bauml, J
   Xie, SX
   Farrar, JT
   Bowman, MA
   Li, SQ
   Bruner, D
   DeMichele, A
   Mao, JJ
AF Bauml, Joshua
   Xie, Sharon X
   Farrar, John T
   Bowman, Marjorie A
   Li, Susan Q
   Bruner, Deborah
   DeMichele, Angela
   Mao, Jun J
TI Expectancy in real and sham electroacupuncture: does believing make it so?
SO Journal of the National Cancer Institute. Monographs
LA English
DT Journal Article
AB BACKGROUND: The large placebo effect observed in prior acupuncture trials  presents a substantial challenge for interpretation of the efficacy of  acupuncture. We sought to evaluate the relationship between response expectancy,  a key component of the placebo effect over time, and treatment outcome in real  and sham electroacupuncture (EA). METHODS: We analyzed data from a randomized  controlled trial of EA and sham acupuncture (SA) for joint pain attributable to  aromatase inhibitors among women with breast cancer. Responders were identified  using the Patient Global Impression of Change instrument at Week 8 (end of  intervention). The Acupuncture Expectancy Scale (AES) was used to measure  expectancy four times during the trial. Linear mixed-effects models were used to  evaluate the association between expectancy and treatment response. RESULTS: In  the wait list control group, AES remained unchanged over treatment. In the SA  group, Baseline AES was significantly higher in responders than nonresponders  (15.5 vs 12.1, P = .005) and AES did not change over time. In the EA group,  Baseline AES scores did not differ between responders and nonresponders (14.8 vs  15.3, P = .64); however, AES increased in responders compared with nonresponders  over time (P = .004 for responder and time interaction term) with significant  difference at the end of trial for responders versus nonresponders (16.2 vs 11.7,  P = .004). CONCLUSIONS: Baseline higher response expectancy predicts treatment  response in SA, but not in EA. Divergent mechanisms may exist for how SA and EA  influence pain outcomes, and patients with low expectancy may do better with EA  than SA.
C1 Division of Hematology/Oncology (JB, AD), Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM), Department of Anesthesia and Critical Care(JTF), Department of Family Medicine and Community Health (SQL, JJM), PerelmanSchool of Medicine at the University of Pennsylvania, Philadelphia, PA (JB, AD);Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA (JB, AD,JJM)
   Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM) andDepartment of Anesthesia and Critical Care (JTF), Perelman School of Medicine atthe University of Pennsylvania, Philadelphia, PA
   Boonshoft School of Medicine,Wright State University, Dayton, OH (MAB)
   Nell Hodgson School of Nursing, EmoryUniversity, Atlanta, GA (DB).
   Division of Hematology/Oncology (JB, AD), Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM), Department of Anesthesia and Critical Care(JTF), Department of Family Medicine and Community Health (SQL, JJM), PerelmanSchool of Medicine at the University of Pennsylvania, Philadelphia, PA (JB, AD);Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA (JB, AD,JJM)
   Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM) andDepartment of Anesthesia and Critical Care (JTF), Perelman School of Medicine atthe University of Pennsylvania, Philadelphia, PA
   Boonshoft School of Medicine,Wright State University, Dayton, OH (MAB)
   Nell Hodgson School of Nursing, EmoryUniversity, Atlanta, GA (DB).
   Division of Hematology/Oncology (JB, AD), Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM), Department of Anesthesia and Critical Care(JTF), Department of Family Medicine and Community Health (SQL, JJM), PerelmanSchool of Medicine at the University of Pennsylvania, Philadelphia, PA (JB, AD);Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA (JB, AD,JJM)
   Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM) andDepartment of Anesthesia and Critical Care (JTF), Perelman School of Medicine atthe University of Pennsylvania, Philadelphia, PA
   Boonshoft School of Medicine,Wright State University, Dayton, OH (MAB)
   Nell Hodgson School of Nursing, EmoryUniversity, Atlanta, GA (DB).
   Division of Hematology/Oncology (JB, AD), Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM), Department of Anesthesia and Critical Care(JTF), Department of Family Medicine and Community Health (SQL, JJM), PerelmanSchool of Medicine at the University of Pennsylvania, Philadelphia, PA (JB, AD);Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA (JB, AD,JJM)
   Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM) andDepartment of Anesthesia and Critical Care (JTF), Perelman School of Medicine atthe University of Pennsylvania, Philadelphia, PA
   Boonshoft School of Medicine,Wright State University, Dayton, OH (MAB)
   Nell Hodgson School of Nursing, EmoryUniversity, Atlanta, GA (DB).
   Division of Hematology/Oncology (JB, AD), Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM), Department of Anesthesia and Critical Care(JTF), Department of Family Medicine and Community Health (SQL, JJM), PerelmanSchool of Medicine at the University of Pennsylvania, Philadelphia, PA (JB, AD);Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA (JB, AD,JJM)
   Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM) andDepartment of Anesthesia and Critical Care (JTF), Perelman School of Medicine atthe University of Pennsylvania, Philadelphia, PA
   Boonshoft School of Medicine,Wright State University, Dayton, OH (MAB)
   Nell Hodgson School of Nursing, EmoryUniversity, Atlanta, GA (DB).
   Division of Hematology/Oncology (JB, AD), Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM), Department of Anesthesia and Critical Care(JTF), Department of Family Medicine and Community Health (SQL, JJM), PerelmanSchool of Medicine at the University of Pennsylvania, Philadelphia, PA (JB, AD);Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA (JB, AD,JJM)
   Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM) andDepartment of Anesthesia and Critical Care (JTF), Perelman School of Medicine atthe University of Pennsylvania, Philadelphia, PA
   Boonshoft School of Medicine,Wright State University, Dayton, OH (MAB)
   Nell Hodgson School of Nursing, EmoryUniversity, Atlanta, GA (DB).
   Division of Hematology/Oncology (JB, AD), Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM), Department of Anesthesia and Critical Care(JTF), Department of Family Medicine and Community Health (SQL, JJM), PerelmanSchool of Medicine at the University of Pennsylvania, Philadelphia, PA (JB, AD);Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA (JB, AD,JJM)
   Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM) andDepartment of Anesthesia and Critical Care (JTF), Perelman School of Medicine atthe University of Pennsylvania, Philadelphia, PA
   Boonshoft School of Medicine,Wright State University, Dayton, OH (MAB)
   Nell Hodgson School of Nursing, EmoryUniversity, Atlanta, GA (DB).
   Division of Hematology/Oncology (JB, AD), Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM), Department of Anesthesia and Critical Care(JTF), Department of Family Medicine and Community Health (SQL, JJM), PerelmanSchool of Medicine at the University of Pennsylvania, Philadelphia, PA (JB, AD);Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA (JB, AD,JJM)
   Center for Clinical Epidemiology and Biostatistics (SXX, JTF, AD, JJM) andDepartment of Anesthesia and Critical Care (JTF), Perelman School of Medicine atthe University of Pennsylvania, Philadelphia, PA
   Boonshoft School of Medicine,Wright State University, Dayton, OH (MAB)
   Nell Hodgson School of Nursing, EmoryUniversity, Atlanta, GA (DB). jun.mao@uphs.upenn.edu.
NR 0
TC 0
SN 1745-661
EI 1052-677
J9 J Natl Cancer Inst Monogr
PD MAR 10
PY 2015
VL 2014
IS 50
BP 302
EP 7
DI 10.1093/jncimonographs/lgu029
PG -295
WC Adult; Aged; Aromatase Inhibitors; adverse effects; Arthralgia; chemically induced; Breast Neoplasms; drug therapy; Electroacupuncture; psychology; Emotions; Female; Humans; Middle Aged; Placebo Effect; Placebos; Treatment Outcome
UT PubMed:25749596
PM 25749596
DA 2015-03-10
ER

PT J
AU Berberian, P
   Obimba, C
   Glickman-Simon, R
   Sethi, T
AF Berberian, Peter
   Obimba, Chinyere
   Glickman-Simon, Richard
   Sethi, Tanmeet
TI HERBS FOR LOW-BACK PAIN, ACUPUNCTURE FOR PSYCHOLOGICAL DISTRESS, OSTEOPATHIC MANIPULATIVE THERAPY FOR CHRONIC MIGRAINE, HONEY DRESSINGS FOR BURNS, VEGETARIAN DIET AND RISK OF COLORECTAL CANCER
SO EXPLORE-THE JOURNAL OF SCIENCE AND HEALING
LA English
DT Editorial Material
ID primary-care patients; headache impact; conventional treatment; integrative treatment; topical application; general-population; prevalence; depression; meat; complementary
C1 [Glickman-Simon, Richard] Tufts Univ, Sch Med, Publ Hlth & Family Med, Boston, MA 02111 USA.
   [Glickman-Simon, Richard] DynaMed, Ipswich, MA USA.
   [Sethi, Tanmeet] Swedish Cherry Hill Family Med Residency Program, Seattle, WA USA.
C3 Tufts University; Swedish Health Services
CR Unknown -, 2011, CONT UPD PROJ REP FO, V0, P0
   Unknown -, 2007, FOOD NUTR PHYS ACT P, V0, P0
   Unknown -, 2014, COCHRANE DATABASE SY, V0, P0
   Unknown -, 1997, BEE PRODUCTS PROPERT, V0, P0
   Unknown -, 2002, HEART VIEWS, V0, P0
   Unknown -, 1900, DOI 10.1177/0333102413485658, V0, P0
   Arvidsdotter T, 2014, BMC COMPLEM ALTERN M, V14, P0, DOI 10.1186/1472-6882-14-210
   Arvidsdotter T, 2013, BMC COMPLEM ALTERN M, V13, P0, DOI 10.1186/1472-6882-13-308
   Astin JA, 2002, CEPHALALGIA, V22, P617, DOI 10.1046/j.1468-2982.2002.00423.x
   BERGMAN A, 1983, AM J SURG, V145, P374, DOI 10.1016/0002-9610(83)90204-0
   Blumenthal Mark, 1998, COMPLETE GERMAN COMM, V0, P0
   Cerritelli F, 2015, COMPLEMENT THER MED, V23, P149, DOI 10.1016/j.ctim.2015.01.011
   Chan DSM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027218
   Chrubasik S, 1999, EUR J ANAESTH, V16, P118
   Chrubasik S, 2010, PHYTOTHER RES, V24, P1877, DOI 10.1002/ptr.3335
   Chrubasik S, 1996, PHYTOMEDICINE, V3, P1, DOI 10.1016/S0944-7113(96)80003-1
   Chrubasik S, 2000, AM J MED, V109, P9, DOI 10.1016/S0002-9343(00)00442-3
   Coeytaux RR, 2006, J CLIN EPIDEMIOL, V59, P374, DOI 10.1016/j.jclinepi.2005.05.010
   Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325
   Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929
   Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X
   Daly EJ, 2010, ANN CLIN PSYCHIATRY, V22, P43
   Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd
   Eisenberg DM, 2012, J ALTERN COMPLEM MED, V18, P354, DOI 10.1089/acm.2011.0408
   Frass M, 2012, OCHSNER J, V12, P45
   Frerick H, 2003, PAIN, V106, P59, DOI 10.1016/S0304-3959(03)00278-1
   Fu XB, 2001, WOUND REPAIR REGEN, V9, P2, DOI 10.1046/j.1524-475x.2001.00002.x
   Gagnier Joel J, 2004, BMC COMPLEMENT ALTERN MED, V4, P13, DOI 10.1186/1472-6882-4-13
   Grabois M, 2005, AM J PHYS MED REHAB, V84, PS29, DOI 10.1097/01.PHM.0000154908.76436.C2
   Johnson A, 1992, OSTOMY WOUND MANAGE, V38, P36
   Jull AB, 2015, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD005083.pub4
   Jull AB, 2008, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD005083.pub2
   Keitel WG, 2001, ARZNEIMITTELFORSCH, V51, P896
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   Kessler RC, 2001, AM J PSYCHIAT, V158, P289, DOI 10.1176/appi.ajp.158.2.289
   Key TJ, 2009, AM J CLIN NUTR, V89, PS1620, DOI 10.3945/ajcn.2009.26736M
   Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193
   Lawler SP, 2006, ANN BEHAV MED, V32, P50, DOI 10.1207/s15324796abm3201_6
   Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x
   Molan P, 2001, BEE WORLD, V82, P22, DOI 10.1080/0005772X.2001.11099498
   Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164
   Orlich MJ, 2015, JAMA INTERN MED, V175, P767, DOI 10.1001/jamainternmed.2015.59
   Oryan A, 1998, J VET MED A, V45, P181, DOI 10.1111/j.1439-0442.1998.tb00815.x
   Robinson KL, 2004, ANN EPIDEMIOL, V14, P467, DOI 10.1016/j.annepidem.2003.11.007
   Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x
   Tantamango-Bartley Y, 2013, CANCER EPIDEM BIOMAR, V22, P286, DOI 10.1158/1055-9965.EPI-12-1060
   Voigt K, 2011, J ALTERN COMPLEM MED, V17, P225, DOI 10.1089/acm.2009.0673
   Wasiak J, 2013, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD002106.pub4
   Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890
NR 52
TC 2
Z9 3
U1 1
U2 37
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1550-8307
EI 1878-7541
J9 EXPLORE-NY
JI Explore-J Sci. Heal.
PD SEP-OCT 15
PY 2015
VL 11
IS 5
BP 410
EP 414
DI 10.1016/j.explore.2015.07.011
PG 5
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CQ7JT
UT WOS:000360780500012
PM 26238168
DA 2026-01-16
ER

PT J
AU Giron, PS
   Haddad, CA
   Lopes, de Almeida Rizzi SK
   Nazário, AC
   Facina, G
AF Giron, Patricia Santolia
   Haddad, Cinira Assad Simão
   Lopes de Almeida Rizzi, Samantha Karlla
   Nazário, Afonso Celso Pinto
   Facina, Gil
TI Effectiveness of acupuncture in rehabilitation of physical and functional
SO Supportive care in cancer : official journal of the Multinational Association of
LA English
DT Journal Article
DE Acupuncture; Breast cancer; Depression; Rehabilitation; Upper limb function
AB PURPOSE: The purpose of the study is to verify the effectiveness of acupuncture  in rehabilitation of physical and functional disorders of women undergoing breast  cancer surgery on the following parameters: pain, range of motion, upper limb  function, and depressive symptoms. METHODS: The following are the inclusion  criteria: women aged more than 18 years with scapular girdle and upper limb pain  after 3 months of surgery and with pain ≥3 in visual analog scale. Patients were  divided into two randomized groups which received weekly treatment during 10  sessions. Kinesiotherapy group (G1)-treated with a predefined kinesiotherapy  protocol of 30 min. Group Acupuncture + Kinesiotherapy (G2)-treated with the same  kinesiotherapy group protocol followed by another 30 min of acupuncture, used in  predefined points. Both groups performed physical examination and answered the  upper limb function and depressive symptoms questionnaires. RESULTS: Forty-eight  patients completed the treatment, 24 in each group. Regarding the pain, the two  groups had statistically significant improvement in all evaluated moments. In the  analysis of depression, it improved significantly only in G1 in the comparison  between the first and the tenth session. The upper limb function had improvement  in G1 only in the comparison between the first and the tenth session and in G2,  in the three evaluation moments. The range of motion (ROM) showed improvement in  all evaluated movements. CONCLUSIONS: There was no difference between groups.  Both groups showed statistically significant improvement of the items assessed:  pain, depression, upper limb function, and ADM, and there was no difference  between them.
C1 , Rua Marselhesa, 249- Vila Mariana, São Paulo, SP, Brazil, 04020060. patysantolia@hotmail.com.
   Department of Gynecology, Federal University of Sao Paulo, Sao Paulo, Brazil.
   Department of Gynecology, Federal University of Sao Paulo, Sao Paulo, Brazil.
   Department of Gynecology, Federal University of Sao Paulo, Sao Paulo, Brazil.
   Department of Gynecology, Federal University of Sao Paulo, Sao Paulo, Brazil.
NR 0
TC 0
SN 1433-733
EI 
J9 Support Care Cancer
PD DEC 17
PY 2015
VL 24
IS 6
BP 2491
EP 6
DI 10.1007/s00520-015-3054-5
PG -2485
WC Acupuncture Therapy; methods; Adult; Aged; Arm; physiopathology; Breast Neoplasms; physiopathology; Depression; etiology; Female; Humans; Male; Middle Aged; Pain Measurement; Range of Motion, Articular; Treatment Outcome
UT PubMed:26670916
PM 26670916
DA 2015-12-17
ER

PT J
AU Yamasaki, SC
   Mendes, MT
   Alponti, RF
   Silveira, PF
AF Yamasaki, Simone C.
   Mendes, Mariana T.
   Alponti, Rafaela F.
   Silveira, Paulo F.
TI Efficacy of parenteral administration of bee venom in experimental arthritis in the rat: A comparison with methotrexate
SO TOXICON
LA English
DT Article
DE Aminopeptidase; Bee venom; Animal venom; Disease-modifying anti-rheumatic drug; Experimental arthritis; Complementary and alternative medicine
ID dipeptidyl-peptidase-iv; collagen-induced arthritis; renin-angiotensin system; blood mononuclear-cells; rheumatoid-arthritis; aminopeptidase activity; acupuncture apipuncture; neutral aminopeptidase; acupoint stimulation; recent insights
AB The use of bee venom (BV) to treat inflammation and pain in arthritis has become increasingly common. This study aimed to compare the effects of BV and methotrexate (MTX), the most used disease-modifying anti-rheumatic drug, in arthritic rats. Edema, erythema, cyanosis, hyperalgesia, reduction of the body mass gain, high circulating tumor necrosis factor alpha (TNF-alpha.) and anti-type II collagen antibodies (AACII), and altered activity of basic (APB) and neutral (APN) aminopeptidases and dipeptidyl peptidase IV (DPPIV) are present in arthritic rats. MTX and/or BV do not affect AACII in healthy or arthritic individuals, but restores TNF-alpha to normal levels in arthritic rats. BV restores body mass gain to normal levels and MTX ameliorates body mass gain. BV contains DPPIV. BV restores APN in synovial fluid (SF) and in soluble fraction (S) from synovial tissue (ST), and DPPIV in solubilized membrane-bound fraction (M) from peripheral blood mononuclear cells (PBMCs). MTX restores APN of SF, as well as ameliorates APB of S-PBMCs, APN of S-ST and DPPIV of M-PBMCs. The combination therapy does not overcome the effects of BV or MTX alone on the peptidase activities. Edema is ameliorated by MTX or BV alone. MTX, but not BV, is effective in reducing hyperalgesia. Data show that anti-arthritic effects of BV at nonacupoints are not negligible when compared with MTX. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Yamasaki, Simone C.; Mendes, Mariana T.; Alponti, Rafaela F.; Silveira, Paulo F.] Inst Butantan, Unit Translat Endocrine Physiol & Pharmacol, Pharmacol Lab, BR-05503900 Sao Paulo, SP, Brazil.
   [Yamasaki, Simone C.] Inst Butantan, Interdept Biotechnol Program, BR-05508900 Sao Paulo, Brazil.
   [Yamasaki, Simone C.] Univ Sao Paulo, BR-05508900 Sao Paulo, Brazil.
C3 Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo
RP Silveira, PF (corresponding author), Inst Butantan, Unit Translat Endocrine Physiol & Pharmacol, Pharmacol Lab, Av Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
EM paulo.silveira@butantan.gov.br
FU FAPESP (Sao Paulo Research Foundation, Brazil) [2007/08311-4]; CNPq (National Council for Scientific and Technological Development, Brazil) [PQ-302533/2011-7]; FAPESP; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/08311-4] Funding Source: FAPESP
CR Abolmaali SS, 2013, CANCER CHEMOTH PHARM, V71, P1115, DOI 10.1007/s00280-012-2062-0
   Al-Abd AM, 2010, EUR J PHARMACOL, V644, P245, DOI 10.1016/j.ejphar.2010.07.006
   Alponti RF, 2010, OBESITY, V18, P1312, DOI 10.1038/oby.2009.378
   Ansorge S, 2009, CLIN CHEM LAB MED, V47, P253, DOI 10.1515/CCLM.2009.063
   Baek YH, 2006, BRAIN RES, V1073, P305, DOI 10.1016/j.brainres.2005.12.086
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen HS, 2006, EXP NEUROL, V200, P386, DOI 10.1016/j.expneurol.2006.02.118
   Cutolo M, 2001, ANN RHEUM DIS, V60, P729, DOI 10.1136/ard.60.8.729
   De Meester I, 2003, ADV EXP MED BIOL, V524, P3
   Doan T, 2005, J CLIN PHARMACOL, V45, P751, DOI 10.1177/0091270005277938
   Rached ICFS, 2010, J ETHNOPHARMACOL, V130, P175, DOI 10.1016/j.jep.2010.04.015
   Gasparello-Clemente E, 2003, PEPTIDES, V24, P1367, DOI 10.1016/j.peptides.2003.08.006
   Goldbergova MP, 2012, MOL IMMUNOL, V52, P273, DOI 10.1016/j.molimm.2012.06.006
   Guerrero ATG, 2006, PHARMACOL BIOCHEM BE, V84, P244, DOI 10.1016/j.pbb.2006.05.008
   Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176
   Hartog A, 2009, BMC MUSCULOSKEL DIS, V10, P0, DOI 10.1186/1471-2474-10-59
   Hashimoto T, 2011, ARTHRITIS RES THER, V13, P0, DOI 10.1186/ar3470
   Hattori A, 2004, BIOL PHARM BULL, V27, P777, DOI 10.1248/bpb.27.777
   Hietala MA, 2004, EUR J IMMUNOL, V34, P1208, DOI 10.1002/eji.200424895
   IwakiEgawa S, 1997, CELL IMMUNOL, V178, P180, DOI 10.1006/cimm.1997.1123
   Kang SS, 2002, AM J CHINESE MED, V30, P73, DOI 10.1142/S0192415X02000089
   Kwon YB, 2001, ACUPUNCTURE ELECTRO, V26, P59, DOI 10.3727/036012901816356054
   Lee JD, 2005, EVID-BASED COMPL ALT, V2, P79, DOI 10.1093/ecam/neh070
   Lee VSY, 2007, INSECT MOL BIOL, V16, P231, DOI 10.1111/j.1365-2583.2006.00718.x
   Li Y, 2011, RHEUMATOL INT, V32, P2415
   Liu Xi-De, 2008, ZHEN CI YAN JIU, V33, P197
   Mantle D, 1999, CLIN CHIM ACTA, V284, P45, DOI 10.1016/S0009-8981(99)00055-8
   Martínez-Martos JM, 2011, BREAST, V20, P444, DOI 10.1016/j.breast.2011.04.008
   Mendes MT, 2013, OPEN J. RHEUMATOL. AUTOIMMUN. DIS, V3, P255, DOI 10.4236/ojra.2013.34040
   Mendes MT, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/730421
   Mendes MT, 2011, REGUL PEPTIDES, V167, P215, DOI 10.1016/j.regpep.2011.02.012
   Meugnier E, 2011, PHYSIOL GENOMICS, V43, P365, DOI 10.1152/physiolgenomics.00127.2010
   Mirshafiey A, 2006, IMMUNOPHARM IMMUNOT, V28, P397, DOI 10.1080/08923970600927447
   Nandakumar KS, 2010, CELL TISSUE RES, V339, P213, DOI 10.1007/s00441-009-0816-8
   Olivo RA, 2008, CLIN DEV IMMUNOL, V2008, P0
   Olivo RA, 2005, BIOCHEM PHARMACOL, V69, P1441, DOI 10.1016/j.bcp.2005.03.002
   Ospelt C, 2010, ARTHRITIS RHEUM-US, V62, P1224, DOI 10.1002/art.27395
   Park HJ, 2004, ARTHRITIS RHEUM-US, V50, P3504, DOI 10.1002/art.20626
   Peiren N, 2005, BBA-PROTEINS PROTEOM, V1752, P1, DOI 10.1016/j.bbapap.2005.07.017
   Penning TD, 2002, J MED CHEM, V45, P3482, DOI 10.1021/jm0200916
   Reinhold D, 2007, ANN NY ACAD SCI, V1110, P402, DOI 10.1196/annals.1423.042
   Roh DH, 2004, J PAIN, V5, P297, DOI 10.1016/j.jpain.2004.05.003
   Roubenoff R, 2009, ARTHRITIS RES THER, V11, P0, DOI 10.1186/ar2658
   Ruiz-Ortega M, 2007, TRENDS CARDIOVAS MED, V17, P19, DOI 10.1016/j.tcm.2006.10.003
   Sakuta T, 2010, ARTHRITIS RHEUM-US, V62, P1319, DOI 10.1002/art.27384
   Sedo A, 2005, ARTHRITIS RES THER, V7, P253, DOI 10.1186/ar1852
   Simjee SU, 2007, ARTHRITIS RES THER, V9, P0, DOI 10.1186/ar2290
   Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594
   Song XQ, 2010, BIOMED PHARMACOTHER, V64, P463, DOI 10.1016/j.biopha.2010.01.007
   Sromova L, 2010, CLIN CHIM ACTA, V411, P1046, DOI 10.1016/j.cca.2010.03.034
   Stojanovich L, 2010, AUTOIMMUN REV, V9, PA271, DOI 10.1016/j.autrev.2009.11.014
   Thanawala V, 2008, CURR DRUG TARGETS, V9, P887, DOI 10.2174/138945008785909356
   Upchurch KS, 2012, RHEUMATOLOGY, V51, P28, DOI 10.1093/rheumatology/kes278
   Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279
   Williams YN, 2003, CLIN EXP IMMUNOL, V131, P68, DOI 10.1046/j.1365-2249.2003.02020.x
   Wood PB, 2009, CURR PAIN HEADACHE R, V13, P434, DOI 10.1007/s11916-009-0071-4
   Xian CJ, 2007, BONE, V41, P842, DOI 10.1016/j.bone.2007.07.021
   Yamasaki SC, 2012, REGUL PEPTIDES, V173, P47, DOI 10.1016/j.regpep.2011.09.004
   Zambotti-Villela L, 2008, J ENDOCRINOL INVEST, V31, P492, DOI 10.1007/BF03346396
NR 59
TC 10
Z9 11
U1 1
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
EI 
J9 TOXICON
JI Toxicon
PD MAY 15
PY 2015
VL 98
IS 
BP 75
EP 88
DI 10.1016/j.toxicon.2015.02.016
PG 14
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA CG6PV
UT WOS:000353425100009
PM 25727381
DA 2026-01-16
ER

PT J
AU Gorski, DH
AF Gorski, David H.
TI Author reply: the role of academic health centres to inform evidence-based integrative oncology practice
SO NATURE REVIEWS CANCER
LA English
DT Letter
ID acupuncture; pain
C1 [Gorski, David H.] Wayne State Univ, Sch Med, Dept Surg, Michael & Marian Ilitch,Univ Hlth Ctr 6C, Detroit, MI 48201 USA.
   [Gorski, David H.] Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA.
   [Gorski, David H.] Barbara Ann Karmanos Canc Inst, Dept Oncol, Detroit, MI 48201 USA.
C3 Wayne State University; Barbara Ann Karmanos Cancer Institute; Barbara Ann Karmanos Cancer Institute
RP Gorski, DH (corresponding author), Wayne State Univ, Sch Med, Dept Surg, Michael & Marian Ilitch,Univ Hlth Ctr 6C, 4201 St Antoine St, Detroit, MI 48201 USA.
EM gorskid@med.wayne.edu
CR Colquhoun D, 2013, ANESTH ANALG, V116, P1360, DOI 10.1213/ANE.0b013e31828f2d5e
   Garcia MK, 2013, J CLIN ONCOL, V31, P952, DOI 10.1200/JCO.2012.43.5818
   Gorski DH, 2014, NAT REV CANCER, V14, P692, DOI 10.1038/nrc3822
   Mao JJ, 2015, NATURE REV CANC, V0, P0
   Mao JJ, 2011, J CANCER SURVIV, V5, P8, DOI 10.1007/s11764-010-0153-7
   Newport F, 2012, GALLUP POLITICS, V0, P0
   Shen YH, 2015, CANCER-AM CANCER SOC, V121, P84, DOI 10.1002/cncr.28973
   Stauffer ME, 2011, INT J INFLAMM, V2011, P0, DOI 10.4061/2011/231926
   Tubach F, 2012, ARTHRIT CARE RES, V64, P1699, DOI 10.1002/acr.21747
   Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654
NR 10
TC 0
Z9 0
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-175X
EI 1474-1768
J9 NAT REV CANCER
JI Nat. Rev. Cancer
PD APR 15
PY 2015
VL 15
IS 4
BP 
EP 
DI 10.1038/nrc3822-c4
PG 1
WC Oncology
SC Oncology
GA CE3WI
UT WOS:000351760300012
PM 25801621
DA 2026-01-16
ER

PT J
AU Li, D
   Lee, Y
   Kim, W
   Lee, K
   Bae, H
   Kim, SK
AF Li, Dongxing
   Lee, Younju
   Kim, Woojin
   Lee, Kyungjin
   Bae, Hyunsu
   Kim, Sun Kwang
TI Analgesic Effects of Bee Venom Derived Phospholipase A2 in a Mouse Model of Oxaliplatin-Induced Neuropathic Pain
SO TOXINS
LA English
DT Article
DE phospholipase A(2); Bee Venom; oxaliplatin; neuropathic pain; noradrenergic
ID regulatory t-cells; adrenergic sensitivity; rat model; acupuncture apipuncture; thermal hyperalgesia; safety profile; spinal-cord; involvement; modulation; mechanism
AB A single infusion of oxaliplatin, which is widely used to treat metastatic colorectal cancer, induces specific sensory neurotoxicity signs that are triggered or aggravated when exposed to cold or mechanical stimuli. Bee Venom (BV) has been traditionally used in Korea to treat various pain symptoms. Our recent study demonstrated that BV alleviates oxaliplatin-induced cold allodynia in rats, via noradrenergic and serotonergic analgesic pathways. In this study, we have further investigated whether BV derived phospholipase A(2) (bvPLA(2)) attenuates oxaliplatin-induced cold and mechanical allodynia in mice and its mechanism. The behavioral signs of cold and mechanical allodynia were evaluated by acetone and a von Frey hair test on the hind paw, respectively. The significant allodynia signs were observed from one day after an oxaliplatin injection (6 mg/kg, i.p.). Daily administration of bvPLA(2) (0.2 mg/kg, i.p.) for five consecutive days markedly attenuated cold and mechanical allodynia, which was more potent than the effect of BV (1 mg/kg, i.p.). The depletion of noradrenaline by an injection of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4, 50 mg/kg, i.p.) blocked the analgesic effect of bvPLA(2), whereas the depletion of serotonin by injecting DL-p-chlorophenylalanine (PCPA, 150 mg/kg, i.p.) for three successive days did not. Furthermore, idazoxan (2-adrenegic receptor antagonist, 1 mg/kg, i.p.) completely blocked bvPLA(2)-induced anti-allodynic action, whereas prazosin (1-adrenegic antagonist, 10 mg/kg, i.p.) did not. These results suggest that bvPLA(2) treatment strongly alleviates oxaliplatin-induced acute cold and mechanical allodynia in mice through the activation of the noradrenergic system, via 2-adrenegic receptors, but not via the serotonergic system.
C1 [Li, Dongxing; Lee, Younju; Bae, Hyunsu; Kim, Sun Kwang] Kyung Hee Univ, Coll Korean Med, Dept Physiol, Seoul 130701, South Korea.
   [Kim, Woojin; Kim, Sun Kwang] Kyung Hee Univ, Grad Sch, Dept East West Med, Seoul 130701, South Korea.
   [Lee, Kyungjin] Kyung Hee Univ, Coll Korean Med, Dept Herbol, Seoul 130701, South Korea.
C3 Kyung Hee University; Kyung Hee University; Kyung Hee University
RP Kim, SK (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Physiol, 26 Kyungheedae Ro, Seoul 130701, South Korea.
EM leedongxing@naver.com; eyounju@naver.com; thasnow@gmail.com; niceday@khu.ac.kr; hbae@khu.ac.kr; skkim77@khu.ac.kr
FU Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14 C0738]
CR Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709
   Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005
   Back SK, 2002, NEUROSCI LETT, V322, P153, DOI 10.1016/S0304-3940(02)00067-8
   Baek YH, 2006, BRAIN RES, V1073, P305, DOI 10.1016/j.brainres.2005.12.086
   BILLINGHAM ME, 1973, NATURE, V245, P163, DOI 10.1038/245163a0
   Binder A, 2007, EUR J CANCER, V43, P2658, DOI 10.1016/j.ejca.2007.07.030
   Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817
   Cassidy J, 2002, SEMIN ONCOL, V29, P11, DOI 10.1053/sonc.2002.35524
   Choi MS, 2013, CYTOKINE, V61, P256, DOI 10.1016/j.cyto.2012.10.005
   Crespi F, 2009, BRAIN RES, V1281, P35, DOI 10.1016/j.brainres.2009.05.021
   De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904
   de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938
   Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P317, DOI 10.1016/S1040-8428(01)00219-0
   Extra JM, 1998, SEMIN ONCOL, V25, P13
   Farquhar-Smith Paul, 2011, CURR OPIN SUPPORT PALLIAT CARE, V5, P1, DOI 10.1097/SPC.0b013e328342f9cc
   Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029
   Grothey A, 2003, SEMIN ONCOL, V30, P5, DOI 10.1016/S0093-7754(03)00399-3
   Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X
   Hord AH, 2001, ANESTH ANALG, V92, P1558, DOI 10.1097/00000539-200106000-00042
   Jeong JK, 2011, INT J MOL MED, V28, P867, DOI 10.3892/ijmm.2011.730
   Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090
   Joseph EK, 2009, J PAIN, V10, P534, DOI 10.1016/j.jpain.2008.12.003
   Kang SY, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/784713
   Kang SY, 2012, J PAIN, V13, P155, DOI 10.1016/j.jpain.2011.10.012
   Kannarkat G, 2007, CURR OPIN NEUROL, V20, P719
   Kim HW, 2005, PHARMACOL RES, V51, P183, DOI 10.1016/j.phrs.2004.07.011
   Kim H, 2015, KIDNEY INT, V88, P550, DOI 10.1038/ki.2015.147
   Kim H, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114726
   KORENMAN EMD, 1981, EXP NEUROL, V72, P63, DOI 10.1016/0014-4886(81)90127-8
   Kudo T, 2011, NEUROSCI LETT, V503, P20, DOI 10.1016/j.neulet.2011.07.056
   Kwon YB, 2001, NEUROSCI LETT, V308, P133, DOI 10.1016/S0304-3940(01)01989-9
   Lamont LA, 2000, VET CLIN N AM-SMALL, V30, P703, DOI 10.1016/S0195-5616(08)70003-2
   Lee DH, 1999, J NEUROPHYSIOL, V81, P2226, DOI 10.1152/jn.1999.81.5.2226
   Lee JH, 2014, BMC COMPLEM ALTERN M, V14, P0, DOI 10.1186/1472-6882-14-471
   Leem JW, 1997, NEUROSCI LETT, V234, P39, DOI 10.1016/S0304-3940(97)00658-7
   Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559
   Lim BS, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/369324
   Ling B, 2008, NEUROPHARMACOLOGY, V55, P724, DOI 10.1016/j.neuropharm.2008.06.007
   Ling B, 2007, TOXICOLOGY, V234, P176, DOI 10.1016/j.tox.2007.02.013
   López-Vales R, 2011, FASEB J, V25, P4240, DOI 10.1096/fj.11-183186
   Maleki N, 2005, INT IMMUNOPHARMACOL, V5, P1723, DOI 10.1016/j.intimp.2005.05.012
   Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6
   Monti MC, 2006, CHEMBIOCHEM, V7, P971, DOI 10.1002/cbic.200500454
   Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024
   Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055
   Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001
   Roh DH, 2004, J PAIN, V5, P297, DOI 10.1016/j.jpain.2004.05.003
   Scullion GA, 2009, NEUROSCIENCE, V164, P415, DOI 10.1016/j.neuroscience.2009.08.046
   Shibata K, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023510
   SOMERFIELD SD, 1988, J RHEUMATOL, V15, P1878
   TRACEY DJ, 1995, PAIN, V60, P317, DOI 10.1016/0304-3959(94)00141-Z
   Yoon SY, 2013, BIOL PHARM BULL, V36, P1787, DOI 10.1248/bpb.b13-00469
   Zarrindast MR, 2002, BEHAV PHARMACOL, V13, P117, DOI 10.1097/00008877-200203000-00003
   Zhang JM, 1997, PAIN, V72, P51, DOI 10.1016/S0304-3959(97)00013-4
   Zhao HX, 2003, ANTIMICROB AGENTS CH, V47, P965, DOI 10.1128/AAC.47.3.965-971.2003
   Zhu JX, 2001, J PHYSIOL-LONDON, V530, P431, DOI 10.1111/j.1469-7793.2001.0431k.x
NR 56
TC 41
Z9 45
U1 3
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6651
EI 
J9 TOXINS
JI Toxins
PD JUL 15
PY 2015
VL 7
IS 7
BP 2422
EP 2434
DI 10.3390/toxins7072422
PG 13
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA CO5HW
UT WOS:000359191200006
PM 26131771
DA 2026-01-16
ER

PT J
AU Glickman-Simon, R
   Lindsay, T
AF Glickman-Simon, Richard
   Lindsay, Tammy
TI CANNABINOIDS FOR CHRONIC PAIN, MEDITERRANEAN DIET AND COGNITIVE FUNCTION; VITAMIN E AND SELENIUM FOR CATARACT PREVENTION; ACUPUNCTURE AND MOXIBUSTION FOR PRIMARY DYSMENORRHEA; MASSAGE THERAPY AND IN VITRO FERTILIZATION
SO EXPLORE-THE JOURNAL OF SCIENCE AND HEALING
LA English
DT Editorial Material
ID age-related cataract; randomized clinical-trial; senile cataract; metaanalysis; supplementation; disease; cancer; women; lens; men
C1 [Glickman-Simon, Richard] Tufts Univ, Sch Med, Publ Hlth & family Med, Boston, MA 02111 USA.
   [Lindsay, Tammy] Missouri Highlands Hlth Care, Ellington, CO 63638 USA.
C3 Tufts University
RP Glickman-Simon, R (corresponding author), Tufts Univ, Sch Med, Publ Hlth & family Med, Boston, MA 02111 USA.
CR Allen D, 2006, BMJ-BRIT MED J, V333, P128, DOI 10.1136/bmj.333.7559.128
   Chiu CJ, 2007, EXP EYE RES, V84, P229, DOI 10.1016/j.exer.2006.05.015
   Christen WG, 2008, OPHTHALMOLOGY, V115, P822, DOI 10.1016/j.ophtha.2007.06.040
   Christen WG, 2015, JAMA OPHTHALMOL, V133, P17, DOI 10.1001/jamaophthalmol.2014.3478
   Christen WG, 2014, OPHTHALMOLOGY, V121, P525, DOI 10.1016/j.ophtha.2013.09.038
   Christen WG, 2010, ARCH OPHTHALMOL-CHIC, V128, P1397, DOI 10.1001/archophthalmol.2010.266
   Coco AS, 1999, AM FAM PHYSICIAN, V60, P489
   Cooper C, 2013, BRIT J PSYCHIAT, V203, P255, DOI 10.1192/bjp.bp.113.127811
   Cousineau TM, 2007, BEST PRACT RES CL OB, V21, P293, DOI 10.1016/j.bpobgyn.2006.12.003
   Ebbesen SMS, 2009, HUM REPROD, V24, P2173, DOI 10.1093/humrep/dep185
   Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303
   French L, 2005, AM FAM PHYSICIAN, V71, P285
   GERSTER H, 1989, Z ERNAHRUNGSWISS, V28, P56, DOI 10.1007/BF02025566
   Grotenhermen F, 2012, DTSCH ARZTEBL INT, V109, P495, DOI 10.3238/arztebl.2012.0495
   Hazekamp A, 2013, J PSYCHOACTIVE DRUGS, V45, P199, DOI 10.1080/02791072.2013.805976
   Hurd MD, 2013, NEW ENGL J MED, V369, P489, DOI 10.1056/NEJMsa1204629
   JACQUES PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P337, DOI 10.1001/archopht.1988.01060130363022
   JACQUES PF, 1988, AM J CLIN NUTR, V48, P152, DOI 10.1093/ajcn/48.1.152
   Kannan P, 2014, J PHYSIOTHER, V60, P13, DOI 10.1016/j.jphys.2013.12.003
   Kondoh E, 2009, HUM REPROD, V24, P945, DOI 10.1093/humrep/den461
   Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864
   Maraini G, 2008, OPHTHALMOLOGY, V115, P599, DOI 10.1016/j.ophtha.2008.01.005
   McNeil JJ, 2004, OPHTHALMOLOGY, V111, P75, DOI 10.1016/j.ophtha.2003.04.009
   Okhowat J, 2015, ALTERN THER HEALTH M, V21, P16
   Pinborg A, 2008, BRIT MED J, V336, P517, DOI 10.1136/bmj.39503.643727.80
   Qu F, 2012, J ALTERN COMPLEM MED, V18, P429, DOI 10.1089/acm.2011.0158
   RASI V, 1992, ANN OPHTHALMOL, V24, P459
   Salvatore P, 2001, FERTIL STERIL, V75, P1119, DOI 10.1016/S0015-0282(01)01775-7
   SPERDUTO RD, 1993, ARCH OPHTHALMOL-CHIC, V111, P1246, DOI 10.1001/archopht.1993.01090090098027
   SUNDELL G, 1990, BRIT J OBSTET GYNAEC, V97, P588, DOI 10.1111/j.1471-0528.1990.tb02545.x
   Teikari JM, 1998, J EPIDEMIOL COMMUN H, V52, P468, DOI 10.1136/jech.52.7.468
   Tian X, 2014, ALTERN THER HEALTH M, V20, P33
   Valls-Pedret C, 2015, JAMA INTERN MED, V175, P1094, DOI 10.1001/jamainternmed.2015.1668
   von Bernhardi R, 2012, ANTIOXID REDOX SIGN, V16, P974, DOI 10.1089/ars.2011.4082
   Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358
   Yeum KJ, 1999, CURR EYE RES, V19, P502, DOI 10.1076/ceyr.19.6.502.5282
   2015, 1900, V21, V0, P16
   2015, 1900, V175, V0, P1094
   2015, 1900, V313, V0, P2456
   2014, 1900, V20, V0, P33
   2015, 1900, V133, V0, P17
NR 43
TC 4
Z9 7
U1 0
U2 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1550-8307
EI 1878-7541
J9 EXPLORE-NY
JI Explore-J Sci. Heal.
PD NOV-DEC 15
PY 2015
VL 11
IS 6
BP 489
EP 493
DI 10.1016/j.explore.2015.08.013
PG 5
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CY1DI
UT WOS:000366146500015
PM 26525669
DA 2026-01-16
ER

PT J
AU Mallory, MJ
   Croghan, KA
   Sandhu, NP
   Lemaine, V
   Degnim, AC
   Bauer, BA
   Cha, SS
   Croghan, IT
AF Mallory, Molly J.
   Croghan, Katrina A.
   Sandhu, Nicole P.
   Lemaine, Valerie
   Degnim, Amy C.
   Bauer, Brent A.
   Cha, Stephen S.
   Croghan, Ivana T.
TI Acupuncture in the Postoperative Setting for Breast Cancer Patients: A Feasibility Study
SO AMERICAN JOURNAL OF CHINESE MEDICINE
LA English
DT Article
DE Acupuncture; Breast Cancer; Breast Reconstruction; Feasibility; Mastectomy; Postsurgical; Quality of Life
ID complementary/alternative medicine; pain; electroacupuncture
AB Acupuncture is used to treat a variety of symptoms and conditions associated with cancer and cancer treatments. The present study was performed to evaluate the feasibility of providing acupuncture in the hospital setting for breast cancer patients and to evaluate the short-term effect of acupuncture on stress, anxiety, and pain. This was an open label study conducted at Mayo Clinic Hospital, Methodist and Saint Marys Campus, Rochester, Minnesota. A total of 20 adult breast cancer patients undergoing mastectomy and/or breast reconstruction were recruited and offered daily acupuncture intervention beginning postoperative day 1 and continuing for the duration of the hospital stay. Outcome measures included the Symptom Visual Analog Scale (VAS) and Satisfaction Question and Was-it-Worth-it (WIWI) Questionnaire. It was found that acupuncture is a feasible option for postoperative breast cancer patients. In addition, it can significantly decrease the levels of anxiety (p = 0.0065), tension/muscular discomfort (p < 0.001) and pain (p = 0.023). The association between acupuncture and relaxation was found to be statistically borderline (p = 0.053). This feasibility study showed that acupuncture can be integrated into a busy postsurgical clinical practice. These results also suggest that acupuncture may be an important intervention in the postoperative setting for breast cancer patients.
C1 [Mallory, Molly J.; Sandhu, Nicole P.; Bauer, Brent A.] Mayo Clin, Dept Med, Rochester, MN 55905 USA.
   [Croghan, Katrina A.] Mayo Clin, Dept Med Res, Rochester, MN 55905 USA.
   [Croghan, Ivana T.] Mayo Clin, Rochester, MN 55905 USA.
   [Lemaine, Valerie; Degnim, Amy C.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA.
   [Cha, Stephen S.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic
RP Mallory, MJ (corresponding author), Mayo Clin, Dept Med, 200 First St SW, Rochester, MN 55905 USA.
EM mallory.molly@mayo.edu
FU General Internal Medicine Faculty Development Committee; Career Development Award; Mayo Clinic Department of Medicine Clinical Research Office; Center for Clinical and Translational Science [UL1 TR000135]
CR An LX, 2014, AM J CHINESE MED, V42, P1099, DOI 10.1142/S0192415X14500682
   Unknown -, 2012, BREAST CANCER RISK IN AMERICAN WOMEN, V0, P0
   Boon H, 2000, J CLIN ONCOL, V18, P2515, DOI 10.1200/JCO.2000.18.13.2515
   Cohen Andrea J, 2005, INTEGR CANCER THER, V4, P131, DOI 10.1177/1534735405276419
   Deng G, 2005, CA-CANCER J CLIN, V55, P109, DOI 10.3322/canjclin.55.2.109
   Dong ZQ, 2013, AM J CHINESE MED, V41, P459, DOI 10.1142/S0192415X1350033X
   Epplein M, 2011, J CLIN ONCOL, V29, P406, DOI 10.1200/JCO.2010.30.6951
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Korinenko Y, 2009, ANN THORAC SURG, V88, P537, DOI 10.1016/j.athoracsur.2009.04.106
   LaRiccia PJ, 2008, MED ACUPUNCT, V20, P239, DOI 10.1089/acu.2008.0634
   Lengacher Cecile A, 2002, ONCOL NURS FORUM, V29, P1445, DOI 10.1188/02.ONF.1445-1452
   Lu WD, 2008, HEMATOL ONCOL CLIN N, V22, P631, DOI 10.1016/j.hoc.2008.04.005
   Mehling WE, 2007, J PAIN SYMPTOM MANAG, V33, P258, DOI 10.1016/j.jpainsymman.2006.09.016
   Montgomery GH, 2004, HEALTH PSYCHOL, V23, P381, DOI 10.1037/0278-6133.23.4.381
   Morris KT, 2000, AM J SURG, V179, P407, DOI 10.1016/S0002-9610(00)00358-5
   Richardson MA, 2000, J CLIN ONCOL, V18, P2505, DOI 10.1200/JCO.2000.18.13.2505
   Sun Y, 2008, BRIT J ANAESTH, V101, P151, DOI 10.1093/bja/aen146
NR 20
TC 23
Z9 27
U1 1
U2 27
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0192-415X
EI 1793-6853
J9 AM J CHINESE MED
JI Am. J. Chin. Med.
PD JUN 15
PY 2015
VL 43
IS 1
BP 45
EP 56
DI 10.1142/S0192415X15500032
PG 12
WC Integrative & Complementary Medicine; Medicine, General & Internal
SC Integrative & Complementary Medicine; General & Internal Medicine
GA CB5WS
UT WOS:000349699300003
PM 25682785
DA 2026-01-16
ER

PT J
AU Li, H
   Shang, XJ
   Dong, QR
AF Li, Huan
   Shang, Xiao-Jun
   Dong, Qi-Rong
TI Effects of transcutaneous electrical nerve stimulation on rats with the third
SO Acupuncture in medicine : journal of the British Medical Acupuncture Society
LA English
DT Journal Article
DE PAIN MANAGEMENT
AB OBJECTIVE: To investigate the analgesic and anti-inflammatory effects of  transcutaneous electrical nerve stimulation (TENS) at local or distant  acupuncture points in a rat model of the third lumbar vertebrae transverse  process syndrome. METHODS: Forty Sprague-Dawley rats were randomly divided into  control, model, model plus local acupuncture point stimulation at BL23  (model+LAS) and model plus distant acupuncture point stimulation at ST36  (model+DAS) groups. All rats except controls underwent surgical third lumbar  vertebrae transverse process syndrome modelling on day 2. Thereafter, rats in the  model+LAS and model+DAS groups were treated daily with TENS for a total of six  treatments (2/100 Hz, 30 min/day) from day 16 to day 29. Thermal pain thresholds  were measured once a week during treatment and were continued until day 57, when  local muscle tissue was sampled for RT-PCR and histopathological examination  after haematoxylin and eosin staining. mRNA expression of interleukin-1 β  (IL-1β), tumour necrosis factor-α (TNF-α) and inducible nitric oxide synthase  (iNOS) was determined. RESULTS: Thermal pain thresholds of all model rats  decreased relative to the control group. Both LAS and DAS significantly increased  the thermal pain threshold at all but one point during the treatment period.  Histopathological assessment revealed that the local muscle tissues around the  third lumbar vertebrae transverse process recovered to some degree in both the  model+LAS and model+DAS groups; however, LAS appeared to have a greater effect.  mRNA expression of IL-1β, TNF-α and iNOS in the local muscle tissues was  increased after modelling and attenuated in both model+LAS and model+DAS groups.  The beneficial effect was greater after LAS than after DAS. CONCLUSIONS: TENS at  both local (BL23) and distant (ST36) acupuncture points had a pain-relieving  effect in rats with the third lumbar vertebrae transverse process syndrome, and  LAS appeared to have greater anti-inflammatory and analgesic effects than DAS.  TRIAL REGISTRATION NUMBER: 09073.
C1 Department of Orthopaedics, The Second Affiliated Hospital of Suzhou University, Suzhou, China Department of Orthopaedics, The First People's Hospital ofChangzhou and the Third Affiliated Hospital of Suzhou University, Changzhou,China.
   Department of Orthopaedics, The First People's Hospital of Changzhou and the Third Affiliated Hospital of Suzhou University, Changzhou, China.
   Department of Orthopaedics, The Second Affiliated Hospital of Suzhou University, Suzhou, China.
NR 0
TC 0
SN 1759-987
EI 
J9 Acupunct Med
PD JUN 25
PY 2015
VL 33
IS 5
BP 400
EP 5
DI 10.1136/acupmed-2014-010752
PG -395
WC Animals; Disease Models, Animal; Low Back Pain; therapy; Lumbar Vertebrae; injuries; Male; Pain Threshold; Rats; Rats, Sprague-Dawley; Spinal Fractures; pathology; Transcutaneous Electric Nerve Stimulation
UT PubMed:26104377
PM 26104377
DA 2015-06-25
ER

PT J
AU Yeh, CH
   Chien, LC
   Chiang, YC
   Ren, DX
   Suen, LKP
AF Yeh, Chao Hsing
   Chien, Lung-Chang
   Chiang, Yi Chien
   Ren, Dianxu
   Suen, Lorna Kwai-Ping
TI Auricular Point Acupressure as an Adjunct Analgesic Treatment for Cancer Patients: A Feasibility Study
SO PAIN MANAGEMENT NURSING
LA English
DT Article
ID quality-of-life; colon-cancer; pain; acupuncture; oncology; trial; prevalence; impact; scale; lung
AB This study aimed (1) to examine the feasibility of an auricular point acupressure (APA) research protocol in terms of recruitment and for the assessment and management of pain and (2) to examine the potential APA analgesic effects for cancer patients. This study was a repeated-measures one-group design. Participants were recruited from the cancer center follow-up clinic affiliated with a large university hospital in the northeastern United States. Participants included 50 patients aged 55-87 years with a diagnosis of cancer. Participants received 7 days of APA treatment for their pain. After appropriate acupoints were identified, vaccaria seeds were carefully taped onto each selected auricular point on each ear. The study recruitment and retention rates were 92% and 91%, respectively. Importantly, the study found preliminary evidence for the analgesic effects of APA for cancer pain management. For example, by the end of the 7-day study, APA reduced pain intensity more than 55% for "worst pain" and about 57% for "average pain" and "pain intensity." Moreover, the use of pain medication was reduced during the APA treatment (e.g., 78% of patients [n = 39] took less pain medication than before the treatment). APA appears to be highly acceptable to patients with cancer-related pain. However, without a placebo control, we cannot draw conclusive evidence for the analgesic effect of APA for cancer patients. A sham group must be added to future studies to differentiate the true effects of APA from the possible psychological effects of the APA treatment. (C) 2015 by the American Society for Pain Management Nursing
C1 [Yeh, Chao Hsing; Ren, Dianxu] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA.
   [Chien, Lung-Chang] Univ Texas Sch Publ Hlth San Antonio, Div Biostat, San Antonio, TX USA.
   [Chien, Lung-Chang] Univ Texas Hlth Sci Ctr San Antonio, Res Adv Community Hlth Ctr, San Antonio, TX 78229 USA.
   [Chiang, Yi Chien] Chang Gung Univ Sci & Technol, Dept Nursing, Kwei San 33302, Tao Yuen, Taiwan.
   [Suen, Lorna Kwai-Ping] Hong Kong Polytech Univ, Sch Nursing, Kowloon, Hong Kong, Peoples R China.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas at San Antonio; Chang Gung University of Science & Technology; Hong Kong Polytechnic University
RP Chiang, YC (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, 261 Wen Hwa 1 Rd, Kwei San 33302, Tao Yuen, Taiwan.
EM ycchiang@gw.cgust.edu.tw
FU American Cancer Society [124638-PEP-13-237-01-PCSM]; Center for Research and Evaluation (CRE) Pilot/Feasibility Study Program, University of Pittsburgh (Pitt), School of Nursing (SoN); Chang Gung Memorial Hospital in Taiwan [BMRPA63]
CR Alimi D, 2000, J PAIN SYMPTOM MANAG, V19, P81, DOI 10.1016/S0885-3924(99)00140-2
   Alimi D, 2003, J CLIN ONCOL, V21, P4120, DOI 10.1200/JCO.2003.09.011
   Unknown -, 1990, REPORT OF THE WORKING GROUP ON AURICULAR ACUPUNCTURE NOMENCLATURE, V0, P0
   Unknown -, 2005, AURICULAR MEDICINE: A COMPLETE MANUAL OF AURICULAR DIAGNOSIS AND TREATMENT, V0, P0
   Barker R, 2006, ACAD EMERG MED, V13, P19, DOI 10.1197/j.aem.2005.07.014
   Benyamin R, 2008, PAIN PHYSICIAN, V11, P0
   Bradley N, 2005, J PAIN SYMPTOM MANAG, V30, P123, DOI 10.1016/j.jpainsymman.2005.02.015
   Buccheri G, 1996, EUR J CANCER, V32A, P1135, DOI 10.1016/0959-8049(95)00664-8
   Cleeland CS, 1994, ANNALS ACADEMY OF MEDICINE SINGAPORE, V23, P129
   Cowan John D, 2003, AM J HOSP PALLIAT CARE, V20, P415, DOI 10.1177/104990910302000604
   Cummings M, 2004, ACUPUNCT MED, V22, P49
   Dunbar-Jacob J, 1993, ANNALS OF BEHAVIORAL MEDICINE, V15S, P0
   Engberg Sandra, 2002, J WOUND OSTOMY CONTINENCE NURS, V29, P252, DOI 10.1067/mjw.2002.127207
   Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056
   Gottschling S, 2008, KLIN PADIATR, V220, P365, DOI 10.1055/s-0028-1086039
   Harden RN, 2005, J PAIN, V6, P364, DOI 10.1016/j.jpain.2005.01.350
   Hopkins Hollis Anne Seton, 2010, ONCOL NURS FORUM, V37, PE344, DOI 10.1188/10.ONF.E344-E348
   Irving G, 2011, J PAIN, V12, P175, DOI 10.1016/j.jpain.2010.06.013
   Lanas A, 2009, AM J MED SCI, V338, P96, DOI 10.1097/MAJ.0b013e3181ad8cd3
   Lee EJ, 2011, J PAIN SYMPTOM MANAG, V42, P589, DOI 10.1016/j.jpainsymman.2011.01.007
   Lu WD, 2010, CURR TREAT OPTION ON, V11, P141, DOI 10.1007/s11864-010-0126-0
   Mercadante S, 2000, J PAIN SYMPTOM MANAG, V20, P104, DOI 10.1016/S0885-3924(00)00160-3
   OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014
   Oleson T, 2013, AURICULOTHERAPY MANUAL: CHINESE AND WESTERN SYSTEMS OF EAR ACUPUNCTURE, V0, P0
   Peng Hao, 2010, ZHONG XI YI JIE HE XUE BAO, V8, P501
   Pignon T, 2004, INT J RADIAT ONCOL, V60, P1204, DOI 10.1016/j.ijrobp.2004.04.040
   PORTENOY RK, 1992, CANCER-AM CANCER SOC, V70, P1616, DOI 10.1002/1097-0142(19920915)70:6<1616::AID-CNCR2820700630>3.0.CO;2-7
   SAS Institute Inc, 2009, SAS I INC SAS ONLINE, V0, P0
   Suen Lorna K P, 2007, COMPLEMENT THER CLIN PRACT, V13, P63, DOI 10.1016/j.ctcp.2006.10.005
   Swanwick M, 2001, PALLIATIVE MED, V15, P9, DOI 10.1191/026921601668030190
   Tranmer JE, 2003, J PAIN SYMPTOM MANAG, V25, P420, DOI 10.1016/S0885-3924(03)00074-5
   Vickers AJ, 2010, TRIALS, V11, P0, DOI 10.1186/1745-6215-11-90
   Wang MC, 2009, J ALTERN COMPLEM MED, V15, P235, DOI 10.1089/acm.2008.0164
   Wang XS, 1999, CANCER, V86, P1848, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1848::AID-CNCR29>3.3.CO;2-D
   Wu HS, 2013, CANCER NURS, V36, P229, DOI 10.1097/NCC.0b013e3182664c95
   Yeh Mei-Ling, 2010, ACTA ANAESTHESIOL TAIWAN, V48, P80, DOI 10.1016/S1875-4597(10)60018-5
NR 36
TC 20
Z9 28
U1 2
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1524-9042
EI 1532-8635
J9 PAIN MANAG NURS
JI Pain Manag. Nurs.
PD JUN 15
PY 2015
VL 16
IS 3
BP 285
EP 293
DI 10.1016/j.pmn.2014.08.005
PG 9
WC Nursing
SC Nursing
GA CJ1AD
UT WOS:000355212500016
PM 25439120
DA 2026-01-16
ER

PT J
AU Tofthagen, C
   Boses, S
   Healy, G
   Jooma, N
AF Tofthagen, Cindy
   Boses, Sarah
   Healy, Gene
   Jooma, Nuruddin
TI Evaluation of Group Acupuncture for Cancer-Related Symptoms: A Retrospective Analysis
SO JOURNAL OF PALLIATIVE MEDICINE
LA English
DT Article
ID induced peripheral neuropathy; chemotherapy
AB Background: Acupuncture is being used for treatment of cancer-related symptoms in numerous settings, yet empirical evidence supporting the effects of acupuncture in this setting is lacking. Group acupuncture is an economical way to provide acupuncture to patients at a reduced cost. Objective: In this retrospective study we sought to evaluate the effects of group acupuncture on specific cancer-related symptoms in persons receiving outpatient cancer treatment. Methods: Patients were receiving group acupuncture treatments through an integrative oncology program in a large community oncology practice in west central Florida. A short patient-completed assessment of seven basic cancer-related symptoms using a 0-10 numeric rating scale was completed at each acupuncture treatment. Basic demographic information, including age, gender, race/ethnicity, and cancer type was obtained from the medical record. Paired sample t-tests were used to evaluate differences in symptoms before the first treatment and at the fourth treatment. Results: Fifty patients completed at least four weekly acupuncture treatments in 2014. Forty-three of them completed symptom assessments and were included in this analysis. The mean age of participants was 66.4 years. The majority of patients were white, non-Hispanic, and female. No significant improvement in symptoms were identified at the third treatment. At the time of the fourth group acupuncture, participants reported significantly less pain/numbness and problems with digestion. Discussion: The results of this study provide evidence to support the efficacy of group acupuncture for pain, neuropathy, and digestive problems in persons with cancer. A minimum of four weekly treatments may be necessary before improvements are noted. Limitations include a retrospective design, incomplete symptom evaluation, and possible response bias. Future studies of group acupuncture for cancer-related symptoms should utilize a prospective, controlled design, use validated measures to thoroughly evaluate targeted symptoms, and include a more racially and ethnically diverse sample.
C1 [Tofthagen, Cindy] Univ S Florida, Coll Nursing, Tampa, FL 33612 USA.
   [Boses, Sarah; Jooma, Nuruddin] Florida Canc Specialists, Integrat Oncol Dept, Largo, FL USA.
   [Healy, Gene] Root Healing Acupuncture, Dunedin, FL USA.
C3 State University System of Florida; University of South Florida; Florida Cancer Specialists
RP Tofthagen, C (corresponding author), Univ S Florida, Coll Nursing, 12901 Bruce B Downs Blvd,MDC22, Tampa, FL 33612 USA.
EM ctofthag@health.usf.edu
CR Bao T, 2011, PAIN RES TREATMENT, V2011, P0
   Bao T, 2014, INTEGR CANCER THER, V13, P396, DOI 10.1177/1534735414534729
   Donald GK, 2011, ACUPUNCT MED, V29, P230, DOI 10.1136/acupmed.2011.010025
   Franconi G, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/516916
   Garcia MK, 2013, J CLIN ONCOL, V31, P952, DOI 10.1200/JCO.2012.43.5818
   Haddad NE, 2014, INTEGR CANCER THER, V13, P371, DOI 10.1177/1534735413520181
   Schroeder S, 2012, ACUPUNCT MED, V30, P4, DOI 10.1136/acupmed-2011-010034
   Tas D, 2014, ASIAN PAC J CANCER P, V15, P3139, DOI 10.7314/APJCP.2014.15.7.3139
   Wong Raimond, 2006, ACUPUNCT MED, V24, P87
NR 9
TC 12
Z9 13
U1 0
U2 15
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-6218
EI 1557-7740
J9 J PALLIAT MED
JI J. Palliat. Med.
PD OCT 1
PY 2015
VL 18
IS 10
BP 878
EP 880
DI 10.1089/jpm.2015.0143
PG 3
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA CS7MY
UT WOS:000362268900015
PM 26218367
DA 2026-01-16
ER

PT J
AU Kim, G
AF Kim, Gangmi
TI Electroacupuncture for postoperative pain and gastrointestinal motility after laparoscopic appendectomy (AcuLap): study protocol for a randomized controlled trial
SO TRIALS
LA English
DT Article
DE Electroacupuncture; Laparoscopic appendectomy; Postoperative pain; Postoperative gastrointestinal motility
ID chemotherapy-induced nausea; colorectal surgery; enhanced recovery; placebo-acupuncture; cancer; care; radiotherapy; metaanalysis; management; programs
AB Background: Acupuncture is a widely serviced complementary medicine. Although acupuncture is suggested for managing postoperative ileus and pain, supporting evidence is weak. The AcuLap trial is designed to provide high-level evidence regarding whether or not electroacupuncture is effective in promoting gastrointestinal motility and controlling pain after laparoscopic surgery. Methods/design: This study is a prospective randomized controlled trial with a three-arm, parallel-group structure evaluating the efficacy of electroacupuncture for gastrointestinal motility and postoperative pain after laparoscopic appendectomy. Patients with appendicitis undergoing laparoscopic surgery are included and randomized into three groups: 1) electroacupuncture group, 2) sham acupuncture group, and 3) control group. Patients receive 1) acupuncture with electrostimulation or 2) fake electroacupuncture with sham device twice a day or 3) no acupuncture after laparoscopic appendectomy. The primary outcome is time to first passing flatus after operation. Secondary outcomes include postoperative pain, analgesics, nausea/vomiting, bowel motility, time to tolerable diet, complications, hospital stay, readmission rates, time to recovery, quality of life, medical costs, and protocol failure rate. Patients and hospital staff (physicians and nurses) are blinded to which group the patient is assigned, electroacupuncture or sham acupuncture. Data analysis personnel are blinded to group assignment among all three groups. Estimated sample size to detect a minimum difference of time to first flatus with 80 % power, 5 % significance, and 10 % drop rate is 29 x 3 groups = 87 patients. Analysis will be performed according to the intention-to-treat principle. Discussion: The AcuLap trial will provide evidence on the merits and/or demerits of electroacupuncture for bowel motility recovery and pain relief after laparoscopic appendectomy.
C1 Dongguk Univ, Coll Med, Dept Surg, Gyeongju Si 780350, Gyeongsangbuk D, South Korea.
C3 Dongguk University
RP Kim, G (corresponding author), Dongguk Univ, Coll Med, Dept Surg, 87 Dongdae Ro, Gyeongju Si 780350, Gyeongsangbuk D, South Korea.
EM gangmikim@gmail.com
FU Daegu-Gyeongbuk Surgical Society research foundation, Korea
CR Alimi D, 2003, J CLIN ONCOL, V21, P4120, DOI 10.1200/JCO.2003.09.011
   Crew Katherine D, 2007, J CANCER SURVIV, V1, P283, DOI 10.1007/s11764-007-0034-x
   Crew KD, 2010, J CLIN ONCOL, V28, P1154, DOI 10.1200/JCO.2009.23.4708
   Dang W, 1998, J TRADIT CHIN MED, V18, P31
   Deng G, 2013, ANN SURG ONCOL, V20, P1164, DOI 10.1245/s10434-012-2759-7
   Deng G, 2008, J THORAC CARDIOV SUR, V136, P1464, DOI 10.1016/j.jtcvs.2008.07.053
   Donohoe CL, 2011, SURG-J R COLL SURG E, V9, P95, DOI 10.1016/j.surge.2010.07.013
   Du YQ, 2011, WORLD CHIN J DIGESTOL, V19, P687
   DUNDEE JW, 1988, BRIT J CLIN PHARMACO, V25, P0
   DUNDEE JW, 1987, LANCET, V1, P1083
   Enblom A, 2012, ANN ONCOL, V23, P1353, DOI 10.1093/annonc/mdr402
   Enblom A, 2011, ACUPUNCT MED, V29, P94, DOI 10.1136/aim.2010.003384
   Garcia MK, 2013, J CLIN ONCOL, V31, P952, DOI 10.1200/JCO.2012.43.5818
   Garcia MK, 2008, MED ACUPUNCT, V20, P83, DOI 10.1089/acu.2008.0607
   Gottschling S, 2008, KLIN PADIATR, V220, P365, DOI 10.1055/s-0028-1086039
   He Bi-mei, 2007, ZHONGGUO ZHEN JIU, V27, P369
   Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5
   Kehlet H, 2002, AM J SURG, V183, P630, DOI 10.1016/S0002-9610(02)00866-8
   Kehlet H, 2008, LANCET, V371, P791, DOI 10.1016/S0140-6736(08)60357-8
   Lee TG, 2011, DIS COLON RECTUM, V54, P21, DOI 10.1007/DCR.0b013e3181fcdb3e
   LI QS, 1994, CHINESE MED J-PEKING, V107, P289
   Lohsiriwat V, 2014, ASIAN PAC J CANCER P, V15, P3825, DOI 10.7314/APJCP.2014.15.8.3825
   Mehling WE, 2007, J PAIN SYMPTOM MANAG, V33, P258, DOI 10.1016/j.jpainsymman.2006.09.016
   Melchart D, 2006, SUPPORT CARE CANCER, V14, P878, DOI 10.1007/s00520-006-0028-7
   Meng ZQ, 2010, WORLD J GASTROENTERO, V16, P104, DOI 10.3748/wjg.v16.i1.104
   Ng SSM, 2013, GASTROENTEROLOGY, V144, P307, DOI 10.1053/j.gastro.2012.10.050
   Nicholson A, 2014, BRIT J SURG, V101, P172, DOI 10.1002/bjs.9394
   Pfister DG, 2010, J CLIN ONCOL, V28, P2565, DOI 10.1200/JCO.2009.26.9860
   POULAIN P, 1997, ACUPUNCT MED, V15, P10
   Rockall TA, 2014, BEST PRACT RES CL GA, V28, P133, DOI 10.1016/j.bpg.2013.11.001
   Shen JN, 2000, JAMA-J AM MED ASSOC, V284, P2755, DOI 10.1001/jama.284.21.2755
   Strasberg SM, 2009, ANN SURG, V250, P177, DOI 10.1097/SLA.0b013e3181afde41
   Streitberger K, 2003, CLIN CANCER RES, V9, P2538
   Sun Bao-Mu, 2010, ZHONG XI YI JIE HE XUE BAO, V8, P641
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wong RHL, 2006, ANN THORAC SURG, V81, P2031, DOI 10.1016/j.athoracsur.2005.12.064
   XIA Y, 1986, JOURNAL OF TRADITIONAL CHINESE MEDICINE, V6, P23
   Yang Yan, 2009, ZHONGGUO ZHEN JIU, V29, P955
   Yin Shuang-hong, 2009, ZHONGGUO ZHEN JIU, V29, P459
   Yu Gui-Jie, 2014, ZHONGGUO ZHEN JIU, V34, P169
   Zhuang CL, 2013, DIS COLON RECTUM, V56, P667, DOI 10.1097/DCR.0b013e3182812842
NR 41
TC 6
Z9 7
U1 1
U2 25
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1745-6215
EI 
J9 TRIALS
JI Trials
PD OCT 14
PY 2015
VL 16
IS 
BP 
EP 
DI 10.1186/s13063-015-0981-x
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CT3MX
UT WOS:000362711900003
PM 26466590
DA 2026-01-16
ER

PT J
AU Tseng, YL
   Hsu, CH
   Tseng, HC
AF Tseng, Yi-Ling
   Hsu, Chun-Hung
   Tseng, Hui-Chen
TI [Using Acupressure to Improve Abdominal Bloating in a Hemicolectomy Patient: A
SO Hu li za zhi The journal of nursing
LA chi
DT Journal Article
DE Zusanli (ST-36); abdominal surgery; acupressure; bloating; nursing experience
AB This article describes a nursing experience applying the protocol of bilateral  Zusanli (ST-36) acupressure to reduce abdominal bloating in a colon cancer  patient who had undergone a right hemicolectomy. The period of care was between  November 13 and November 23, 2014. Data were collected through direct care,  interviews, observation, and physical assessment. The main health problems of the  patient included anxiety, surgical wound pain, and abdominal bloating. We  provided pre- and postoperative routine nursing care, wound pain management, and  the protocol of Zusanli (ST-36) acupressure for reducing abdominal bloating.  Results of care recorded the first passage of flatus and intestinal motility  during the second postoperative day, with no complaints of bloating from the  fourth postoperative day. The subject exhibited a relaxed mood and slept soundly  following each acupressure session. Furthermore, the subject reported  experiencing no abdominal bloating during the week following discharge, during  which he continued to follow the acupressure protocol. This article provides  support via an instance of nursing care for the effectiveness of the Zusanli  (ST-36) acupressure in improving abdominal bloating and thus reducing the  complications of hemicolectomy surgery.
C1 School of Nursing, Kaohsiung Medical University, Taiwan, ROC.
   Department of Traditional Chinese Medicine, Kaohsiung Medical University Hospital, Taiwan, ROC.
   School of Nursing, Kaohsiung Medical University, Taiwan, ROC. huchts@kmu.edu.tw.
NR 0
TC 0
SN 
EI 0047-262
J9 Hu Li Za Zhi
PD OCT 29
PY 2015
VL 62
IS 5
BP 96
EP 102
DI 10.6224/JN62.5.96
PG 6
WC Acupressure; Colectomy; adverse effects; Gastrointestinal Motility; Humans; Male; Middle Aged; Postoperative Complications; prevention & control
UT PubMed:26507632
PM 26507632
DA 2015-10-29
ER

PT J
AU Wu, X
   Chung, VC
   Hui, EP
   Ziea, ET
   Ng, BF
   Ho, RS
   Tsoi, KK
   Wong, SY
   Wu, JC
AF Wu, Xinyin
   Chung, Vincent C H
   Hui, Edwin P
   Ziea, Eric T C
   Ng, Bacon F L
   Ho, Robin S T
   Tsoi, Kelvin K F
   Wong, Samuel Y S
   Wu, Justin C Y
TI Effectiveness of acupuncture and related therapies for palliative care of cancer:
SO Scientific reports
LA English
DT Journal Article
AB Acupuncture and related therapies such as moxibustion and transcutaneous  electrical nerve stimulation are often used to manage cancer-related symptoms,  but their effectiveness and safety are controversial. We conducted this overview  to summarise the evidence on acupuncture for palliative care of cancer. Our  systematic review synthesised the results from clinical trials of patients with  any type of cancer. The methodological quality of the 23 systematic reviews in  this overview, assessed using the Methodological Quality of Systematic Reviews  Instrument, was found to be satisfactory. There is evidence for the therapeutic  effects of acupuncture for the management of cancer-related fatigue,  chemotherapy-induced nausea and vomiting and leucopenia in patients with cancer.  There is conflicting evidence regarding the treatment of cancer-related pain, hot  flashes and hiccups, and improving patients' quality of life. The available  evidence is currently insufficient to support or refute the potential of  acupuncture and related therapies in the management of xerostomia, dyspnea and  lymphedema and in the improvement of psychological well-being. No serious adverse  effects were reported in any study. Because acupuncture appears to be relatively  safe, it could be considered as a complementary form of palliative care for  cancer, especially for clinical problems for which conventional care options are  limited.
C1 Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong.
   Jockey Club School of Public Health and Primary Care, The Chinese University of 
   Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong.
   Jockey Club School of Public Health and Primary Care, The Chinese University of 
   Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong.
   Comprehensive Cancer Trials Unit, The Chinese University of Hong Kong, Hong Kong.
   Chinese Medicine Department, Hong Kong Hospital Authority, Hong Kong.
   Chinese Medicine Department, Hong Kong Hospital Authority, Hong Kong.
   Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong.
   Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong.
   Big Data Decision Analytics Research Centre, The Chinese University of Hong Kong, 
   Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong.
   Jockey Club School of Public Health and Primary Care, The Chinese University of 
   Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong.
   Department of Medicine &Therapeutics, The Chinese University of Hong Kong, Hong
NR 0
TC 0
SN 2045-232
EI 
J9 Sci Rep
PD NOV 27
PY 2015
VL 5
IS 
BP 16776
EP 16776
DI 10.1038/srep16776
PG 0
WC Acupuncture Therapy; adverse effects; Dyspnea; etiology; Hiccup; etiology; Humans; Nausea; etiology; Neoplasms; complications; Palliative Care; Randomized Controlled Trials as Topic; Treatment Outcome; Vomiting; etiology; Xerostomia; etiology
UT PubMed:26608664
PM 26608664
DA 2015-11-27
ER

PT J
AU Mao, JJ
AF Mao, Jun J
TI Reply to Sham procedure inadequate.
SO Cancer
LA English
DT Letter
C1 Department of Family Medicine and Community Health, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University ofPennsylvania, Philadelphia, Pennsylvania.
NR 0
TC 0
SN 1097-014
EI 
J9 Cancer
PD JAN 8
PY 2015
VL 121
IS 7
BP 1148
EP 9
DI 10.1002/cncr.29115
PG -1139
WC Anxiety; therapy; Aromatase Inhibitors; adverse effects; Arthralgia; chemically induced; Breast Neoplasms; drug therapy; Depression; therapy; Electroacupuncture; methods; Fatigue; therapy; Female; Humans; Sleep Wake Disorders; therapy
UT PubMed:25565387
PM 25565387
DA 2015-01-08
ER

PT J
AU Chang, KL
   Fillingim, R
   Hurley, RW
   Schmidt, S
AF Chang, Ku-Lang
   Fillingim, Roger
   Hurley, Robert W
   Schmidt, Siegfried
TI Chronic pain management: nonpharmacological therapies for chronic pain.
SO FP essentials
LA English
DT Journal Article
AB Nonpharmacologic therapies have become a vital part of managing chronic pain  (CP). Although these can be used as stand-alone therapies, nonpharmacologic  treatments often are used to augment and complement pharmacologic treatments (ie,  multimodal therapy). Nonpharmacologic approaches can be classified as behavioral,  cognitive, integrative, and physical therapies. Core principles in developing a  treatment plan are explaining the nature of the CP condition, setting appropriate  goals, and developing a comprehensive treatment approach and plan for adherence.  Clinicians should become familiar with these interventions so that they can offer  patients flexibility in the pain management approach. Effective noninvasive  treatment modalities for CP include behavioral therapy for short-term pain  relief; cognitive behavioral therapy for reducing long-term pain and disability;  hypnosis as adjunctive therapy; guided imagery, diaphragmatic breathing, and  muscle relaxation, especially for cancer-related pain; mindfulness-based stress  reduction for patients with chronic low back pain; acupuncture for multiple pain  conditions; combination manipulation, manual therapy, endurance exercise,  stretching, and strengthening for chronic neck pain; animal-assisted therapy; and  S-adenosyl-L-methionine for joint pain. Guidelines for use of these treatment  modalities are based on expert panel recommendations in combination with data  from randomized controlled trials.
C1 University of Florida Health Family Medicine - Hampton Oaks, 200 SW 62nd Blvd Suite D, Gainesville, FL 32608, changk@shands.ufl.edu.
   Clinical and Translational Research Building Room 3216, 2004 Mowry Road, Gainesville, FL 32610-0404, RFillingim@dental.ufl.edu.
   MCW Pain Management Center, 959 N. North Mayfair Road, Milwaukee, WI 53226, rwhurley2010@gmail.com.
   University of Florida Health Family Medicine - Hampton Oaks, 200 SW 62nd Blvd Suite D, Gainesville, FL 32608, siggy@shands.ufl.edu.
NR 0
TC 0
SN 
EI 2159-300
J9 FP Essent
PD MAY 15
PY 2015
VL 432
IS 
BP 21
EP 6
DI 
PG -15
UT PubMed:25970869
PM 25970869
DA 2015-05-15
ER

PT J
AU Liu, X
   Li, SQ
   Wang, BG
   An, LX
   Ren, XJ
   Wu, HF
AF Liu, Xing
   Li, Shuqin
   Wang, Baoguo
   An, Lixin
   Ren, Xiujun
   Wu, Haifeng
TI Intraoperative and postoperative anaesthetic and analgesic effect of multipoint transcutaneous electrical acupuncture stimulation combined with sufentanil anaesthesia in patients undergoing supratentorial craniotomy
SO ACUPUNCTURE IN MEDICINE
LA English
DT Article
ID acupoint stimulation; controlled-trial; clinical-trial; electroacupuncture; pain; recovery; nausea; pharmacokinetics; surgery
AB Objectives To investigate the anaesthetic and analgesic effect of multipoint transcutaneous electrical acupuncture stimulation (TEAS) during supratentorial tumour resection for postoperative recovery and side effects. Methods In a blinded clinical trial, 92 patients scheduled for supratentorial craniotomy under general anaesthesia were randomly allocated into either a multipoint TEAS (n=46) or a sham TEAS group (n=46). All patients received total intravenous anaesthesia (TIVA) with propofol and sufentanil. The target concentration of sufentanil was adjusted and recorded according to mean arterial pressure (MAP), heart rate (HR) and bispectral index (BIS). Patients in the TEAS group received TEAS 30 min before anaesthesia induction and this was maintained throughout the operation at four pairs of acupuncture points. Postoperative pain, recovery and side effects were evaluated. Results Eighty-eight patients completed the study. Continuous monitoring of MAP, HR and BIS showed stable values with no significant differences between the two groups (p>0.05). Sufentanil target plasma concentration in TEAS patients was significantly lower at some time points during supratentorial craniotomy, and total sufentanil consumption was significantly higher in the sham group (p<0.05). Postoperative recovery and pain were significantly improved by TEAS (p<0.001), without the postoperative side effects. Conclusions Multipoint TEAS at both proximal and distal points combined with TIVA can significantly decrease intraoperative sufentanil requirements, increase pain relief on postoperative day 1 and improve postoperative recovery of patients during supratentorial tumour resection, with no significant increase of side effects. These findings suggest that multipoint TEAS may be clinically effective as an adjunct to analgesia in intraoperative anaesthesia and postoperative pain treatment and may speed recovery.
C1 [Liu, Xing; Li, Shuqin; An, Lixin] Capital Med Univ, Tian Tan Hosp, Dept Anesthesiol, Beijing, Peoples R China.
   [Wang, Baoguo] Capital Med Univ, Sanbo Brain Hosp, Dept Anesthesiol, Beijing, Peoples R China.
   [Ren, Xiujun] Beijing Univ Chinese Med, Sch Acupuncture Moxibust & Tuina, Beijing, Peoples R China.
   [Wu, Haifeng] China Rehabil Res Ctr, Teaching Affairs Dept, Beijing, Peoples R China.
C3 Capital Medical University; Capital Medical University; Beijing University of Chinese Medicine
RP Wang, BG (corresponding author), Dept Anesthesiol, Beijing 100093, Peoples R China.
EM baoguowang766@163.com
FU National key basic research development programme (973 programme) of China [2013CB531901]
CR An LX, 2014, AM J CHINESE MED, V42, P1099, DOI 10.1142/S0192415X14500682
   An Li-xin, 2010, ZHONGGUO ZHEN JIU, V30, P669
   BOVILL JG, 1984, ANESTHESIOLOGY, V61, P502, DOI 10.1097/00000542-198411000-00004
   Cheng H, 2011, CHINESE MED J-PEKING, V124, P1229, DOI 10.3760/cma.j.issn.0366-6999.2011.08.020
   Chiu JH, 2001, AM J VET RES, V62, P178, DOI 10.2460/ajvr.2001.62.178
   Fanti L, 2003, AM J GASTROENTEROL, V98, P312, DOI 10.1016/S0002-9270(02)05899-9
   Habib AS, 2006, ANESTH ANALG, V102, P581, DOI 10.1213/01.ane.0000189217.19600.5c
   Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1
   Kvorning N, 2003, ACTA ANAESTH SCAND, V47, P818, DOI 10.1034/j.1399-6576.2003.00171.x
   Larson JD, 2010, PLAST RECONSTR SURG, V125, P989, DOI 10.1097/PRS.0b013e3181ccdc23
   Lee A, 2006, BEST PRACT RES-CLIN, V20, P303, DOI 10.1016/j.bpa.2005.10.009
   Li GY, 2013, ACUPUNCT MED, V31, P51, DOI 10.1136/acupmed-2012-010254
   Ni XL, 2012, PEDIATR ANESTH, V22, P805, DOI 10.1111/j.1460-9592.2012.03822.x
   Pomeranz B, 1996, J ALTERN COMPLEMENT MED, V2, P53, DOI 10.1089/acm.1996.2.53
   RICHARDSON PH, 1986, PAIN, V24, P15, DOI 10.1016/0304-3959(86)90023-0
   Sahmeddini MA, 2010, J ALTERN COMPLEM MED, V16, P53, DOI 10.1089/acm.2009.0288
   SHAFER SL, 1991, ANESTHESIOLOGY, V74, P53, DOI 10.1097/00000542-199101000-00010
   Si Jun-li, 2009, NAN FANG YI KE DA XUE XUE BAO, V29, P2064
   Staikou C, 2013, ARCH MED SCI, V9, P713, DOI 10.5114/aoms.2013.36898
   Tsang HC, 2011, EVID-BASED COMPL ALT, V2011, P0
   Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6
   Wang H, 2014, BRIT J ANAESTH, V112, P1075, DOI 10.1093/bja/aeu001
   Wang SM, 2008, ANESTH ANALG, V106, P611, DOI 10.1213/ane.0b013e318160644d
   Wang XQ, 2010, J NEUROSURG ANESTH, V22, P128, DOI 10.1097/ANA.0b013e3181c9fbde
   Xiujun R, 2010, REGIONAL HOMOGENEITY, V0, P333
   Yang CX, 2012, ACUPUNCTURE ELECTRO, V37, P125, DOI 10.3727/036012912X13831831256249
   Zhang Q, 2014, ANAESTHESIA, V69, P832, DOI 10.1111/anae.12639
NR 27
TC 45
Z9 55
U1 0
U2 33
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0964-5284
EI 1759-9873
J9 ACUPUNCT MED
JI Acupunct. Med.
PD AUG 15
PY 2015
VL 33
IS 4
BP 270
EP 276
DI 10.1136/acupmed-2014-010749
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CQ1UW
UT WOS:000360386600003
PM 25926298
DA 2026-01-16
ER

PT J
AU Tao, W
   Luo, X
   Cui, B
   Liang, D
   Wang, C
   Duan, Y
   Li, X
   Zhou, S
   Zhao, M
   Li, Y
   He, Y
   Wang, S
   Kelley, KW
   Jiang, P
   Liu, Q
AF Tao, Weiwei
   Luo, Xi
   Cui, Bai
   Liang, Dapeng
   Wang, Chunli
   Duan, Yangyang
   Li, Xiaofen
   Zhou, Shiyu
   Zhao, Mingjie
   Li, Yi
   He, Yumin
   Wang, Shaowu
   Kelley, Keith W
   Jiang, Ping
   Liu, Quentin
TI Practice of traditional Chinese medicine for psycho-behavioral intervention
SO Oncotarget
LA English
DT Journal Article
DE cancer; meta-analysis; psycho-behavioral interventions; quality of life; traditional Chinese medicine
AB BACKGROUND: Cancer patients suffer from diverse symptoms, including depression,  anxiety, pain, and fatigue and lower quality of life (QoL) during disease  progression. This study aimed to evaluate the benefits of Traditional Chinese  Medicine psycho-behavioral interventions (TCM PBIs) on improving QoL by  meta-analysis. RESULTS: The six TCM PBIs analyzed were acupuncture, Chinese  massage, Traditional Chinese Medicine five elements musical intervention (TCM  FEMI), Traditional Chinese Medicine dietary supplement (TCM DS), Qigong and Tai  Chi. Although both TCM PBIs and non-TCM PBIs reduced functional impairments in  cancer patients and led to pain relief, depression remission, reduced time to  flatulence following surgery and sleep improvement, TCM PBIs showed more  beneficial effects as assessed by reducing both fatigue and gastrointestinal  distress. In particular, acupuncture relieved fatigue, reduced diarrhea and  decreased time to flatulence after surgery in cancer patients, while therapeutic  Chinese massage reduced time to flatulence and time to peristaltic sound.  METHODS: Electronic literature databases (PubMed, CNKI, VIP, and Wanfang) were  searched for randomized, controlled trials conducted in China. The primary  intervention was TCM PBIs. The main outcome was health-related QoL (HR QoL)  post-treatment. We applied standard meta analytic techniques to analyze data from  papers that reached acceptable criteria. CONCLUSION: These findings demonstrate  the efficacy of TCM PBIs in improving QoL in cancer patients and establish that  TCM PBIs represent beneficial adjunctive therapies for cancer patients.
C1 Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
   Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South 
   College of Nursing, Dalian Medical University, Dalian, China.
   Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
   Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South 
   Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
   Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South 
   Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
   Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South 
   Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
   Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South 
   Department of Radiology, Second Affiliated Hospital, Dalian Medical University, Dalian, China.
   School of Public Health, Dalian Medical University, Dalian, China.
   Department of Psychology, Dalian Medical University, Dalian, China.
   Dalian Medical University Magazine, Dalian, China.
   School of Art, Dalian Medical University, Dalian, China.
   Shanghai University of Traditional Chinese Medicine, Shanghai, China.
   Department of Radiology, Second Affiliated Hospital, Dalian Medical University, Dalian, China.
   Integrative Immunology and Behavior Program, Department of Animal Sciences, College of ACES, Urbana, IL, USA.
   Department of Pathology, College of Medicine, University of Illinois at 
   Graduate School, Dalian Medical University, Dalian, China.
   Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
   Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South
NR 0
TC 0
SN 1949-255
EI 
J9 Oncotarget
PD OCT 27
PY 2015
VL 6
IS 37
BP 39725
EP 39
DI 10.18632/oncotarget.5388
PG -39686
WC Acupuncture Therapy; methods; Behavior Therapy; methods; Clinical Trials as Topic; Diet Therapy; methods; Fatigue; therapy; Female; Gastrointestinal Diseases; therapy; Humans; Male; Massage; methods; Medicine, Chinese Traditional; methods; Middle Aged; Neoplasms; physiopathology; Outcome Assessment, Health Care; methods; Pain; physiopathology; Psychotherapy; methods; Qigong; Quality of Life; Tai Ji
UT PubMed:26498685
PM 26498685
DA 2015-10-27
ER

PT J
AU Alimi, D
AF Alimi, David
TI Xerostomia induced by radiotherapy
SO THERAPEUTICS AND CLINICAL RISK MANAGEMENT
LA English
DT Letter
ID auricular acupuncture; ear acupuncture; cancer pain
C1 [Alimi, David] Univ Pittsburgh, Med Ctr, Dept Anesthesiol, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh
RP Alimi, D (corresponding author), Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA.
EM davalimi7@gmail.com
CR Alimi D, 2000, J PAIN SYMPTOM MANAG, V19, P81, DOI 10.1016/S0885-3924(99)00140-2
   Alimi D, 2003, J CLIN ONCOL, V21, P4120, DOI 10.1200/JCO.2003.09.011
   Alimi D, 2002, MED ACUPUNCT, V13, P18
   Alimi D, 2004, DOULEUR EN ONCOLOGIE, V0, P74
   Alimi D, 2012, REV ODONTOSTOMATOL, V41, P245
   Alimi D, 2014, PHOTON J RADIOLOGY, V125, P133
   Unknown -, 2011, NOMENCLATURE NORMATI, V0, P372
   Bourdiol RJ, 1980, ELEMENTS AURICULOTHE, V0, P0
   Cho ZH, 2002, J ALTERN COMPLEM MED, V8, P399, DOI 10.1089/107555302760253577
   Dorfer L, 1999, LANCET, V354, P1023, DOI 10.1016/S0140-6736(98)12242-0
   Gaudy JF, 2005, MANUEL ANALGESIE STO, V0, P193
   Gori L, 2007, EVID-BASED COMPL ALT, V4, P13, DOI 10.1093/ecam/nem106
   Jacquemin D, 2014, MANUEL SOINS PALLIAT, V0, P285
   Nogier R, 2014, MED ACUPUNCT, V26, P76, DOI 10.1089/acu.2014.1035
   Pinna R, 2015, THER CLIN RISK MANAG, V11, P171, DOI 10.2147/TCRM.S70652
   Rabischong P, 2014, MED ACUPUNCT, V26, P84, DOI 10.1089/acu.2014.1038
   Romoli M, 2014, NEUROL SCI, V35, PS189, DOI 10.1007/s10072-014-1768-7
NR 17
TC 5
Z9 5
U1 0
U2 13
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-203X
EI 
J9 THER CLIN RISK MANAG
JI Therap. Clin. Risk Manag.
PD JUN 15
PY 2015
VL 11
IS 
BP 1149
EP 1152
DI 10.2147/TCRM.S88021
PG 4
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA CO7CN
UT WOS:000359315200001
PM 26347207
DA 2026-01-16
ER

PT J
AU Hershman, DL
   Loprinzi, C
   Schneider, BP
AF Hershman, Dawn L
   Loprinzi, Charles
   Schneider, Bryan P
TI Symptoms: Aromatase Inhibitor Induced Arthralgias.
SO Advances in experimental medicine and biology
LA English
DT Review
AB Recent clinical trials have demonstrated that aromatase inhibitors (AIs) are  slightly more effective than tamoxifen at reducing breast cancer recurrences.  However, breast cancer patients receiving AIs have a higher incidence of  musculoskeletal symptoms, particularly joint pain and stiffness. Musculoskeletal  pain and stiffness can lead to noncompliance and increased utilization of health  care resources. There is a suggestion that the syndrome is the result of estrogen  deprivation and may share components with autoimmune diseases such as Sjögren's  syndrome. Several factors may increase the likelihood of developing AI  arthralgia, such as prior chemotherapy, prior hormone replacement therapy, and  increased weight; there are inconsistencies with regard to the data on genetic  predispositions to this syndrome. While several studies have been done to  evaluate interventions to treat or prevent AI arthralgia, no clear treatment has  emerged as being particularly beneficial. Much of the research has been limited  by small sample size, difficulty blinding patients to placebo, inconsistent  definitions of the syndrome, multiple patient reported outcomes, lack of  objective outcome measures and heterogeneous patient populations. We are at the  early stages of research in characterizing, understanding etiology, preventing  and treating AI arthralgias; however much work is being done in this area which,  hopefully, will ultimately improve the lives of women with breast cancer.
C1 Medicine and Epidemiology, Herbert Irving Comprehensive Cancer Center, Columbia University, 161 Fort Washington, 1068, New York, NY, 10032, USA,dlh23@cumc.columbia.edu.
NR 0
TC 0
SN 
EI 0065-259
J9 Adv Exp Med Biol
PD JUN 11
PY 2015
VL 862
IS 
BP 89
EP 100
DI 10.1007/978-3-319-16366-6_7
PG 11
WC Acupuncture Therapy; Aromatase Inhibitors; adverse effects; Arthralgia; chemically induced; Breast Neoplasms; drug therapy; Chondroitin; therapeutic use; Female; Glucosamine; therapeutic use; Humans; Risk Factors; Vitamin D Deficiency; complications
UT PubMed:26059931
PM 26059931
DA 2015-06-11
ER

PT J
AU Xu, L
   Xu, T
AF Xu, Linling
   Xu, Tianshu
TI [A literature review on acupuncture and moxibustion for prevention and treatment
SO Zhongguo zhen jiu = Chinese acupuncture & moxibustion
LA chi
DT Review
AB To explore the status of acupuncture and moxibustion for prevention and treatment  of lung cancer in current years; literature regarding acupuncture and moxibustion  for prevention and treatment of lung cancer between 2003 and 2013 from SCI  journals was retrieved and analyzed. As a result, 20 papers were included, which  were published in 17 journals including Journal of Clinical Oncology, Chest,  Respirology and Lung Cancer, etc. Of them, 3 papers discussed the effects of  acupuncture on progressing of lung cancer; 4 articles confirmed that acupuncture  could reduce myelosuppression and digestive tract reactions induced by  radiotherapy and chemotherapy; 6 papers showed that acupuncture could relieve  pain or fatigue of lung cancer; 3 papers indicated that acupuncture could  palliate dyspnea in lung cancer patients. It is concluded by domestic and  overseas researches that acupuncture and moxibustion are effective and safe for  symptoms of lung cancer, which is worthy of further study.
NR 0
TC 0
SN 
EI 0255-293
J9 Zhongguo Zhen Jiu
PD OCT 21
PY 2015
VL 35
IS 6
BP 638
EP 40
DI 
PG -598
WC Acupuncture Therapy; Bibliometrics; Humans; Lung Neoplasms; prevention & control; Moxibustion; Publications; statistics & numerical data
UT PubMed:26480578
PM 26480578
DA 2015-10-21
ER

PT J
AU Hsiung, WT
   Chang, YC
   Yeh, ML
   Chang, YH
AF Hsiung, Wan-Ting
   Chang, Yi-Chuan
   Yeh, Mei-Ling
   Chang, Yung-Hsien
TI Acupressure improves the postoperative comfort of gastric cancer patients: A
SO Complementary therapies in medicine
LA English
DT Journal Article
DE Acupressure; Defecation; Flatus; Gastric cancer; Nausea; Pain; Postoperative comfort; Vomiting
AB OBJECTIVE: This pilot study evaluated whether acupressure affected the  postoperative comfort of gastric cancer patients following a subtotal  gastrectomy. METHODS: A randomised controlled trial was conducted. Sixty patients  were recruited from 141-bed general surgery ward at a 3000-bed medical centre in  Northern Taiwan. Participants were randomly assigned to either a control group  receiving regular postoperative care or to the experimental group receiving  additional acupressure at acupoints of Neiquan (P6) and Zusanli (ST36) for 3  consecutive days. RESULTS: The similarities between two groups were in  postoperative pain and the onset of postoperative nausea and vomiting (PONV) at  the baseline. Following acupressure, significant differences were found in  postoperative pain (P=.03) and time of first flatus (P=.04); but not PONV  (P=.49), nor the time of first defecation (P=.34). CONCLUSIONS: Acupressure is a  simple, noninvasive, safe, and economical procedure for improving the comfort of  patients who undergo surgery for gastric cancer. Acupressure at the P6 and ST36  acupoints can improve postoperative comfort by alleviating pain and decreasing  the time until first flatus. However, additional research is necessary to  elucidate how acupressure can improve postoperative outcomes.
C1 Department of Nursing, Taipei Veterans General Hospital, Taiwan, ROC.
   Department of Nursing, Fooyin University, Taiwan, ROC
   National Taipei University of Nursing and Health Sciences, Taiwan, ROC.
   School of Nursing, National Taipei University of Nursing and Health Sciences, Taiwan, ROC. 
   China Medical University and Hospital, Taiwan, ROC.
EM meiling@ntunhs.edu.tw
NR 0
TC 0
SN 1873-696
EI 
J9 Complement Ther Med
PD JUN 9
PY 2015
VL 23
IS 3
BP 339
EP 46
DI 10.1016/j.ctim.2015.03.010
PG -293
WC Acupressure; Acupuncture Points; Aged; Female; Gastrectomy; adverse effects; Humans; Male; Middle Aged; Pain, Postoperative; epidemiology; Postoperative Nausea and Vomiting; epidemiology; Stomach Neoplasms; epidemiology
UT PubMed:26051568
PM 26051568
DA 2015-06-09
ER

PT J
AU Hay, W
AF Hay, William
TI Sham procedure inadequate.
SO Cancer
LA English
DT Letter
C1 Department of Family Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
NR 0
TC 0
SN 1097-014
EI 
J9 Cancer
PD JAN 8
PY 2015
VL 121
IS 7
BP 1148
EP 1148
DI 10.1002/cncr.29114
PG 0
WC Anxiety; therapy; Aromatase Inhibitors; adverse effects; Arthralgia; chemically induced; Breast Neoplasms; drug therapy; Depression; therapy; Electroacupuncture; methods; Fatigue; therapy; Female; Humans; Sleep Wake Disorders; therapy
UT PubMed:25565320
PM 25565320
DA 2015-01-08
ER

PT J
AU Bidan, L
   Gong, P
   Zhang, W
   Li, J
   Huang, J
   Yu, Z
AF Bidan, Lou
   Gong, Ping
   Zhang, Wei
   Li, Jinxiang
   Huang, Jie
   Yu, Zhaoan
TI [Theoretical study of corresponding points for pain].
SO Zhongguo zhen jiu = Chinese acupuncture & moxibustion
LA chi
DT Journal Article
AB The theoretical basis of "corresponding points" originates from opposing  needling, contralateral needling and distal needling in acupuncture. It is to  select points in corresponding area that is distant from diseased re gion to  balance yin and yang and to activate meridians. Acupuncture at corresponding  points, through reflex regu- lation of nervous system. could activate protective  inhibition of cerebral cortex and cutoff of local malignant stimu lation, leading  to quick elimination of pain. In clinic, it is mostly used for pain-related  diseases.
NR 0
TC 0
SN 
EI 0255-293
J9 Zhongguo Zhen Jiu
PD APR 25
PY 2015
VL 35
IS 1
BP 77
EP 9
DI 
PG -68
WC Acupuncture Points; Acupuncture Therapy; Humans; Medicine in Literature; Pain Management
UT PubMed:25906577
PM 25906577
DA 2015-04-25
ER

PT J
AU Halsey, EJ
   Xing, M
   Stockley, RC
AF Halsey, Elizabeth J.
   Xing, Mei
   Stockley, Rachel C.
TI Acupuncture for joint symptoms related to aromatase inhibitor therapy in postmenopausal women with early-stage breast cancer: a narrative review
SO ACUPUNCTURE IN MEDICINE
LA English
DT Article
DE ACUPUNCTURE
ID musculoskeletal symptoms; induced arthralgia; randomized-trial; double-blind; tamoxifen; anastrozole; exemestane; letrozole; survivors; pain
AB Background Aromatase inhibitor-induced musculoskeletal syndrome (AIMSS) leads to discontinuation of aromatase inhibitor therapy in a significant proportion of patients with breast cancer. Acupuncture is popular among cancer patients and has previously been shown to improve symptoms in a range of musculoskeletal complaints. Aim To determine the effectiveness and safety of acupuncture for the management of AIMSS in postmenopausal women with early-stage breast cancer. Methods A literature search was carried out for randomised controlled trials (RCTs) on acupuncture for AIMSS in postmenopausal women with early-stage breast cancer. Characteristics of trials and outcomes were extracted from the retrieved articles, which were also assessed for risk of bias and quality of reporting. Results Four RCTs were retrieved of sample size 32-67 (totalling 190 participants). Compliance with treatment was high and rates of adverse events were low. Of the three two-arm RCTs, two found no difference between acupuncture and sham acupuncture and one found that acupuncture was statistically superior to sham acupuncture. The fourth RCT, which incorporated three arms, found acupuncture and sham acupuncture to be statistically superior to usual care but there was no difference between true and sham acupuncture. Three trials that used non-penetrating sham as the control found no effect of acupuncture over sham, but the one trial that used superficial needle insertion found acupuncture to be superior. Conclusions Acupuncture is safe and results in improvement in AIMSS symptoms, but similar benefits are also elicited by non-penetrating sham acupuncture. Future research should seek to establish the durability of improvements.
C1 [Halsey, Elizabeth J.; Xing, Mei; Stockley, Rachel C.] Manchester Metropolitan Univ, Dept Hlth Profess, Manchester M15 6GX, Lancs, England.
C3 Manchester Metropolitan University
RP Halsey, EJ (corresponding author), Manchester Metropolitan Univ, Dept Hlth Profess, Birley Bldg,Manchester Campus,Bonsall St, Manchester M15 6GX, Lancs, England.
EM Elizabeth.j.halsey@stu.mmu.ac.uk
CR Bao T, 2013, BREAST CANCER RES TR, V138, P167, DOI 10.1007/s10549-013-2427-z
   Baum M, 2002, LANCET, V359, P2131
   Briot K, 2010, BREAST CANCER RES TR, V120, P127, DOI 10.1007/s10549-009-0692-7
   García MC, 2014, ENCYCLOP MATH APPL, V154, P1
   Coleman RE, 2008, CANCER TREAT REV, V34, P275, DOI 10.1016/j.ctrv.2007.10.004
   Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331
   Crew KD, 2007, J CLIN ONCOL, V25, P3877, DOI 10.1200/JCO.2007.10.7573
   Crew KD, 2010, J CLIN ONCOL, V28, P1154, DOI 10.1200/JCO.2009.23.4708
   Din OS, 2010, BREAST CANCER RES TR, V120, P525, DOI 10.1007/s10549-010-0757-7
   Dizdar O, 2009, J CLIN ONCOL, V27, P4955, DOI 10.1200/JCO.2008.20.5435
   Filshie Jacqueline, 2005, ACUPUNCT MED, V23, P171
   Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f
   Galantino ML, 2013, ALTERN THER HEALTH M, V19, P38
   Galantino ML, 2012, INTEGR CANCER THER, V11, P313, DOI 10.1177/1534735411413270
   Henry NL, 2012, J CLIN ONCOL, V30, P936, DOI 10.1200/JCO.2011.38.0261
   Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25
   Kaptchuk TJ, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015591
   Kubo M, 2012, ANTICANCER RES, V32, P2331
   Langevin HM, 2011, EVID-BASED COMPL ALT, V2011, P0, DOI 10.1155/2011/180805
   Lumachi F, 2013, CURR MED CHEM, V20, P596, DOI 10.2174/092986713804999303
   MacPherson H, 2001, COMPLEMENT THER MED, V9, P246, DOI 10.1054/ctim.2001.0488
   MacPherson H, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093739
   MacPherson H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0077438
   Mao JJ, 2014, EUR J CANCER, V50, P267, DOI 10.1016/j.ejca.2013.09.022
   Mao JJ, 2009, CANCER, V115, P3631, DOI 10.1002/cncr.24419
   Molassiotis A, 2006, SUPPORT CARE CANCER, V14, P260, DOI 10.1007/s00520-005-0883-7
   Morales L, 2007, BREAST CANCER RES TR, V104, P87, DOI 10.1007/s10549-006-9394-6
   Niravath P, 2013, ANN ONCOL, V24, P1443, DOI 10.1093/annonc/mdt037
   Office for National Statistics, 2012, CANC REG STAT, V0, P0
   Oh B, 2013, ACUPUNCT MED, V31, P264, DOI 10.1136/acupmed-2012-010309
   Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451
   Rastelli AL, 2011, BREAST CANCER RES TR, V129, P107, DOI 10.1007/s10549-011-1644-6
   Stan D, 2013, HEMATOL ONCOL CLIN N, V27, P805, DOI 10.1016/j.hoc.2013.05.005
   Swenson KK, 2013, ONCOL NURS FORUM, V40, P549, DOI 10.1188/13.ONF.549-557
   Teig Silje, 2006, ACUPUNCT MED, V24, P80
   Thürlimann B, 2005, NEW ENGL J MED, V353, P2747
   Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654
NR 37
TC 9
Z9 11
U1 0
U2 11
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0964-5284
EI 1759-9873
J9 ACUPUNCT MED
JI Acupunct. Med.
PD JUN 15
PY 2015
VL 33
IS 3
BP 188
EP 195
DI 10.1136/acupmed-2014-010735
PG 8
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CM2QO
UT WOS:000357526900003
PM 25733539
DA 2026-01-16
ER

PT J
AU Baker, BS
   Hoffman, CJ
AF Baker, Barbara S.
   Hoffman, Caroline J.
TI Emotional Freedom Techniques (EFT) to reduce the side effects associated with tamoxifen and aromatase inhibitor use in women with breast cancer: A service evaluation
SO EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE
LA English
DT Article
DE Breast cancer; Emotional Freedom Techniques; Adjuvant hormonal therapies; Side effects
ID quality-of-life; adjuvant endocrine therapy; hormonal-therapy; menopausal symptoms; discontinuation; anastrozole; fatigue; acupuncture; recurrence; adherence
AB Introdution: Adverse effects associated with tamoxifen and aromatase inhibitor use are the most common reason reported by women with breast cancer for discontinuing hormonal therapies. Poor compliance is associated with an increased risk of mortality and early recurrence. The primary aim of this study was to evaluate Emotional Freedom Techniques (EFT) for improving mood state, and secondarily, menopausal symptoms, fatigue, and pain experienced by women with breast cancer receiving hormonal therapies. Methods: Participants (n = 41) received a three-week course of EFT, consisting of one session of three hours per week, followed by use of the self-tool over the next nine weeks as required. Self-report questionnaires were used to assess mood, pain, fatigue, endocrine (menopausal) symptoms and hot flushes and night sweats, together with a hot flush diary, at baseline and at 6 and 12 weeks. Participants also completed 7-day home practice sheets for the first six weeks, a feedback form at six weeks and were invited to attend a follow-up focus group at eight weeks. Results: Statistically significant improvements in Total Mood Disturbance (p = 0.005; p = 0.008), and anxiety (p = 0.003; p = 0.028), depression(p = 0.006; p = 0.020) and fatigue (p = 0.008; p = 0.033) occurred at both 6 and 12 weeks, respectively, compared to baseline. In addition, mean fatigue interference and global scores, numbers of hot flushes and the hot flush problem rating score decreased at 6 and/or 12 weeks. Discussion/conclusions: These preliminary findings suggest that EFT may be an effective self-help tool for women with breast cancer experiencing side effects from hormonal therapies. (C) 2014 Elsevier GmbH. All rights reserved.
C1 [Baker, Barbara S.; Hoffman, Caroline J.] The Haven, London SW6 1TB, England.
RP Baker, BS (corresponding author), The Haven, Effie Rd, London SW6 1TB, England.
EM barbara.baker@thehaven.org.uk; caroline.hoffman@thehaven.org.uk
CR Ayers B, 2012, MENOPAUSE, V19, P749, DOI 10.1097/gme.0b013e31823fe835
   Ayres LR, 2014, INT J CLIN PHARM-NET, V36, P45, DOI 10.1007/s11096-013-9833-5
   Baker BS, 2013, EUR J INTEGR MED, V5, P153, DOI 10.1016/j.eujim.2012.10.002
   Barron TI, 2013, BRIT J CANCER, V109, P1513, DOI 10.1038/bjc.2013.518
   Bougea AM, 2013, EXPLORE-NY, V9, P91, DOI 10.1016/j.explore.2012.12.005
   Bowles EJA, 2012, J ONCOL PRACT, V8, PE149, DOI 10.1200/JOP.2012.000543
   Brattberg G, 2008, INTEGRATIVE MEDICINE: A CLINICIANS JOURNAL, V7, P30
   CASSILETH B R, 1985, JOURNAL OF PSYCHOSOCIAL ONCOLOGY, V3, P99
   Church D, 2013, PSYCHOLOGY, V4, P645, DOI 10.4236/PSYCH.2013.48092
   Cleeland CS, 1994, ANNALS ACADEMY OF MEDICINE SINGAPORE, V23, P129
   Craig G, 2011, THE EFT MANUAL, V0, P0
   Crew KD, 2010, J CLIN ONCOL, V28, P1154, DOI 10.1200/JCO.2009.23.4708
   Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6
   Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8
   Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1
   Desai K, 2013, SUPPORT CARE CANCER, V21, P43, DOI 10.1007/s00520-012-1490-z
   Fallowfield LJ, 1999, BREAST CANCER RES TR, V55, P189
   Feinstein D, 2012, REV GEN PSYCHOL, V16, P364, DOI 10.1037/a0028602
   Gallicchio L, 2012, CLIMACTERIC, V15, P339, DOI 10.3109/13697137.2011.620658
   Glaus A, 2006, ANN ONCOL, V17, P801, DOI 10.1093/annonc/mdl030
   Hershman DL, 2011, BREAST CANCER RES TR, V126, P529, DOI 10.1007/s10549-010-1132-4
   HUNTER MS, 1995, BRIT J CLIN PSYCHOL, V34, P589, DOI 10.1111/j.2044-8260.1995.tb01493.x
   Makubate B, 2013, BRIT J CANCER, V108, P1515, DOI 10.1038/bjc.2013.116
   Mann E, 2012, LANCET ONCOL, V13, P309, DOI 10.1016/S1470-2045(11)70364-3
   Mao JJ, 2013, PHARMACOEPIDEM DR S, V22, P256, DOI 10.1002/pds.3365
   McNair DM, 1971, EITS MANUAL PROFILE, V0, P0
   Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N
   Molassiotis A, 2012, J CLIN ONCOL, V30, P4470, DOI 10.1200/JCO.2012.41.6222
   Rostock M, 2011, GYNECOL ENDOCRINOL, V27, P844, DOI 10.3109/09513590.2010.538097
   Savard J, 2005, J CLIN ONCOL, V23, P6083, DOI 10.1200/JCO.2005.09.548
   Shi QL, 2013, J PAIN, V14, P290, DOI 10.1016/j.jpain.2012.11.010
   Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280
   Stewart A, 2013, JOURNAL OF PSYCHOLOGICAL THERAPIES IN PRIMARY CARE, V2, P71
   Takei H, 2012, BREAST CANCER RES TR, V133, P227, DOI 10.1007/s10549-011-1943-y
NR 34
TC 15
Z9 19
U1 1
U2 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1876-3820
EI 1876-3839
J9 EUR J INTEGR MED
JI Eur. J. Integr. Med.
PD APR 15
PY 2015
VL 7
IS 2
BP 136
EP 142
DI 10.1016/j.eujim.2014.10.004
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CG5SA
UT WOS:000353353100007
DA 2026-01-16
ER

PT J
AU Henry, NL
   Griggs, JJ
AF Henry, N. Lynn
   Griggs, Jennifer J.
TI The Power of the Placebo in Symptom Management
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Editorial Material
ID inhibitor-induced arthralgia; stage breast-cancer; controlled-trial; double-blind; randomized-trial; women; pain; acupuncture; duloxetine; therapy
C1 [Henry, N. Lynn; Griggs, Jennifer J.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan
RP Henry, NL (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.
CR Arnold LM, 2005, PAIN, V119, P5, DOI 10.1016/j.pain.2005.06.031
   Burstein HJ, 2007, BREAST, V16, P223, DOI 10.1016/j.breast.2007.01.011
   Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082
   Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65
   Crew KD, 2010, J CLIN ONCOL, V28, P1154, DOI 10.1200/JCO.2009.23.4708
   Cruciani RA, 2012, J CLIN ONCOL, V30, P3864, DOI 10.1200/JCO.2011.40.2180
   Felson DT, 2005, ARTHRITIS RHEUM-US, V52, P2594, DOI 10.1002/art.21364
   Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2
   Folkerd EJ, 2014, J CLIN ONCOL, V32, P1396, DOI 10.1200/JCO.2013.53.9411
   Gotay C, 2011, EXPERT REV PHARM OUT, V11, P0, DOI 10.1586/ERP.11.80
   Henry NL, 2012, J CLIN ONCOL, V30, P936, DOI 10.1200/JCO.2011.38.0261
   Henry NL, 2008, ONCOLOGY-NY, V22, P1401
   Hershman DL, 2015, J CLIN ONCOL, V33, P1910, DOI 10.1200/JCO.2014.59.5595
   Irwin ML, 2015, J CLIN ONCOL, V33, P1104, DOI 10.1200/JCO.2014.57.1547
   Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25
   Kastelein JJP, 2014, J CLIN LIPIDOL, V8, P94, DOI 10.1016/j.jacl.2013.10.003
   Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006
   Loprinzi CL, 2009, J CLIN ONCOL, V27, P2831, DOI 10.1200/JCO.2008.19.6253
   Morales L, 2008, J CLIN ONCOL, V26, P3147, DOI 10.1200/JCO.2007.15.4005
   Niravath P, 2013, ANN ONCOL, V24, P1443, DOI 10.1093/annonc/mdt037
   Peciña M, 2014, SOC COGN AFFECT NEUR, V9, P1013, DOI 10.1093/scan/nst079
   Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813
   Spathis A, 2014, J CLIN ONCOL, V32, P1882, DOI 10.1200/JCO.2013.54.4346
   Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005
NR 24
TC 9
Z9 10
U1 0
U2 6
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN 0732-183X
EI 1527-7755
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD JUN 10
PY 2015
VL 33
IS 17
BP 1870
EP U21
DI 10.1200/JCO.2015.61.1004
PG 5
WC Oncology
SC Oncology
GA CK1WQ
UT WOS:000355999800004
PM 25940722
DA 2026-01-16
ER

PT J
AU Song, HJ
   Seo, HJ
   Lee, H
   Son, H
   Choi, SM
   Lee, S
AF Song, Hyun Jin
   Seo, Hyun-Ju
   Lee, Heeyoung
   Son, Heejeong
   Choi, Sun Mi
   Lee, Sanghun
TI Effect of self-acupressure for symptom management: A systematic review
SO COMPLEMENTARY THERAPIES IN MEDICINE
LA English
DT Article
DE Acupressure; Self-administration; Signs and Symptoms
ID efficacy; quality; point
AB Objectives: To assess the efficacy and safety of self-administered acupressure to alleviate symptoms of various health problems, including allergic disease, cancer, respiratory disease, dysmenorrhea, perceived stress, insomnia, and sleep disturbances. Methods: We searched core, Korean, Chinese, and Japanese databases, including Ovid-MEDLINE, Ovid-EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), the Cumulative Index to Nursing and Allied Health Literature (CINAHL), six representative electronic Korean medical databases, China National Knowledge Infrastructure (CNKI), and Japan Science and Technology Information Aggregator (J-STAGE). We included randomized controlled trials (RCTs) and quasi-RCTs that examined disease-specific effects or symptom relief, adverse reactions, and quality-of-life (QOL) for self-administered acupressure. Data collection and assessment of the methodological quality of the included studies were conducted by two independent reviewers. Results: Eight RCTs and two quasi-RCTs showed positive effects and safety of self-acupressure therapy in clinically diverse populations. Quality assessment revealed moderate quality for the RCTs, with 50% or more of the trials assessed as presenting a low risk of bias in seven domains. All of the selected 10 studies reported positive effects for primary outcomes of self-acupressure therapy for symptom management, including significant improvements in symptom scores in allergic disease, nausea and vomiting in cancer, symptom scores in respiratory disease, pain symptoms in dysmenorrhea, and stress/fatigue scores and sleep disturbances in healthy people. Conclusions: Our findings suggest that self-administered acupressure shows promise to alleviate the symptoms of various health problems. Therefore, further research with larger samples and methodologically well-designed RCTs is required to establish the efficacy of self-administered acupressure. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Song, Hyun Jin] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea.
   [Seo, Hyun-Ju] Chosun Univ, Coll Med, Dept Nursing, Kwangju 501759, South Korea.
   [Lee, Heeyoung] Seoul Natl Univ, Bundang Hosp, Publ Hlth Med Serv, Songnam, South Korea.
   [Son, Heejeong] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.
   [Choi, Sun Mi; Lee, Sanghun] Korea Inst Oriental Med, Taejon, South Korea.
C3 Sungkyunkwan University (SKKU); Chosun University; Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Oriental Medicine (KIOM)
RP Seo, HJ (corresponding author), Chosun Univ, Coll Med, Dept Nursing, 309 Pilmum Daero, Kwangju 501759, South Korea.
EM shj5th@korea.ac.kr
FU Korea Institute of Oriental Medicine (KIOM) in South Korea [K12210]
CR Bazarganipour F, 2010, INT J GYNECOL OBSTET, V111, P105, DOI 10.1016/j.ijgo.2010.04.030
   Beal MW, 1999, J NURSE-MIDWIFERY, V44, P217, DOI 10.1016/S0091-2182(99)00054-3
   Chao Hui-Lin, 2013, ONCOL NURS FORUM, V40, PE61, DOI 10.1188/13.ONF.E61-E68
   Chen HM, 2004, J ADV NURS, V48, P380, DOI 10.1111/j.1365-2648.2004.03236.x
   Dibble SL, 2007, ONCOL NURS FORUM, V34, P815, DOI 10.1188/07.ONF.813-820
   Fritz DJ, 2013, J AM BOARD FAM MED, V26, P61, DOI 10.3122/jabfm.2013.01.120157
   Higgins J, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.ED000049
   Honda Y, 2012, OPEN J MED PSYCHOL, V01, P20, DOI 10.4236/ojmp.2012.13004
   Jiang HR, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/169692
   Kim SY, 2013, J CLIN EPIDEMIOL, V66, P408, DOI 10.1016/j.jclinepi.2012.09.016
   Kim Wonill, 2004, KOREAN JOURNAL OF ACUPUNCTURE, V21, P81
   Lee EJ, 2011, J PAIN SYMPTOM MANAG, V42, P589, DOI 10.1016/j.jpainsymman.2011.01.007
   Lee JS, 2011, INT J NEUROSCI, V121, P409, DOI 10.3109/00207454.2011.570465
   Lee KC, 2012, ACUPUNCT MED, V30, P8, DOI 10.1136/acupmed-2011-010088
   Lu MJ, 2013, NURS RES, V62, P130, DOI 10.1097/NNR.0b013e3182781524
   Maa S H, 1997, J CARDIOPULM REHABIL, V17, P268, DOI 10.1097/00008483-199707000-00008
   Maa SH, 2003, J ALTERN COMPLEM MED, V9, P659, DOI 10.1089/107555303322524517
   Maa SH, 2007, J CLIN NURS, V16, P794, DOI 10.1111/j.1365-2702.2005.01515.x
   National Cancer Institute, 2007, AC, V0, P0
   Noroozinia Heydar, 2013, ACTA MED IRAN, V51, P163
   Rerksuppaphol Lakkana, 2012, J MED ASSOC THAI, V95 Suppl 12, P0
   Robinson N, 2011, BMC COMPLEM ALTERN M, V11, P0, DOI 10.1186/1472-6882-11-88
   Shin YH, 2004, CANCER NURS, V27, P267, DOI 10.1097/00002820-200407000-00002
   Smith CA, 2011, COCHRANE DB SYST REV, V7, P0
   Wong C L, 2010, COMPLEMENT THER CLIN PRACT, V16, P64, DOI 10.1016/j.ctcp.2009.10.002
   Wu HS, 2004, J ADV NURS, V45, P252, DOI 10.1046/j.1365-2648.2003.02886.x
   Xue CC, 2011, ANN ALLERG ASTHMA IM, V106, P168, DOI 10.1016/j.anai.2010.11.006
   Yang MH, 2007, J CLIN NURS, V16, P308, DOI 10.1111/j.1365-2702.2006.01428.x
   Yeh CH, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/196978
   Yeung WF, 2012, SLEEP MED, V13, P971, DOI 10.1016/j.sleep.2012.06.003
   Yip YB, 2004, COMPLEMENT THER MED, V12, P28, DOI 10.1016/j.ctim.2003.12.003
   Zhang CS, 2010, CLIN OTOLARYNGOL, V35, P6, DOI 10.1111/j.1749-4486.2009.02067.x
NR 32
TC 79
Z9 86
U1 0
U2 32
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0965-2299
EI 1873-6963
J9 COMPLEMENT THER MED
JI Complement. Ther. Med.
PD FEB 15
PY 2015
VL 23
IS 1
BP 68
EP 78
DI 10.1016/j.ctim.2014.11.002
PG 11
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CB6II
UT WOS:000349730300010
PM 25637155
DA 2026-01-16
ER

PT J
AU Tofthagen, C
   Boses, S
   Healy, G
   Jooma, N
AF Tofthagen, Cindy
   Boses, Sarah
   Healy, Gene
   Jooma, Nuruddin
TI Evaluation of Group Acupuncture for Cancer-Related Symptoms: A Retrospective
SO Journal of palliative medicine
LA English
DT Journal Article
AB BACKGROUND: Acupuncture is being used for treatment of cancer-related symptoms in  numerous settings, yet empirical evidence supporting the effects of acupuncture  in this setting is lacking. Group acupuncture is an economical way to provide  acupuncture to patients at a reduced cost. OBJECTIVE: In this retrospective study  we sought to evaluate the effects of group acupuncture on specific cancer-related  symptoms in persons receiving outpatient cancer treatment. METHODS: Patients were  receiving group acupuncture treatments through an integrative oncology program in  a large community oncology practice in west central Florida. A short  patient-completed assessment of seven basic cancer-related symptoms using a 0-10  numeric rating scale was completed at each acupuncture treatment. Basic  demographic information, including age, gender, race/ethnicity, and cancer type  was obtained from the medical record. Paired sample t-tests were used to evaluate  differences in symptoms before the first treatment and at the fourth treatment.  RESULTS: Fifty patients completed at least four weekly acupuncture treatments in  2014. Forty-three of them completed symptom assessments and were included in this  analysis. The mean age of participants was 66.4 years. The majority of patients  were white, non-Hispanic, and female. No significant improvement in symptoms were  identified at the third treatment. At the time of the fourth group acupuncture,  participants reported significantly less pain/numbness and problems with  digestion. DISCUSSION: The results of this study provide evidence to support the  efficacy of group acupuncture for pain, neuropathy, and digestive problems in  persons with cancer. A minimum of four weekly treatments may be necessary before  improvements are noted. Limitations include a retrospective design, incomplete  symptom evaluation, and possible response bias. Future studies of group  acupuncture for cancer-related symptoms should utilize a prospective, controlled  design, use validated measures to thoroughly evaluate targeted symptoms, and  include a more racially and ethnically diverse sample.
C1 1 College of Nursing, University of South Florida , Tampa, Florida.
   2 Integrative Oncology Department, Florida Cancer Specialists , Largo, Florida.
   3 Root Healing Acupuncture , Dunedin, Florida.
   2 Integrative Oncology Department, Florida Cancer Specialists , Largo, Florida.
NR 0
TC 0
SN 1557-774
EI 
J9 J Palliat Med
PD JUL 29
PY 2015
VL 18
IS 10
BP 878
EP 80
DI 10.1089/jpm.2015.0143
PG -798
WC Acupuncture Therapy; economics; Adult; Aged; Aged, 80 and over; Ambulatory Care; economics; Digestive System Diseases; etiology; Female; Florida; Group Processes; Humans; Male; Middle Aged; Neoplasms; complications; Neuralgia; etiology; Pain Management; methods; Retrospective Studies
UT PubMed:26218367
PM 26218367
DA 2015-07-29
ER

PT J
AU Hsiung, WT
   Chang, YC
   Yeh, ML
   Chang, YH
AF Hsiung, Wan-Ting
   Chang, Yi-Chuan
   Yeh, Mei-Ling
   Chang, Yung-Hsien
TI Acupressure improves the postoperative comfort of gastric cancer patients: A randomised controlled trial
SO COMPLEMENTARY THERAPIES IN MEDICINE
LA English
DT Article
DE Acupressure; Postoperative comfort; Gastric cancer; Pain; Nausea; Vomiting; Flatus; Defecation
ID acupoint electrical-stimulation; gastrointestinal motility; controlled analgesia; capsicum plaster; pain; nausea; acupuncture; surgery; acustimulation; decompression
AB Objective: This pilot study evaluated whether acupressure affected the postoperative comfort of gastric cancer patients following a subtotal gastrectomy. Methods: A randomised controlled trial was conducted. Sixty patients were recruited from 141-bed general surgery ward at a 3000-bed medical centre in Northern Taiwan. Participants were randomly assigned to either a control group receiving regular postoperative care or to the experimental group receiving additional acupressure at acupoints of Neiquan (P6) and Zusanli (ST36) for 3 consecutive days. Results: The similarities between two groups were in postoperative pain and the onset of postoperative nausea and vomiting (PONV) at the baseline. Following acupressure, significant differences were found in postoperative pain (P=.03) and time of first flatus (P=.04); but not PONV (P=.49), nor the time of first defecation (P=.34). Conclusions: Acupressure is a simple, noninvasive, safe, and economical procedure for improving the comfort of patients who undergo surgery for gastric cancer. Acupressure at the P6 and ST36 acupoints can improve postoperative comfort by alleviating pain and decreasing the time until first flatus. However, additional research is necessary to elucidate how acupressure can improve postoperative outcomes. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Hsiung, Wan-Ting] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan.
   [Chang, Yi-Chuan] Fooyin Univ, Dept Nursing, Kaohsiung, Taiwan.
   [Chang, Yi-Chuan] Natl Taipei Univ Nursing & Hlth Sci, Taipei, Taiwan.
   [Yeh, Mei-Ling] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei, Taiwan.
   [Chang, Yung-Hsien] China Med Univ & Hosp, Taichung, Taiwan.
C3 Taipei Veterans General Hospital; Fooyin University; National Taipei University of Nursing & Health Science (NTUNHS); National Taipei University of Nursing & Health Science (NTUNHS); China Medical University Taiwan; China Medical University Hospital - Taiwan
RP Yeh, ML (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, 365 Minte Rd, Taipei, Taiwan.
EM meiling@ntunhs.edu.tw
CR Abraham Jenny, 2008, J PERIOPER PRACT, V18, P543
   Agarwal A, 2000, CAN J ANAESTH, V47, P319, DOI 10.1007/BF03020945
   Agarwal A, 2002, CAN J ANAESTH, V49, P554, DOI 10.1007/BF03017380
   Ali T, 2007, SOUTH MED J, V100, P281, DOI 10.1097/SMJ.0b013e31802f3795
   Amir SH, 2007, J ANAESTHESIOL CLIN PHARMACOL, V23, P383
   Unknown -, 2019, W PAC REG PARTN FOR, V0, P0
   Unknown -, 2004, CONTEMPORARY MERIDIANS AND ACUPOINTS IN PRACTICE, V0, P0
   Apfel CC, 2009, BRIT J ANAESTH, V103, P359, DOI 10.1093/bja/aep177
   Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022
   Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E
   Aubrun F, 2012, BRIT J ANAESTH, V108, P193, DOI 10.1093/bja/aer458
   Chen CJ, 2012, WORLD J GASTROENTERO, V18, P251, DOI 10.3748/wjg.v18.i3.251
   Chen LL, 2003, AM J CHINESE MED, V31, P781, DOI 10.1142/S0192415X03001466
   Chen YC, 2005, TAIWAN J CHINESE MED, V4, P5
   Chou Fan-Hao, 2005, KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, V21, P314
   Chung YC, 2014, PAIN MANAG NURS, V15, P738, DOI 10.1016/j.pmn.2013.07.010
   Chung YC, 2014, INT J NURS STUD, V51, P370, DOI 10.1016/j.ijnurstu.2013.06.007
   Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207
   Doran K, 2010, AM J CRIT CARE, V19, P553, DOI 10.4037/ajcc2010900
   Frey UH, 2009, BRIT J ANAESTH, V102, P620, DOI 10.1093/bja/aep014
   Golembiewski Julie A, 2002, J PERIANESTH NURS, V17, P364, DOI 10.1053/jpan.2002.36596
   Ho CM, 2006, OBSTET GYNECOL SURV, V61, P498
   Kawasaki N, 2009, SURG TODAY, V39, P225, DOI 10.1007/s00595-008-3861-0
   Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X
   Kim KS, 2006, ANESTH ANALG, V103, P709, DOI 10.1213/01.ane.0000228864.74691.9f
   Kotani N, 2001, ANESTHESIOLOGY, V95, P349, DOI 10.1097/00000542-200108000-00015
   Lee A, 2009, COCHRANE DB SYST REV, V2, P1, DOI 10.1002/14651858.CD006854.PUB2
   Lin JG, 2002, PAIN, V99, P509, DOI 10.1016/S0304-3959(02)00261-0
   Mack LA, 2004, ANN SURG, V240, P845, DOI 10.1097/01.sla.0000143299.72623.73
   Madsen D, 2005, AM J NURS, V105, P40, DOI 10.1097/00000446-200512000-00029
   Mathers CD, 2006, PUBLIC LIB SCI, V3, P2015
   MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971
   Meyer HJ, 2011, DTSCH ARZTEBL INT, V108, P698, DOI 10.3238/arztebl.2011.0698
   Misra MN, 2005, CAN J ANAESTH, V52, P485, DOI 10.1007/BF03016527
   Mochiki E, 2007, SURG TODAY, V37, P1023, DOI 10.1007/s00595-007-3525-5
   Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613
   Rhodes V A, 1984, CANCER NURS, V7, P33
   Rhodes V A, 1999, ONCOL NURS FORUM, V26, P889
   Robinson N, 2011, BMC COMPLEM ALTERN M, V11, P0, DOI 10.1186/1472-6882-11-88
   Shin YH, 2004, CANCER NURS, V27, P267, DOI 10.1097/00002820-200407000-00002
   Soltani AE, 2010, ARCH IRAN MED, V13, P288, DOI 010134/AIM.007
   Sun Y, 2008, BRIT J ANAESTH, V101, P151, DOI 10.1093/bja/aen146
   Turgut S, 2007, EUR J ANAESTH, V24, P87, DOI 10.1017/S0265021506001190
   Wang SG, 2007, CHIN J SURG INTEGR T, V13, P143
   Wu HC, 2009, CHINESE MED J-PEKING, V122, P1743, DOI 10.3760/cma.j.issn.0366-6999.2009.15.005
   Yang ES, 2011, PFLUG ARCH EUR J PHY, V462, P645, DOI 10.1007/s00424-011-1017-3
   Yeh ML, 2004, MERIDIANS ACUPOINTS, V0, P0
   Yeh ML, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/316212
   Yeh ML, 2011, INT J NURS STUD, V48, P703, DOI 10.1016/j.ijnurstu.2010.10.009
   Yeh ML, 2010, ALTERN THER HEALTH M, V16, P10
   Yin JY, 2010, AUTON NEUROSCI-BASIC, V157, P31, DOI 10.1016/j.autneu.2010.03.007
NR 53
TC 37
Z9 42
U1 0
U2 37
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0965-2299
EI 1873-6963
J9 COMPLEMENT THER MED
JI Complement. Ther. Med.
PD JUN 15
PY 2015
VL 23
IS 3
BP 339
EP 346
DI 10.1016/j.ctim.2015.03.010
PG 8
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CL5JZ
UT WOS:000356997500005
PM 26051568
DA 2026-01-16
ER

PT J
AU Ben-Arye, E
   Samuels, N
   Schiff, E
   Raz, OG
   Sharabi, IS
   Lavie, O
AF Ben-Arye, Eran
   Samuels, Noah
   Schiff, Elad
   Raz, Orit Gressel
   Sharabi, Ilanit Shalom
   Lavie, Ofer
TI Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy
SO SUPPORTIVE CARE IN CANCER
LA English
DT Article
DE Integrative medicine; Gynecologic oncology; Quality of life; Chemotherapy; Complementary medicine
ID ovarian-cancer; complementary medicine; alternative medicine; care; acupuncture; paclitaxel; service
AB Integrative oncology incorporates complementary medicine (CM) therapies in patients with cancer. We explored the impact of an integrative oncology therapeutic regimen on quality-of-life (QOL) outcomes in women with gynecological cancer undergoing chemotherapy. A prospective preference study examined patients referred by oncology health care practitioners (HCPs) to an integrative physician (IP) consultation and CM treatments. QOL and chemotherapy-related toxicities were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and Measure Yourself Concerns and Wellbeing (MYCAW) questionnaire, at baseline and at a 6-12-week follow-up assessment. Adherence to the integrative care (AIC) program was defined as a parts per thousand yen4 CM treatments, with a parts per thousand currency sign30 days between each session. Of 128 patients referred by their HCP, 102 underwent IP consultation and subsequent CM treatments. The main concerns expressed by patients were fatigue (79.8 %), gastrointestinal symptoms (64.6 %), pain and neuropathy (54.5 %), and emotional distress (45.5 %). Patients in both AIC (n = 68) and non-AIC (n = 28) groups shared similar demographic, treatment, and cancer-related characteristics. ESAS fatigue scores improved by a mean of 1.97 points in the AIC group on a scale of 0-10 and worsened by a mean of 0.27 points in the non-AIC group (p = 0.033). In the AIC group, MYCAW scores improved significantly (p < 0.0001) for each of the leading concerns as well as for well-being, a finding which was not apparent in the non-AIC group. An IP-guided CM treatment regimen provided to patients with gynecological cancer during chemotherapy may reduce cancer-related fatigue and improve other QOL outcomes.
C1 [Ben-Arye, Eran; Samuels, Noah; Raz, Orit Gressel; Sharabi, Ilanit Shalom] Clalit Hlth Serv, Oncol Serv, Lin Kou Med Ctr, Integrat Oncol Program, Haifa, Israel.
   [Ben-Arye, Eran] Technion Israel Inst Technol, Complementary & Tradit Med Unit, Dept Family Med, Fac Med, Haifa, Israel.
   [Samuels, Noah] Chaim Sheba Med Ctr, Tal Ctr Integrat Med, Inst Oncol, IL-52621 Tel Hashomer, Israel.
   [Schiff, Elad] Bnai Zion Hosp, Dept Internal Med, Haifa, Israel.
   [Schiff, Elad] Bnai Zion Hosp, Integrat Surg Serv, Haifa, Israel.
   [Lavie, Ofer] Carmel Hosp, Dept Obstet & Gynecol, Gynecol Oncol Serv, Haifa, Israel.
C3 Clalit Health Services; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Chaim Sheba Medical Center; Bnai Zion Medical Center; Bnai Zion Medical Center; Clalit Health Services; Carmel Medical Center
RP Ben-Arye, E (corresponding author), Technion Israel Inst Technol, Complementary & Tradit Med Unit, Dept Family Med, Fac Med, Haifa, Israel.
EM eranben@netvision.net.il
CR Abouzeid AH, 2014, INT J PHARMACEUT, V464, P178, DOI 10.1016/j.ijpharm.2014.01.009
   Ahn WS, 2004, INT J GYNECOL CANCER, V14, P589, DOI 10.1111/j.1048-891X.2004.14403.x
   Andersen MR, 2012, GYNECOL ONCOL, V124, P465, DOI 10.1016/j.ygyno.2011.10.029
   Ben-Arye E, 2014, SUPPORT CARE CANCER, V22, P627, DOI 10.1007/s00520-013-2016-z
   Ben-Arye E, 2012, PATIENT EDUC COUNS, V89, P423, DOI 10.1016/j.pec.2012.02.011
   Ben-Arye E, 2012, INT J GYNECOL CANCER, V22, P146, DOI 10.1097/IGC.0b013e318226c614
   Danhauer Suzanne C, 2008, J SOC INTEGR ONCOL, V6, P47
   Delia P, 2007, WORLD J GASTROENTERO, V13, P912, DOI 10.3748/wjg.v13.i6.912
   Deng G, 2008, CURR ONCOL S, V15, P0
   Deng Gary E, 2009, J SOC INTEGR ONCOL, V7, P85
   Etheridge Amy S, 2009, JOURNAL OF DIETARY SUPPLEMENTS, V6, P104, DOI 10.1080/19390210902861817
   Frenkel M, 2010, INTEGR CANCER THER, V9, P276, DOI 10.1177/1534735410378663
   Gross AH, 2013, CANCER NURS, V36, P256, DOI 10.1097/NCC.0b013e31826f3bc4
   Helpman L, 2011, INT J GYNECOL CANCER, V21, P587, DOI 10.1097/IGC.0b013e31820fa24a
   King MT, 2014, INT J GYNECOL CANCER, V24, P865, DOI 10.1097/IGC.0000000000000167
   León-Pizarro C, 2007, PSYCHO-ONCOLOGY, V16, P971, DOI 10.1002/pon.1171
   Lu WD, 2009, J ALTERN COMPLEM MED, V15, P745, DOI 10.1089/acm.2008.0589
   Nazik E, 2012, ASIAN PAC J CANCER P, V13, P21, DOI 10.7314/APJCP.2012.13.1.021
   Oldenmenger WH, 2013, J PAIN SYMPTOM MANAG, V45, P1083, DOI 10.1016/j.jpainsymman.2012.06.007
   Paterson C, 2007, COMPLEMENT THER MED, V15, P38, DOI 10.1016/j.ctim.2006.03.006
   Rhode JM, 2008, INT J GYNECOL OBSTET, V103, P111, DOI 10.1016/j.ijgo.2008.06.001
   Sieja K, 2004, GYNECOL ONCOL, V93, P320, DOI 10.1016/j.ygyno.2003.12.013
   von Gruenigen VE, 2006, GYNECOL ONCOL, V103, P120, DOI 10.1016/j.ygyno.2006.01.059
   You Q, 2009, INT J GYNECOL CANCER, V19, P567, DOI 10.1111/IGC.0b013e31819d8b48
NR 24
TC 31
Z9 36
U1 0
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0941-4355
EI 1433-7339
J9 SUPPORT CARE CANCER
JI Support. Care Cancer
PD DEC 15
PY 2015
VL 23
IS 12
BP 3411
EP 3419
DI 10.1007/s00520-015-2690-0
PG 9
WC Oncology; Health Care Sciences & Services; Rehabilitation
SC Oncology; Health Care Sciences & Services; Rehabilitation
GA CV1PN
UT WOS:000364030600007
PM 25752885
DA 2026-01-16
ER

PT J
AU Liu, X
   Li, S
   Wang, B
   An, L
   Ren, X
   Wu, H
AF Liu, Xing
   Li, Shuqin
   Wang, Baoguo
   An, Lixin
   Ren, Xiujun
   Wu, Haifeng
TI Intraoperative and postoperative anaesthetic and analgesic effect of multipoint
SO Acupuncture in medicine : journal of the British Medical Acupuncture Society
LA English
DT Journal Article
DE COMPLEMENTARY MEDICINE
AB OBJECTIVES: To investigate the anaesthetic and analgesic effect of multipoint  transcutaneous electrical acupuncture stimulation (TEAS) during supratentorial  tumour resection for postoperative recovery and side effects. METHODS: In a  blinded clinical trial, 92 patients scheduled for supratentorial craniotomy under  general anaesthesia were randomly allocated into either a multipoint TEAS (n=46)  or a sham TEAS group (n=46). All patients received total intravenous anaesthesia  (TIVA) with propofol and sufentanil. The target concentration of sufentanil was  adjusted and recorded according to mean arterial pressure (MAP), heart rate (HR)  and bispectral index (BIS). Patients in the TEAS group received TEAS 30 min  before anaesthesia induction and this was maintained throughout the operation at  four pairs of acupuncture points. Postoperative pain, recovery and side effects  were evaluated. RESULTS: Eighty-eight patients completed the study. Continuous  monitoring of MAP, HR and BIS showed stable values with no significant  differences between the two groups (p>0.05). Sufentanil target plasma  concentration in TEAS patients was significantly lower at some time points during  supratentorial craniotomy, and total sufentanil consumption was significantly  higher in the sham group (p<0.05). Postoperative recovery and pain were  significantly improved by TEAS (p<0.001), without the postoperative side effects.  CONCLUSIONS: Multipoint TEAS at both proximal and distal points combined with  TIVA can significantly decrease intraoperative sufentanil requirements, increase  pain relief on postoperative day 1 and improve postoperative recovery of patients  during supratentorial tumour resection, with no significant increase of side  effects. These findings suggest that multipoint TEAS may be clinically effective  as an adjunct to analgesia in intraoperative anaesthesia and postoperative pain  treatment and may speed recovery. TRIAL REGISTRATION NUMBER: Chinese Clinical  Trial Registry (registration number ChiCTR-TRC-10001078).
C1 Department of Anesthesiology, Beijing, Tian Tan Hospital, Capital Medical University, Beijing, China.
   Department of Anesthesiology, Beijing, Tian Tan Hospital, Capital Medical University, Beijing, China.
   Department of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
   Department of Anesthesiology, Beijing, Tian Tan Hospital, Capital Medical University, Beijing, China.
   School of Acupuncture-moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
   Teaching Affairs Department, China Rehabilitation Research Center, Beijing, China.
NR 0
TC 0
SN 1759-987
EI 
J9 Acupunct Med
PD MAY 1
PY 2015
VL 33
IS 4
BP 270
EP 6
DI 10.1136/acupmed-2014-010749
PG -264
WC Acupuncture Analgesia; Acupuncture Points; Adult; Anesthesia, General; Anesthetics; administration & dosage; Combined Modality Therapy; Craniotomy; Female; Humans; Intraoperative Care; Male; Middle Aged; Pain, Postoperative; drug therapy; Sufentanil; administration & dosage; Supratentorial Neoplasms; surgery; Transcutaneous Electric Nerve Stimulation
UT PubMed:25926298
PM 25926298
DA 2015-05-01
ER

PT J
AU Chien, TJ
   Liu, CY
   Chang, YF
   Fang, CJ
   Hsu, CH
AF Chien, Tsai-Ju
   Liu, Chia-Yu
   Chang, Yi-Fang
   Fang, Ching-Ju
   Hsu, Chung-Hua
TI Acupuncture for Treating Aromatase Inhibitor-Related Arthralgia in Breast Cancer: A Systematic Review and Meta-Analysis
SO JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
LA English
DT Review
ID general fact-g; postmenopausal women; randomized-trial; tamoxifen therapy; musculoskeletal symptoms; functional assessment; osteoarthritis index; tenosynovial changes; adjuvant treatment; western-ontario
AB Purpose: Acupuncture has been used as a complementary medical treatment for arthralgia and other types of pain. The objective of this review is to assess the effectiveness of acupuncture in the treatment of arthralgia in patients with breast cancer who were treated with aromatase inhibitors (AIs). Methods: A literature search was performed, without language restrictions, of 10 databases from their inception through February 2014. The literature reviewed included randomized clinical trials (RCTs) and clinical trials that compared real versus sham acupuncture for the treatment of AI-related musculoskeletal symptoms (AIMSS). The methodologic quality of these trials was assessed by using the modified Jadad Quality Scale. Meta-analytic software (RevMan 5.0) was used to analyze the data. Results: Five To compare the effects of real versus sham acupuncture, five RCTs were assessed by meta-analysis and quality analysis. Three of the RCTs reported favorable effects with regard to use of acupuncture in reducing pain and joint-related symptoms, while the other two RCTs did not. The meta-analysis showed trends toward reduced pain and stiffness in patients given acupuncture compared with those who received sham treatment (n=82; pain, mean difference: -2.07 [95% confidence interval (CI), -4.72 to 0.57]; p=0.12; stiffness, mean difference: -86.10 [95% CI, -249.11 to 76.92]; p=0.30), although these differences were not statistically significant. Conclusions: Acupuncture has been reported as a safe and promising treatment for AIMSS, but the present analysis indicated that the effects were not statistically significant. Other outcome measurements, such as imaging studies, would be worth including in future studies to further confirm the efficacy of acupuncture in AIMSS.
C1 [Chien, Tsai-Ju; Liu, Chia-Yu; Hsu, Chung-Hua] Natl Yang Ming Univ, Inst Tradit Med, Taipei 11221, Taiwan.
   [Chien, Tsai-Ju] Taipei City Hosp, Div Hematooncol, Branch Zhong Xing, Dept Internal Med, Taipei, Taiwan.
   [Liu, Chia-Yu; Hsu, Chung-Hua] Taipei City Hosp, Branch Linsen & Chinese Med, Taipei, Taiwan.
   [Liu, Chia-Yu; Hsu, Chung-Hua] Taiwan Int Tradit Chinese Med Training Ctr, Taipei, Taiwan.
   [Chang, Yi-Fang] Mackay Mem Hosp, Dept Hematol & Oncol, Taipei, Taiwan.
   [Chang, Yi-Fang] Mackay Mem Hosp, Good Clin Res Ctr, Taipei, Taiwan.
   [Fang, Ching-Ju] Mackay Mem Hosp, Med Lib, Taipei, Taiwan.
C3 National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital
RP Hsu, CH (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, 155 Li Nong St,Sec 2, Taipei 11221, Taiwan.
EM owlherbs@yahoo.com.tw
CR Bao T, 2011, CANCER RES, V71, P0, DOI 10.1158/0008-5472.SABCS11-P4-12-13
   Bao T, 2013, BREAST CANCER RES TR, V138, P167, DOI 10.1007/s10549-013-2427-z
   Baum M, 2002, LANCET, V359, P2131
   Beith JM, 2011, J CLIN ONCOL, V29, P0, DOI 10.1200/jco.2011.29.15_suppl.tps120
   Burstein HJ, 2007, BREAST, V16, P223, DOI 10.1016/j.breast.2007.01.011
   CHEN XH, 1992, EUR J PHARMACOL, V211, P203
   Chumsri S, 2011, J STEROID BIOCHEM, V125, P13, DOI 10.1016/j.jsbmb.2011.02.001
   Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331
   Crew Katherine D, 2007, J CANCER SURVIV, V1, P283, DOI 10.1007/s11764-007-0034-x
   Crew KD, 2007, J CLIN ONCOL, V25, P3877, DOI 10.1200/JCO.2007.10.7573
   Crew KD, 2010, J CLIN ONCOL, V28, P1154, DOI 10.1200/JCO.2009.23.4708
   Gandek B, 2015, ARTHRIT CARE RES, V67, P216, DOI 10.1002/acr.22415
   Gao Z, 2013, J TRADIT CHIN MED, V33, P1
   Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312
   Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250
   Harada N, 1997, J STEROID BIOCHEM, V61, P175
   Hawker GA, 2011, ARTHRIT CARE RES, V63, PS240, DOI 10.1002/acr.20543
   Henry NL, 2012, J CLIN ONCOL, V30, P936, DOI 10.1200/JCO.2011.38.0261
   Henry NL, 2010, CANCER-AM CANCER SOC, V116, P4360, DOI 10.1002/cncr.25385
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Jong MS, 2006, ACUPUNCTURE ELECTRO, V31, P45, DOI 10.3727/036012906815844337
   JORDAN VC, 1995, ANNU REV PHARMACOL, V35, P195, DOI 10.1146/annurev.pharmtox.35.1.195
   Lafferty WE, 2006, AM J MANAG CARE, V12, P397
   Lee EH, 2004, JPN J CLIN ONCOL, V34, P393, DOI 10.1093/jjco/hyh070
   Leeb BF, 2003, RHEUMATOLOGY, V42, P1173, DOI 10.1093/rheumatology/keg319
   Liberati Alessandro, 2009, PLOS MED, V6, Pe1000100, DOI 10.1371/journal.pmed.1000100
   Liberati Alessandro, 2009, BMJ-BRIT MED J, V339, Pb2700, DOI 10.1136/bmj.b2700
   Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006
   Lintermans A, 2013, ANN ONCOL, V24, P350, DOI 10.1093/annonc/mds290
   Liu MH, 2012, BREAST CANCER RES, V14, P0, DOI 10.1186/bcr3137
   Lu WD, 2010, CURR TREAT OPTION ON, V11, P141, DOI 10.1007/s11864-010-0126-0
   Mao JJ, 2009, INTEGR CANCER THER, V8, P123, DOI 10.1177/1534735409332903
   Mao JJ, 2014, EUR J CANCER, V50, P267, DOI 10.1016/j.ejca.2013.09.022
   McDonnell DP, 1999, TRENDS ENDOCRIN MET, V10, P301, DOI 10.1016/S1043-2760(99)00177-0
   McManus Claire A, 2007, ACUPUNCT MED, V25, P36
   Mendoza T, 2006, EUR J PAIN, V10, P353, DOI 10.1016/j.ejpain.2005.06.002
   Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356
   Morales L, 2008, J CLIN ONCOL, V26, P3147, DOI 10.1200/JCO.2007.15.4005
   Oh B, 2013, ACUPUNCT MED, V31, P264, DOI 10.1136/acupmed-2012-010309
   Paley CA, 2011, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD007753.pub2
   Partridge AH, 2003, J CLIN ONCOL, V21, P602, DOI 10.1200/JCO.2003.07.071
   Salaffi F, 2003, OSTEOARTHR CARTILAGE, V11, P551, DOI 10.1016/S1063-4584(03)00089-X
   SJOLUND B, 1977, ACTA PHYSIOL SCAND, V100, P382, DOI 10.1111/j.1748-1716.1977.tb05964.x
   Towler P, 2013, SUPPORT CARE CANCER, V21, P2913, DOI 10.1007/s00520-013-1882-8
   VALLADARES LE, 1979, ENDOCRINOLOGY, V105, P431, DOI 10.1210/endo-105-2-431
   Victorson D, 2008, QUAL LIFE RES, V17, P1137, DOI 10.1007/s11136-008-9398-2
   Wu MT, 2002, NEUROIMAGE, V16, P1028, DOI 10.1006/nimg.2002.1145
   Yoo YC, 2011, YONSEI MED J, V52, P1016, DOI 10.3349/ymj.2011.52.6.1016
NR 56
TC 46
Z9 51
U1 0
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1075-5535
EI 1557-7708
J9 J ALTERN COMPLEM MED
JI J. Altern. Complement Med.
PD MAY 1
PY 2015
VL 21
IS 5
BP 251
EP 260
DI 10.1089/acm.2014.0083
PG 10
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CH5WA
UT WOS:000354105100001
PM 25915433
DA 2026-01-16
ER

PT J
AU Wu, XY
   Chung, VCH
   Hui, EP
   Ziea, ETC
   Ng, BFL
   Ho , RST
   Tsoi, KKF
   Wong, SYS
   Wu, JCY
AF Wu, Xinyin
   Chung, Vincent C. H.
   Hui, Edwin P.
   Ziea, Eric T. C.
   Ng, Bacon F. L.
   Ho, Robin S. T.
   Tsoi, Kelvin K. F.
   Wong, Samuel Y. S.
   Wu, Justin C. Y.
TI Effectiveness of acupuncture and related therapies for palliative care of cancer: overview of systematic reviews
SO SCIENTIFIC REPORTS
LA English
DT Article
ID search strategy; hot flashes; metaanalyses; management; safety; pain; interventions; moxibustion; fatigue; quality
AB Acupuncture and related therapies such as moxibustion and transcutaneous electrical nerve stimulation are often used to manage cancer-related symptoms, but their effectiveness and safety are controversial. We conducted this overview to summarise the evidence on acupuncture for palliative care of cancer. Our systematic review synthesised the results from clinical trials of patients with any type of cancer. The methodological quality of the 23 systematic reviews in this overview, assessed using the Methodological Quality of Systematic Reviews Instrument, was found to be satisfactory. There is evidence for the therapeutic effects of acupuncture for the management of cancer-related fatigue, chemotherapy-induced nausea and vomiting and leucopenia in patients with cancer. There is conflicting evidence regarding the treatment of cancer-related pain, hot flashes and hiccups, and improving patients' quality of life. The available evidence is currently insufficient to support or refute the potential of acupuncture and related therapies in the management of xerostomia, dyspnea and lymphedema and in the improvement of psychological well-being. No serious adverse effects were reported in any study. Because acupuncture appears to be relatively safe, it could be considered as a complementary form of palliative care for cancer, especially for clinical problems for which conventional care options are limited.
C1 [Wu, Xinyin; Chung, Vincent C. H.; Hui, Edwin P.; Wong, Samuel Y. S.; Wu, Justin C. Y.] Chinese Univ Hong Kong, Hong Kong Inst Integrat Med, Hong Kong, Hong Kong, Peoples R China.
   [Wu, Xinyin; Chung, Vincent C. H.; Ho, Robin S. T.; Tsoi, Kelvin K. F.; Wong, Samuel Y. S.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.
   [Hui, Edwin P.] Chinese Univ Hong Kong, Comprehens Canc Trials Unit, Hong Kong, Hong Kong, Peoples R China.
   [Ziea, Eric T. C.; Ng, Bacon F. L.] Hong Kong Hosp Author, Chinese Med Dept, Hong Kong, Hong Kong, Peoples R China.
   [Tsoi, Kelvin K. F.] Chinese Univ Hong Kong, Big Data Decis Analyt Res Ctr, Hong Kong, Hong Kong, Peoples R China.
   [Wu, Justin C. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong
RP Chung, VCH (corresponding author), Chinese Univ Hong Kong, Hong Kong Inst Integrat Med, Hong Kong, Hong Kong, Peoples R China.
EM vchung@cuhk.edu.hk
FU Hospital Authority of Hong Kong [8110016609]
CR Adams D, 2011, PEDIATRICS, V128, PE1575, DOI 10.1542/peds.2011-1091
   Unknown -, 2008, CONSUM REP, V73, P40
   Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI 10.1200/JCO.2010.34.4614
   Bow E, 2014, TREATMENT PREVENTION, V0, P0
   Chao LF, 2009, BREAST CANCER RES TR, V118, P255, DOI 10.1007/s10549-009-0533-8
   Chen HY, 2013, BMC COMPLEM ALTERN M, V13, P0, DOI 10.1186/1472-6882-13-362
   Cheon S, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/804746
   Choi TY, 2012, COMPLEMENT THER MED, V20, P447, DOI 10.1016/j.ctim.2012.07.007
   Choi TY, 2012, SUPPORT CARE CANCER, V20, P1147, DOI 10.1007/s00520-012-1432-9
   Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008
   Coster WJ, 2013, AM J OCCUP THER, V67, P162, DOI 10.5014/ajot.2013.006015
   Dos Santos S, 2010, MED ACUPUNCT, V22, P81, DOI 10.1089/acu.2009.0730
   Ezzo JM, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD002285.pub2
   Finnegan-John J, 2013, INTEGR CANCER THER, V12, P276, DOI 10.1177/1534735413485816
   Frisk JW, 2014, SUPPORT CARE CANCER, V22, P1409, DOI 10.1007/s00520-014-2126-2
   Gargon E, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0099111
   Haidich AB, 2013, J CLIN EPIDEMIOL, V66, P371, DOI 10.1016/j.jclinepi.2012.10.014
   Higgins J, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.ED000049
   Hoffmann TC, 2014, BMJ-BRIT MED J, V348, P0, DOI 10.1136/bmj.g1687
   Hurlow A, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD006276.pub3
   International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA, V0, P0
   Ioannidis JPA, 2010, BRIT MED J, V341, P0, DOI 10.1136/bmj.c4875
   Itoh Kazunori, 2008, CHIN MED, V3, P2, DOI 10.1186/1749-8546-3-2
   Joos S, 2006, SCAND J GASTROENTERO, V41, P1056, DOI 10.1080/00365520600580688
   Koornstra RHT, 2014, CANCER TREAT REV, V40, P791, DOI 10.1016/j.ctrv.2014.01.004
   Lee H, 2005, EUR J PAIN, V9, P437, DOI 10.1016/j.ejpain.2004.10.004
   Lee MS, 2009, SUPPORT CARE CANCER, V17, P763, DOI 10.1007/s00520-009-0589-3
   Lee MS, 2009, BREAST CANCER RES TR, V115, P497, DOI 10.1007/s10549-008-0230-z
   Lee S, 2014, SUPPORT CARE CANCER, V22, P1429, DOI 10.1007/s00520-014-2161-z
   Levy MH, 2009, J NATL COMPR CANC NE, V7, P436, DOI 10.6004/jnccn.2009.0031
   Lian WL, 2014, CHIN J INTEGR MED, V20, P136, DOI 10.1007/s11655-013-1439-1
   Loudon K, 2015, BMJ-BRIT MED J, V350, P0, DOI 10.1136/bmj.h2147
   Lu Weidong, 2007, J SOC INTEGR ONCOL, V5, P1, DOI 10.2310/7200.2006.035
   Lu WD, 2008, HEMATOL ONCOL CLIN N, V22, P631, DOI 10.1016/j.hoc.2008.04.005
   Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47
   Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732
   OSullivan EM, 2010, ACUPUNCT MED, V28, P191, DOI 10.1136/aim.2010.002733
   Paley CA, 2011, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD007753.pub2
   Peng Hao, 2010, ZHONG XI YI JIE HE XUE BAO, V8, P501
   Piao HH, 2010, LISHIZHEN MED MAT ME, V21, P1476, DOI 10.3969/j.issn.1008-0805.2010.06.087
   Posadzki P, 2013, SUPPORT CARE CANCER, V21, P2067, DOI 10.1007/s00520-013-1765-z
   Prady SL, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001577
   Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518
   Shea BJ, 2007, BMC MED RES METHODOL, V7, P0, DOI 10.1186/1471-2288-7-10
   Towler P, 2013, SUPPORT CARE CANCER, V21, P2913, DOI 10.1007/s00520-013-1882-8
   Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654
   Wilczynski NL, 2007, J CLIN EPIDEMIOL, V60, P29, DOI 10.1016/j.jclinepi.2006.04.001
   Witt CM, 2012, BMC COMPLEM ALTERN M, V12, P0, DOI 10.1186/1472-6882-12-148
   Wu XY, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/812179
   Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE
   Zeng YC, 2014, INTEGR CANCER THER, V13, P193, DOI 10.1177/1534735413510024
   Zhang JH, 2010, B WORLD HEALTH ORGAN, V88, P915, DOI 10.2471/BLT.10.076737
   Zheng Y, 2014, J LIAONING UNIV TRADIT CHIN MED, V16, P152, DOI 10.13194/j.issn.1673-842x.2014.01.055
NR 55
TC 59
Z9 60
U1 0
U2 60
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD NOV 26
PY 2015
VL 5
IS 
BP 
EP 
DI 10.1038/srep16776
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CX0JJ
UT WOS:000365382400001
DA 2026-01-16
ER

PT J
AU Fiorini, FR
   Santoro, R
   Cristofaro, G
   Buongiorno, A
   Mannelli, G
   Picconi, M
   Gallo, O
AF Fiorini, F. R.
   Santoro, R.
   Cristofaro, G.
   Buongiorno, A.
   Mannelli, G.
   Picconi, M.
   Gallo, O.
TI Potential use of acupuncture in the treatment of first bite syndrome
SO AMERICAN JOURNAL OF OTOLARYNGOLOGY
LA English
DT Article
ID parapharyngeal space; botulinum toxin; complication; surgery
AB Objectives: First bite syndrome (FBS) is an early postoperative pain syndrome characterized by the sudden onset of pain in the parotid region at the first bite of each meal. The etiology is not certain, hence a standardized therapy does not exist. Methods: A 50-year old woman referred to us complaining of a swelling in the right parotid region. Fine-needle aspiration biopsy (FNAB) was diagnostic for pleomorphus adenoma of the deep lobe of the parotid gland. A 50-year old man presented with a mass in the right side of the neck, FNAB was diagnostic for parapharyngeal space neurinoma. The first patient was submitted to total parotidectomy with facial nerve preservation, the second to extracapsular dissection of the tumor. A week after surgery both patients developed FBS. A qualitative/quantitative description of pain was obtained by means of a self-coded questionnaire. The score ranges from 8 to 44, corresponding to the lowest and the highest discomfort possible, respectively. Acupuncture was used to treat these 2 patients. The treatment protocol comprised 6 sessions, one per week, lasting 30 minutes each. Results: Our questionnaire was administered before and after treatment and the score dropped from 33 to 25 in the female, from 30 to 15 in the male patient. Conclusion: PBS is a complication of upper cervical surgery with a high morbidity rate. We describe the first two cases of FBS that were successfully treated with acupuncture in our ENT department We believe that this procedure may represent a valid therapeutic alternative in the future. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Fiorini, F. R.; Santoro, R.; Cristofaro, G.; Buongiorno, A.; Mannelli, G.; Gallo, O.] Univ Florence, Deparment Surg & Translat Med, Otorhinolaryngol Clin 1, I-50121 Florence, Italy.
   [Picconi, M.] Sinergie Private Practice & Panakeia, Sch Naturopathy, Florence, Italy.
C3 University of Florence
RP Fiorini, FR (corresponding author), Via Largo Brambilla 3, I-50134 Florence, Italy.
EM francescaromanafiorini@gmail.com
CR Abdeldaoui A, 2013, EUR ANN OTORHINOLARY, V130, P123, DOI 10.1016/j.anorl.2012.08.001
   Albasri H, 2011, BRIT J ORAL MAX SURG, V49, P154, DOI 10.1016/j.bjoms.2009.10.035
   Ali MJ, 2008, OTOLARYNG HEAD NECK, V139, P742, DOI 10.1016/j.otohns.2008.08.015
   Amin N, 2014, J LARYNGOL OTOL, V128, P166, DOI 10.1017/S002221511300354X
   Chiu AG, 2002, HEAD NECK-J SCI SPEC, V24, P996, DOI 10.1002/hed.10162
   Deganello A, 2011, J LARYNGOL OTOL, V125, P428, DOI 10.1017/S002221511000294X
   Diercks GR, 2011, LARYNGOSCOPE, V121, P760, DOI 10.1002/lary.21282
   Kawashima Y, 2008, AURIS NASUS LARYNX, V35, P109, DOI 10.1016/j.anl.2007.06.005
   Laccourreye O, 2013, EUR ANN OTORHINOLARY, V130, P269, DOI 10.1016/j.anorl.2012.11.003
   Lee BJ, 2009, HEAD NECK-J SCI SPEC, V31, P989, DOI 10.1002/hed.21054
   Lieberman SM, 2011, HEAD NECK-J SCI SPEC, V33, P1539, DOI 10.1002/hed.21412
   Linkov G, 2012, LARYNGOSCOPE, V122, P1773, DOI 10.1002/lary.23372
   Martlew RA, 2009, ANAESTHESIA, V64, P97, DOI 10.1111/j.1365-2044.2008.05804.x
   Netterville JL, 1998, ARCH OTOLARYNGOL, V124, P1133, DOI 10.1001/archotol.124.10.1133
   Pfister DG, 2010, J CLIN ONCOL, V28, P2565, DOI 10.1200/JCO.2009.26.9860
NR 15
TC 7
Z9 11
U1 0
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0196-0709
EI 1532-818X
J9 AM J OTOLARYNG
JI Am. J. Otolaryngol.
PD MAY-JUN 15
PY 2015
VL 36
IS 3
BP 484
EP 487
DI 10.1016/j.amjoto.2015.01.023
PG 4
WC Otorhinolaryngology
SC Otorhinolaryngology
GA CI2QU
UT WOS:000354592900036
PM 25783766
DA 2026-01-16
ER

PT J
AU Thompson, LM
   Osian, SR
   Jacobsen, PB
   Johnstone, PA
AF Thompson, Lora M A
   Osian, Sarah Rausch
   Jacobsen, Paul B
   Johnstone, Peter A S
TI Patient-reported Outcomes of Acupuncture for Symptom Control in Cancer.
SO Journal of acupuncture and meridian studies
LA English
DT Journal Article
DE acupuncture; cancer symptom management; patient-reported outcomes; quality of life; satisfaction
AB Acupuncture is increasingly offered as a treatment option for managing  cancer-related symptoms. In addition to randomized controlled trials,  patient-reported outcomes may be needed to establish treatment effectiveness.  This study retrospectively examined the symptoms and the satisfaction ratings of  90 patients receiving acupuncture at an integrative oncology clinic. At least two  acupuncture sessions were completed by 72% of the sample. The prevalence rates of  fatigue, pain, anxiety, physical distress, emotional distress, and poor quality  of life before acupuncture were > 62%. Paired t tests revealed a significant  reduction in symptoms from baseline until after the first acupuncture session and  after the last session (p < 0.05). Fewer (21%) patients reported nausea, which  was significantly reduced after the first session, but not the last session.  Reductions represented clinically meaningful differences in 33-41% of patients  after the first session and in 41-53% of patients after the last session for all  symptoms, except nausea. A small subset of patients (0-8%) reported worsening  symptoms after acupuncture. The majority were satisfied with the service. The  results of this study suggest that acupuncture may be useful as an adjunct  treatment for cancer symptom management. While high-quality trials are still  needed to establish the treatment's efficacy, patients may benefit from these  primarily safe, low-cost services.
C1 H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA. 
   Center for Health Equity and Quality Research, Department of Emergency Medicine, Divisions of Palliative Care and Corporate Wellness, University of FloridaJacksonville, Jacksonville, USA.
   H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
   H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
EM lora.thompson@moffitt.org
NR 0
TC 0
SN 2093-815
EI 
J9 J Acupunct Meridian Stud
PD JUN 24
PY 2015
VL 8
IS 3
BP 127
EP 33
DI 10.1016/j.jams.2015.04.002
PG -94
WC Acupuncture Therapy; Adult; Aged; Fatigue; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; psychology; Pain; Patient Outcome Assessment; Patient Satisfaction; Quality of Life; Retrospective Studies; Young Adult
UT PubMed:26100066
PM 26100066
DA 2015-06-24
ER

PT J
AU Xiong, XJ
   Li, SJ
   Zhang, YQ
AF Xiong, X. J.
   Li, S. J.
   Zhang, Y. Q.
TI Massage therapy for essential hypertension: a systematic review
SO JOURNAL OF HUMAN HYPERTENSION
LA English
DT Review
ID traditional chinese medicine; blood-pressure; alternative therapy; randomized-trial; tissue massage; breast-cancer; global burden; complementary; acupuncture; perspective
AB Massage, an ancient Chinese healing art, is widely practiced for symptom relief in hypertensive patients with anxiety, depression, headache, vertigo, chronic pain in neck, shoulder and back. A large number of case series and clinical trials have been published. However, it is still unclear whether massage can be recommended as an effective therapy for essential hypertension (EH). We estimated the current clinical evidence of massage for EH. Articles published before 10 December 2013 were searched using Cochrane Library, PubMed, EMBASE, Chinese Scientific Journal Database (VIP), Chinese Biomedical Literature Database, Wanfang data and Chinese National Knowledge Infrastructure. Randomized controlled trials comparing massage with any type of control intervention were included. Trials testing massage combined with antihypertensive drugs versus antihypertensive drugs were included as well. Meta-analysis was performed on the effects on blood pressure (BP). Twenty-four articles involving 1962 patients with EH were selected. Methodological quality of most trials was evaluated as generally low. Meta-analyses demonstrated that massage combined with antihypertensive drugs may be more effective than antihypertensive drugs alone in lowering both systolic BP (SBP; mean difference (MD): - 6.92 (- 10.05, - 3.80); P<0.0001) and diastolic BP (MD: - 3.63 (- 6.18, - 1.09); P = 0.005); massage appears beneficial for reducing SBP (MD: - 3.47 (- 5.39, - 1.56); P = 0.0004) for hypertensive patients as compared with antihypertensive drugs. Safety of massage is still unclear. There is some encouraging evidence of massage for EH. However, because of poor methodological quality, the evidence remains weak. Rigorously designed trials are needed to validate the use of massage in future.
C1 [Xiong, X. J.] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Cardiol, Beijing 100053, Peoples R China.
   [Li, S. J.] Tsinghua Univ, Sch Life Sci, Dept Biol Sci & Technol, Beijing 100084, Peoples R China.
   [Zhang, Y. Q.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
C3 China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Tsinghua University; McMaster University
RP Xiong, XJ (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Dept Cardiol, Beixiange 5, Beijing 100053, Peoples R China.
EM xiongxingjiangtcm@163.com
CR Unknown -, 2005, SEQUENCE STRATIGRAPH, V0, P0
   Aourell Moa, 2005, COMPLEMENT THER CLIN PRACT, V11, P242, DOI 10.1016/j.ctcp.2005.02.008
   Bramlage P, 2010, J CLIN HYPERTENS, V12, P666, DOI 10.1111/j.1751-7176.2010.00322.x
   Brattberg G, 1999, EUR J PAIN, V3, P235, DOI 10.1016/S1090-3801(99)90050-2
   Braun LA, 2012, J THORAC CARDIOV SUR, V144, P1453, DOI 10.1016/j.jtcvs.2012.04.027
   Brook RD, 2013, HYPERTENSION, V61, P1360, DOI 10.1161/HYP.0b013e318293645f
   CAFARELLI E, 1992, SPORTS MED, V14, P1, DOI 10.2165/00007256-199214010-00001
   Cambron JA, 2006, J ALTERN COMPLEM MED, V12, P65, DOI 10.1089/acm.2006.12.65
   Cassileth BR, 2004, J PAIN SYMPTOM MANAG, V28, P244, DOI 10.1016/j.jpainsymman.2003.12.016
   [陈军 Chen Jun], 2010, 中华中医药杂志 CHINA JOURNAL OF TRADITIONAL CHINESE MEDICINE AND PHARMACY, V25, P1708
   Cherkin DC, 2003, ANN INTERN MED, V138, P898, DOI 10.7326/0003-4819-138-11-200306030-00011
   Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Day A L, 2009, G ITAL MED LAV ERGON, V31, P0
   Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569
   Ernst E, 2003, RHEUMATOLOGY, V42, P1101, DOI 10.1093/rheumatology/keg306
   Ezzati Majid, 2002, LANCET (NORTH AMERICAN EDITION), V360, P1347, DOI 10.1016/S0140-6736(02)11403-6
   Fellowes D, 2004, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858
   Field TM, 1998, AM PSYCHOL, V53, P1270, DOI 10.1037/0003-066X.53.12.1270
   Fisher JW, 1914, J AMER MED ASSOC, V63, P1752
   Flachskampf FA, 2007, CIRCULATION, V115, P3121, DOI 10.1161/CIRCULATIONAHA.106.661140
   Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013
   GOATS GC, 1994, BRIT J SPORT MED, V28, P153, DOI 10.1136/bjsm.28.3.153
   Hansen NV, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004989.pub2
   Hernandez-Reif M, 1998, INT J NEUROSCI, V96, P1
   Hu J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028696
   Hu Jun, 2005, ZHONG XI YI JIE HE XUE BAO, V3, P429
   Hur MH, 2007, INT J NEUROSCI, V117, P1281, DOI 10.1080/00207450600936650
   IRNICH D, 2001, BRITISH MEDICAL JOURNAL, V322, P1
   Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006
   Ju MS, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/403251
   Kangas M, 2008, PSYCHOL BULL, V134, P700, DOI 10.1037/a0012825
   Kaplan NM, 2006, HYPERTENSION, V48, P815, DOI 10.1161/01.HYP.0000241069.80574.76
   Kaye AD, 2008, J ALTERN COMPLEM MED, V14, P125, DOI 10.1089/acm.2007.0665
   Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3
   Kutner JS, 2008, ANN INTERN MED, V149, P369, DOI 10.7326/0003-4819-149-6-200809160-00003
   Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8
   Lee MS, 2007, J HYPERTENS, V25, P1525, DOI 10.1097/HJH.0b013e328092ee18
   Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
   Liberati Alessandro, 2009, PLOS MED, V6, Pe1000100, DOI 10.1371/journal.pmed.1000100
   Lin MC, 2001, CIRCULATION, V103, P2038
   Liu JP, 2013, BMJ OPEN, V3, P0, DOI 10.1136/bmjopen-2013-002968
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Mansoor GA, 2001, AM J HYPERTENS, V14, P971, DOI 10.1016/S0895-7061(01)02172-0
   Mashour NH, 1998, ARCH INTERN MED, V158, P2225, DOI 10.1001/archinte.158.20.2225
   Moeini Mahin, 2011, IRAN J NURS MIDWIFERY RES, V16, P61
   Moraska A, 2010, EVID-BASED COMPL ALT, V7, P409, DOI 10.1093/ecam/nen029
   Morris KT, 2000, AM J SURG, V179, P407, DOI 10.1016/S0002-9610(00)00358-5
   Moyer CA, 2004, PSYCHOL BULL, V130, P3, DOI 10.1037/0033-2909.130.1.3
   Olney CM, 2005, BIOL RES NURS, V7, P98, DOI 10.1177/1099800405280827
   Perlman AI, 2006, ARCH INTERN MED, V166, P2533, DOI 10.1001/archinte.166.22.2533
   Plaugher G, 2002, J MANIP PHYSIOL THER, V25, P221, DOI 10.1067/mmt.2002.123171
   Rees RW, 2000, EUR J CANCER, V36, P1359, DOI 10.1016/S0959-8049(00)00099-X
   REISSLAND N, 1987, SOC SCI MED, V25, P231, DOI 10.1016/0277-9536(87)90226-7
   Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232
   Scott M, 2009, J EQUINE VET SCI, V29, P687, DOI 10.1016/j.jevs.2009.07.017
   Supaat I, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/171852
   Vickers A, 1999, BRIT MED J, V319, P1254, DOI 10.1136/bmj.319.7219.1254
   Vickers A, 2004, COCHRANE DATABASE OF SYSTEMATIC REVIEWS, V0, P0, DOI DOI 10.1002/14651858.CD000390.PUB2
   Vora CK, 2005, CURR HYPERTENS REP, V7, P275, DOI 10.1007/s11906-005-0025-0
   Wandell P E, 2013, DIABETES METAB, V39, P411, DOI 10.1016/j.diabet.2013.02.002
   Wang JX, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082745
   Wang J, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/215254
   Wang J, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/978398
   Wang J, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/706125
   Wang J, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/268542
   Weerapong P, 2005, SPORTS MED, V35, P235, DOI 10.2165/00007256-200535030-00004
   Wu XY, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/812179
   Xiong XJ, 2014, COMPLEMENT THER MED, V22, P187, DOI 10.1016/j.ctim.2013.11.005
   Xiong XJ, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/275279
   Xiong XJ, 2013, HYPERTENS RES, V36, P570, DOI 10.1038/hr.2013.18
   Zeitlin D, 2000, PSYCHOSOM MED, V62, P83, DOI 10.1097/00006842-200001000-00012
NR 95
TC 32
Z9 41
U1 1
U2 50
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0950-9240
EI 1476-5527
J9 J HUM HYPERTENS
JI J. Hum. Hypertens.
PD MAR 15
PY 2015
VL 29
IS 3
BP 143
EP 151
DI 10.1038/jhh.2014.52
PG 9
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA CB5MM
UT WOS:000349671500002
PM 24990417
DA 2026-01-16
ER

PT J
AU Lee, JW
   Lee, WB
   Kim, W
   Min, BI
   Lee, H
   Cho, SH
AF Lee, Jung-Woo
   Lee, Won Bock
   Kim, Woojin
   Min, Byung-Il
   Lee, HyangSook
   Cho, Seung-Hun
TI Traditional herbal medicine for cancer pain: A systematic review and meta-analysis
SO COMPLEMENTARY THERAPIES IN MEDICINE
LA English
DT Review
DE Traditional herbal medicine; Cancer pain; Systematic review; Meta-analysis
ID randomized controlled-trials; quality-of-life; acupuncture treatment
AB Background: The effectiveness of traditional herbal medicine (THM) as an adjunctive therapy for cancer pain is unclear. Objective: To assess the effectiveness of THM as an adjunctive therapy for cancer pain using randomized controlled trials (RCTs). Methods: Five electronic databases, including those from the UK and China, were systematically searched for the period before September 2013. All RCTs involving the use of THM in combination with conventional cancer therapy for cancer pain were included. Results: Twenty-four RCTs involving 4889 patients with cancer pain were systematically reviewed. Among them, nine studies of 952 patients reported a significant decrease in the number of patients with cancer pain in the treatment group. Four studies of 1696 patients reported a significant decrease in the degree of pain in the treatment group. Conclusion: The results of these studies suggest that THM combined with conventional therapy is efficacious as an adjunctive therapy for patients with cancer pain. However, more research, including well-designed, rigorous, and larger clinical trials, are necessary to address these issues. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Lee, Jung-Woo; Lee, Won Bock; Kim, Woojin; Min, Byung-Il] Kyung Hee Univ, Grad Sch, Dept East West Med, Seoul 130701, South Korea.
   [Min, Byung-Il] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul 130701, South Korea.
   [Lee, HyangSook] Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul 130701, South Korea.
   [Cho, Seung-Hun] Kyung Hee Univ, Med Ctr, Hosp Korean Med, Seoul 130701, South Korea.
C3 Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital
RP Cho, SH (corresponding author), Kyung Hee Univ, Med Ctr, Hosp Korean Med, 1 Heogi Dong, Seoul 130701, South Korea.
EM chosh@khmc.or.kr
FU National Research Foundation of Korea (NRF) - Korea government [MEST] [2012-0005755]
CR Bao YJ, 2010, CHIN J INTEGR MED, V16, P309, DOI 10.1007/s11655-010-0501-5
   Cao J, 2006, CAO JIANXIONG XU GUI, V13, P48
   Chan KKL, 2011, ANN ONCOL, V22, P2241, DOI 10.1093/annonc/mdq749
   Chen G, 2005, JIANGSU TRADITIONAL, V26, P16
   Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569
   ERNST E, 1994, J LAB CLIN MED, V124, P178
   Feng Ying-Lu, 2005, ZHONGGUO ZHONG XI YI JIE HE ZA ZHI, V25, P534
   Gözüm S, 2003, CANCER NURS, V26, P230
   Higgins JP, 2011, COCHRANE HDB SYSTEMA, V5, P0
   Hróbjartsson A, 2010, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003974.pub3
   Jeong JS, 2010, INTEGR CANCER THER, V9, P331, DOI 10.1177/1534735410383170
   LI HL, 2002, HEBEI MED J, V26, P146
   Lin D, 2001, NEW CHIN MED, V33, P18, DOI 10.1097/00004836-200111000-00018
   Lin Jian-jun, 2005, CHIN J INTEGR MED, V11, P104
   Liu J, 2001, ZHONGGUO ZHONG XI YI JIE HE ZA ZHI, V21, P262
   Ma T, 2003, CHINA J CANC PREV TR, V10, P297, DOI 10.16073/j.cnki.cjcpt.2003.03.029
   Madsen MV, 2009, BMJ-BRIT MED J, V338, P0, DOI 10.1136/bmj.a3115
   MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W
   Moher D, 2000, BJS-BRIT J SURG, V87, P1448, DOI 10.1046/j.1365-2168.2000.01610.x
   Pan Yun-Ling, 2007, ZHONGGUO ZHONG XI YI JIE HE ZA ZHI, V27, P807
   Pan Yun-ling, 2006, ZHONGGUO ZHONG XI YI JIE HE ZA ZHI, V26, P604
   Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003
   Richardson MA, 2000, J CLIN ONCOL, V18, P2505, DOI 10.1200/JCO.2000.18.13.2505
   Schuler MS, 2005, J AM GERIATR SOC, V53, P549, DOI 10.1111/j.1532-5415.2005.53178_6.x
   SHI HC, 2005, GUIDING J TCM, V11, P21
   Tian HQ, 2010, CHIN J INTEGR MED, V16, P102, DOI 10.1007/s11655-010-0102-3
   Tian JH, 2010, AM J CHINESE MED, V38, P15, DOI 10.1142/S0192415X10007646
   van den Beuken-van Everdingen MHJ, 2009, J PAIN SYMPTOM MANAG, V38, P216, DOI 10.1016/j.jpainsymman.2008.08.014
   Wan D, 2004, CHIN J INTEGR MED, V10, P175
   Wang B, 2000, ZHONGGUO ZHONG XI YI JIE HE ZA ZHI, V20, P736
   [魏琳 Wei Lin], 2003, 中国新药杂志 CHINESE JOURNAL NEW DRUGS, V12, P663
   Wu Mian-hua, 2005, ZHONGGUO ZHONG XI YI JIE HE ZA ZHI, V25, P218
   Wu TH, 2008, ASIA PAC J CLIN NUTR, V17, P17
   Xu L, 2007, INTEGR CANCER THER, V6, P208, DOI 10.1177/1534735407305705
   Zhang M, 2001, ACTA U TRADITIONIS M, V15, P31, DOI 10.16306/j.1008-861x.2001.02.012
   Zhang Qing, 2007, ZHONGGUO ZHONG XI YI JIE HE ZA ZHI, V27, P400
   Zhang Ting, 2006, CHIN J INTEGR MED, V12, P180
NR 37
TC 30
Z9 32
U1 0
U2 12
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0965-2299
EI 1873-6963
J9 COMPLEMENT THER MED
JI Complement. Ther. Med.
PD APR 15
PY 2015
VL 23
IS 2
BP 265
EP 274
DI 10.1016/j.ctim.2015.02.003
PG 10
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CH0TE
UT WOS:000353734500016
PM 25847565
DA 2026-01-16
ER

PT J
AU Berberian, P
   Obimba, C
   Glickman-Simon, R
   Sethi, T
AF Berberian, Peter
   Obimba, Chinyere
   Glickman-Simon, Richard
   Sethi, Tanmeet
TI Herbs for Low-Back Pain, Acupuncture for Psychological Distress, Osteopathic
SO Explore (New York, N.Y.)
LA English
DT Journal Article
NR 0
TC 0
SN 1878-754
EI 
J9 Explore (NY)
PD AUG 5
PY 2015
VL 11
IS 5
BP 410
EP 4
DI 10.1016/j.explore.2015.07.011
PG -406
UT PubMed:26238168
PM 26238168
DA 2015-08-05
ER

PT J
AU Li, GY
   Li, SQ
   Sun, LZ
   Lin, FG
   Wang, BG
AF Li, Guoyan
   Li, Shuqin
   Sun, Lizhi
   Lin, Fangcai
   Wang, Baoguo
TI A comparison study of immune-inflammatory response in electroacupuncture and transcutaneous electrical nerve stimulation for patients undergoing supratentorial craniotomy
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Transcutaneous electrical nerve stimulation (TENS); electroacupuncture (EA); immuno-inflammatory; supratentorial craniotomy
ID low-back-pain; rats; release; block
AB Objective: The effect of transcutaneous electrical nerve stimulation (TENS) on immuno-inflammatory response was tested and the differences between electroacupuncture (EA) and TENS in immuno-inflammatory response in patients undergoing supratentorial craniotomy were explored. Methods: 51 patients received craniotomy were randomly divided into 3 groups: control (group C, n=18), EA (group A, n=19) and TENS (group T, n=14) groups. Blood samples were collected before anesthesia (TO) and 30 min (T1), 2 h (T2) and 4 h (T3) after induction of anesthesia to measure the levels of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-8, IL-10, IgM, IgA and IgG. Results: No significant difference existed between group A and group T during craniotomy. IgM and IgA decreased significantly in group C compared with groups A and T at T2 and T3 time points. Compared with group C, there were significant differences in TNF-a, IgM and IgA levels at TO in groups A and T; no significant difference was found in the levels of IgG, IL-10 and IL-8. Conclusion: EA and TENS could reduce immunosuppression in patients undergoing supratentorial craniotomy and it has significance in choice of treatment in immunosuppressive therapy.
C1 [Li, Guoyan; Sun, Lizhi] North China Grid Co Ltd, Beijing Elect Power Hosp, Dept Anesthesiol, Beijing, Peoples R China.
   [Li, Shuqin] Beijing Tiantan Hosp, Dept Anesthesiol, Beijing, Peoples R China.
   [Lin, Fangcai] North China Grid Co Ltd, Beijing Elect Power Hosp, Dept Gen Surg, Beijing, Peoples R China.
   [Wang, Baoguo] Beijing Sanbo Brain Hosp, Dept Anesthesiol & Pain Management, Beijing, Peoples R China.
C3 Capital Medical University; Capital Medical University
RP Wang, BG (corresponding author), Sanbo Brain Hosp, Dept Anesthesiol, 50 Xiang Shan Yi Ke Song, Beijing 100093, Peoples R China.
EM baoguowang77@126.com
FU state grid program of science and technology [SGHBOOO-AJJS1400182]; National Key Basic Research Program on innovation and application study of combined acupuncture drug [2013CB531901]
CR Arai YC, 2012, EVID-BASED COMPL ALT, V0, P0
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chu H, 2013, BMC COMPLEM ALTERN M, V13, P0, DOI 10.1186/1472-6882-13-84
   DeSantana Josimari M, 2008, CURR RHEUMATOL REP, V10, P492
   Ding LC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057477
   Fang JF, 2013, BMC COMPLEM ALTERN M, V13, P0, DOI 10.1186/1472-6882-13-134
   Gu G, 2011, J INT MED RES, V39, P1783, DOI 10.1177/147323001103900521
   Keskin EA, 2012, GYNECOL OBSTET INVES, V74, P76, DOI 10.1159/000337720
   Khalil Z, 2000, J GERONTOL A-BIOL, V55, PB257, DOI 10.1093/gerona/55.6.B257
   Kita K, 2013, J NEUROENG REHABIL, V10, P0, DOI 10.1186/1743-0003-10-55
   Kloth L C, 1996, ADV WOUND CARE, V9, P42
   Kutlu AK, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/361832
   Lan F, 2012, MINERVA ANESTESIOL, V78, P887
   Li GY, 2013, ACUPUNCT MED, V31, P51, DOI 10.1136/acupmed-2012-010254
   Liu SJ, 2011, ANESTH ANALG, V113, P572, DOI 10.1213/ANE.0b013e3182278237
   Pinosky ML, 1996, ANESTH ANALG, V83, P1256, DOI 10.1097/00000539-199612000-00022
   Sabino GS, 2008, J PAIN, V9, P157, DOI 10.1016/j.jpain.2007.09.003
   Sluka KA, 2006, ARCH PHYS MED REHAB, V87, P1137, DOI 10.1016/j.apmr.2006.04.023
   Stein C, 2013, BRAZ J PHYS THER, V17, P93, DOI 10.1590/S1413-35552012005000083
   Trinh K, 2007, SPINE, V32, P236, DOI 10.1097/01.brs.0000252100.61002.d4
   WANG JQ, 1992, INT J NEUROSCI, V65, P117, DOI 10.3109/00207459209003283
   Yokoyama M, 2001, ANESTH ANALG, V92, P463, DOI 10.1213/00000539-200102000-00035
   Zaniewska R, 2012, MED PR, V63, P295
   Zhang WT, 2003, NEUROREPORT, V14, P1591, DOI 10.1097/00001756-200308260-00010
NR 24
TC 1
Z9 4
U1 0
U2 6
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
EI 
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PD JUN 15
PY 2015
VL 8
IS 1
BP 1156
EP 1161
DI 
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CB8RA
UT WOS:000349897200140
PM 25785107
DA 2026-01-16
ER

PT J
AU Rossi, E
   Vita, A
   Baccetti, S
   Di Stefano, M
   Voller, F
   Zanobini, A
AF Rossi, Elio
   Vita, Alessandra
   Baccetti, Sonia
   Di Stefano, Mariella
   Voller, Fabio
   Zanobini, Alberto
TI Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe
SO SUPPORTIVE CARE IN CANCER
LA English
DT Article
DE Complementary and alternative medicine; Integrative oncology; European centres; Cancer patients; EPAAC survey
ID prevalence; care
AB The Region of Tuscany Health Department was included as an associated member in WP7 "Healthcare" of the European Partnership for Action Against Cancer (EPAAC), initiated by the EU Commission in 2009. The principal aim was to map centres across Europe prioritizing those that provide public health services and operating within the national health system in integrative oncology (IO). A cross-sectional descriptive survey design was used to collect data. A questionnaire was elaborated concerning integrative oncology therapies to be administered to all the national health system oncology centres or hospitals in each European country. These institutes were identified by convenience sampling, searching on oncology websites and forums. The official websites of these structures were analysed to obtain more information about their activities and contacts. Information was received from 123 (52.1 %) out of the 236 centres contacted until 31 December 2013. Forty-seven out of 99 responding centres meeting inclusion criteria (47.5 %) provided integrative oncology treatments, 24 from Italy and 23 from other European countries. The number of patients seen per year was on average 301.2 +/- 337. Among the centres providing these kinds of therapies, 33 (70.2 %) use fixed protocols and 35 (74.5 %) use systems for the evaluation of results. Thirty-two centres (68.1 %) had research in progress or carried out until the deadline of the survey. The complementary and alternative medicines (CAMs) more frequently provided to cancer patients were acupuncture 26 (55.3 %), homeopathy 19 (40.4 %), herbal medicine 18 (38.3 %) and traditional Chinese medicine 17 (36.2 %); anthroposophic medicine 10 (21.3 %); homotoxicology 6 (12.8 %); and other therapies 30 (63.8 %). Treatments are mainly directed to reduce adverse reactions to chemo-radiotherapy (23.9 %), in particular nausea and vomiting (13.4 %) and leucopenia (5 %). The CAMs were also used to reduce pain and fatigue (10.9 %), to reduce side effects of iatrogenic menopause (8.8 %) and to improve anxiety and depression (5.9 %), gastrointestinal disorders (5 %), sleep disturbances and neuropathy (3.8 %). Mapping of the centres across Europe is an essential step in the process of creating a European network of centres, experts and professionals constantly engaged in the field of integrative oncology, in order to increase, share and disseminate the knowledge in this field and provide evidence-based practice.
C1 [Rossi, Elio; Vita, Alessandra; Baccetti, Sonia; Di Stefano, Mariella] Tuscan Network Integrat Med, Reg Hlth Minist Reg Tuscany Italy, Dept Res Innovat & Human Resources, I-50100 Florence, Italy.
   [Voller, Fabio] Tuscan Reg Agcy Healthcare, Operat Unit Epidemiol, Florence, Italy.
   [Zanobini, Alberto] Reg Hlth Minist Reg Tuscany, Dept Res Innovat & Human Resources, Florence, Italy.
RP Rossi, E (corresponding author), Tuscan Network Integrat Med, Reg Hlth Minist Reg Tuscany Italy, Dept Res Innovat & Human Resources, Via T Alderotti 26 N, I-50100 Florence, Italy.
EM retemedicinaintegrata@regione.toscana.it
FU European Union through the Executive Agency for Health and Consumers of the European Commission
CR Ben-Arye E, 2013, MED ONCOL, V30, P0, DOI 10.1007/s12032-013-0511-1
   Boon H, 2004, BMC HEALTH SERV RES, V4, P0, DOI 10.1186/1472-6963-4-15
   CASSILETH BR, 2005, INTEGRATIVE ONCOLOGY, V0, P0
   Cramer H, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/383142
   Deng Gary E, 2009, J SOC INTEGR ONCOL, V7, P85
   Egan Bernadette, 2012, COMPLEMENT THER CLIN PRACT, V18, P75, DOI 10.1016/j.ctcp.2011.11.003
   Ernst E, 2000, COMPLEMENT THER MED, V8, P32, DOI 10.1016/S0965-2299(00)90833-1
   Ernst E, 1998, CANCER-AM CANCER SOC, V83, P777, DOI 10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O
   Gansler T, 2008, CANCER-AM CANCER SOC, V113, P1048, DOI 10.1002/cncr.23659
   Horneber M, 2012, INTEGR CANCER THER, V11, P187, DOI 10.1177/1534735411423920
   Johannessen H, 2008, TUMORI, V94, P406
   Mittring N, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/316950
   Molassiotis A, 2005, ANN ONCOL, V16, P655, DOI 10.1093/annonc/mdi110
   Sagar SM, 2008, CURR ONCOL, V15, P166
   Sagar Stephen M, 2006, J SOC INTEGR ONCOL, V4, P27
   Salomonsen LJ, 2011, BMC COMPLEM ALTERN M, V11, P0, DOI 10.1186/1472-6882-11-4
   Scott J A, 2005, EUR J ONCOL NURS, V9, P131, DOI 10.1016/j.ejon.2005.03.012
NR 17
TC 75
Z9 84
U1 2
U2 38
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0941-4355
EI 1433-7339
J9 SUPPORT CARE CANCER
JI Support. Care Cancer
PD JUN 15
PY 2015
VL 23
IS 6
BP 1795
EP 1806
DI 10.1007/s00520-014-2517-4
PG 12
WC Oncology; Health Care Sciences & Services; Rehabilitation
SC Oncology; Health Care Sciences & Services; Rehabilitation
GA CH1ON
UT WOS:000353791200038
PM 25471177
DA 2026-01-16
ER

PT J
AU Blackburn, H
   West, S
AF Blackburn, Helen
   West, Sandra
TI Management of Postembolization Syndrome Following Hepatic Transarterial
SO Cancer nursing
LA English
DT Review
AB BACKGROUND: Transarterial chemoembolization (TACE) is an established treatment in  managing liver primary neoplasms or liver metastases. Postembolization syndrome  (PES) is a common adverse event defined as fever without associated sepsis, pain  in the right upper quadrant, and nausea and/or vomiting. OBJECTIVE: This  integrative review aims to identify effective management strategies for PES or  one of its characterizing symptoms (fever, pain, and nausea and/or vomiting).  METHODS: Searches of electronic databases MEDLINE, EMBASE, and CINAHL were  conducted. Fifteen articles were identified for inclusion. Seven addressed all  symptoms of PES, and 8 studies focused on individual symptoms of PES. RESULTS:  Interventions identified are intra-arterial lidocaine, oral and intravenous  analgesics, steroids, wrist-ankle acupuncture, antibiotics, and 5-HT3 receptor  antagonists. Findings are explicated according to individual symptoms of PES.  Intra-arterial lidocaine, steroids, and a 5-HT3 receptor antagonist are found to  offer potential benefit in the management of PES symptoms. CONCLUSION: A number  of interventions have shown potential benefit in the management of PES. A  systemic approach using combination therapy is necessary to effectively manage  characterizing symptoms. Further research is needed to determine the impact of  primary disease site, TACE technique, and chemotherapeutic agent on PES.  IMPLICATIONS FOR PRACTICE: Oncology nurses are uniquely placed to undertake  thorough patient assessment after TACE and implement early intervention to  effectively manage PES.
C1 Author Affiliations: North Shore Private Hospital (Ms Blackburn) and Sydney Nursing School, University of Sydney (Ms Blackburn and Dr West), New South Wales,Australia.
NR 0
TC 0
SN 1538-980
EI 
J9 Cancer Nurs
PD OCT 21
PY 2015
VL 39
IS 5
BP E1
EP E18
DI 10.1097/NCC.0000000000000302
PG 1
WC Abdominal Pain; therapy; Acupuncture Analgesia; methods; Administration, Oral; Analgesics; therapeutic use; Anti-Bacterial Agents; therapeutic use; Chemoembolization, Therapeutic; methods; Disease Management; Drug Therapy, Combination; methods; Fever of Unknown Origin; therapy; Humans; Infusions, Intra-Arterial; methods; Injections, Intravenous; methods; Lidocaine; therapeutic use; Liver Neoplasms; drug therapy; Morphine; therapeutic use; Oncology Nursing; methods; Oxycodone; therapeutic use; Postoperative Nausea and Vomiting; therapy; Serotonin 5-HT3 Receptor Antagonists; therapeutic use; Steroids; therapeutic use
UT PubMed:26484962
PM 26484962
DA 2015-10-21
ER

PT J
AU Zhang, X
   Li, W
AF Zhang, Xinxin
   Li, Weihong
TI [Efficacy on endometriosis treated with electroacupuncture].
SO Zhongguo zhen jiu = Chinese acupuncture & moxibustion
LA chi
DT Journal Article
AB OBJECTIVE: To compare the difference in the clinical efficacy on endometriosis  (EM) between electroacupuncture (EA) and western medication. METHODS: Seventy-two  EM patients were divided into an EA group and a western medication group  according to visiting departments, 36 cases in each one. In the EA group,  acupuncture was applied to Qihai (CV 6), Guanyuan (CV 4), Zhongji (CV 3), Zigong  (EX-CA 1), Diji (SP 8), Sanyinjiao (SP 6), Hegu (LI 4) and Taichong (LR 3). After  qi arrival, G6805-I pulse electronic apparatus was attached to bilateral Zigong  (EX-CA 1), Guanyuan (CV 4) and Zhongji (CV 3), with continuous wave, 70 Hz in  frequency, 3 mA in intensity. The EA was given once every two days. In the  western medication group, mifepristone tablets were prescribed for oral  administration, 12. 5 mg per treatment, once a day, for 6 months. The pain degree  was observed before and after treatment and the clinical efficacy and recurrence  rate were evaluated in the two groups. The enzyme-linked immunoassay (ELISA) was  adopted to determine the tumor marker serum CA125 before and after treatment in  the two groups. RESULTS: The total effective rate was 94. 4% (34/36) in the EA  group and was 91. 7% (33/36) in the western medication group, without significant  difference (P>0. 05). The pain score after treatment was lower than that before  treatment in the two groups (both P< 0. 01), but the score after treatment in the  EA group was lower than that in the western medication group (P<0. 05). Serum  CA125 was reduced after treatment in the patients of the two groups (both P<0.  01), and serum CA125 after treatment in the EA group was lower than that in the  western medication group (P<0. 05). In the follow-up visit of one year, the  reoccurrence rate was 17. 6% (6/34) in the EA group and was 33. 3% (11/33) in the  western medication group, indicating the significant difference (P<0. 05).  CONCLUSION: EA achieves the significant clinical efficacy and the reoccurrence  rate in 1 year in the EA group is obviously lower than that in the western  medication group. This therapy could be promoted in clinical practice of  acupuncture and moxibustion.
NR 0
TC 0
SN 
EI 0255-293
J9 Zhongguo Zhen Jiu
PD JUN 10
PY 2015
VL 35
IS 4
BP 323
EP 6
DI 
PG -317
WC Acupuncture Points; Adult; Electroacupuncture; Endometriosis; therapy; Female; Humans; Middle Aged; Treatment Outcome; Young Adult
UT PubMed:26054137
PM 26054137
DA 2015-06-10
ER

PT J
AU Li, GY
   Li, SQ
   Sun, LZ
   Lin, FC
   Wang, BG
AF Li, Guoyan
   Li, Shuqin
   Sun, Lizhi
   Lin, Fangcai
   Wang, Baoguo
TI RETRACTED: A comparison study of immune-inflammatory response in electroacupuncture and transcutaneous electrical nerve stimulation for patients undergoing supratentorial craniotomy(Retracted article. See vol.9,pg.20464,2016)
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article; Retracted Publication
DE Transcutaneous electrical nerve stimulation (TENS); electroacupuncture (EA); immuno-inflammatory; supratentorial craniotomy
ID low-back-pain; rats; release; block
AB Objective: The effect of transcutaneous electrical nerve stimulation (TENS) on immuno-inflammatory response was tested and the differences between electroacupuncture (EA) and TENS in immuno-inflammatory response in patients undergoing supratentorial craniotomy were explored. Methods: 51 patients received craniotomy were divided randomly into 3 groups: control (group C, n=18), EA (group A, n=19) and TENS (group T, n=14) groups. Blood samples were collected before anesthesia (T0) and 30 min (T1), 2 h (T2) and 4 h (T3) after induction of anesthesia to measure the levels of tumor necrosis factor-a (TNF-alpha), interleukin (IL)-8, IL-10, IgM, IgA and IgG.. Results: No significant difference existed between groups A and group T during craniotomy. IgM and IgA decreased significantly in group C compared with groups A and T at T2 and T3 time points. Compared with group C, there were significant difference in TNF-alpha, IgM and IgA level at T0 in groups A and T; no significant difference was found in the levels of IgG, IL-10 and IL-8. Conclusion: EA and TENS could reduce immunosuppression in patients undergoing supratentorial craniotomy and it has significance in choice of treatment in immunosuppressive therapy.
C1 [Li, Guoyan; Sun, Lizhi] Beijing Elect Power Hosp, North China Grid Co Ltd, Dept Anesthesiol, Beijing, Peoples R China.
   [Li, Shuqin] Beijing Tiantan Hosp, Dept Anesthesiol, Beijing, Peoples R China.
   [Lin, Fangcai] Beijing Elect Power Hosp, North China Grid Co Ltd, Dept Gen Surg, Beijing, Peoples R China.
   [Wang, Baoguo] Beijing Sanbo Brain Hosp, Dept Anesthesiol & Pain Management, Beijing, Peoples R China.
C3 Capital Medical University; Capital Medical University
RP Wang, BG (corresponding author), Sanbo Brain Hosp, Dept Anesthesiol, 50 Xiang Shan Yi Ke Song, Beijing 100093, Peoples R China.
EM baoguowang77@126.com
FU National Key Basic Research Program [2013-CB531901];  [SGHBOOO-AJJS1400182]
CR Arai YCP, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/727121
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chu H, 2013, BMC COMPLEM ALTERN M, V13, P0, DOI 10.1186/1472-6882-13-84
   DeSantana Josimari M, 2008, CURR RHEUMATOL REP, V10, P492
   Ding LC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057477
   Fang JF, 2013, BMC COMPLEM ALTERN M, V13, P0, DOI 10.1186/1472-6882-13-134
   Gu G, 2011, J INT MED RES, V39, P1783, DOI 10.1177/147323001103900521
   Keskin EA, 2012, GYNECOL OBSTET INVES, V74, P76, DOI 10.1159/000337720
   Khalil Z, 2000, J GERONTOL A-BIOL, V55, PB257, DOI 10.1093/gerona/55.6.B257
   Kita K, 2013, J NEUROENG REHABIL, V10, P0, DOI 10.1186/1743-0003-10-55
   Kloth L C, 1996, ADV WOUND CARE, V9, P42
   Koca Kutlu A, 2013, EVID-BASED COMPL ALT, V2013, P0
   Lan F, 2012, MINERVA ANESTESIOL, V78, P887
   Li GY, 2013, ACUPUNCT MED, V31, P51, DOI 10.1136/acupmed-2012-010254
   Liu SJ, 2011, ANESTH ANALG, V113, P572, DOI 10.1213/ANE.0b013e3182278237
   Pinosky ML, 1996, ANESTH ANALG, V83, P1256, DOI 10.1097/00000539-199612000-00022
   Sabino GS, 2008, J PAIN, V9, P157, DOI 10.1016/j.jpain.2007.09.003
   Sluka KA, 2006, ARCH PHYS MED REHAB, V87, P1137, DOI 10.1016/j.apmr.2006.04.023
   Stein C, 2013, BRAZ J PHYS THER, V17, P93, DOI 10.1590/S1413-35552012005000083
   Trinh K, 2007, SPINE, V32, P236, DOI 10.1097/01.brs.0000252100.61002.d4
   WANG JQ, 1992, INT J NEUROSCI, V65, P117, DOI 10.3109/00207459209003283
   Yokoyama M, 2001, ANESTH ANALG, V92, P463, DOI 10.1213/00000539-200102000-00035
   Zaniewska R, 2012, MED PR, V63, P295
   Zhang WT, 2003, NEUROREPORT, V14, P1591, DOI 10.1097/00001756-200308260-00010
NR 24
TC 4
Z9 6
U1 0
U2 11
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
EI 
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PD JUN 15
PY 2015
VL 8
IS 2
BP 2662
EP 2667
DI 
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CJ2HX
UT WOS:000355306000132
PM 25932216
DA 2026-01-16
ER

PT J
AU Romeo, MJ
   Parton, B
   Russo, RA
   Hays, LS
   Conboy, L
AF Romeo, Melissa J.
   Parton, Barbara
   Russo, Rachel A.
   Hays, Lewis S.
   Conboy, Lisa
TI ACUPUNCTURE TO TREAT THE SYMPTOMS OF PATIENTS IN A PALLIATIVE CARE SETTING
SO EXPLORE-THE JOURNAL OF SCIENCE AND HEALING
LA English
DT Article
DE palliative; hospice; acupuncture; pain; well-being; anxiety
ID cancer; complementary; pain; management; medicine; dyspnea; relief; nausea; life
AB Introduction: Patients enrolled in hospice and palliative care programs experience a vast array of symptoms requiring the expertise of a multidisciplinary team to address. Acupuncture can be an effective addition to a hospice team whose goal is maximum comfort and quality of life (QOL). The objective of this project was to examine the effectiveness of acupuncture to relieve symptoms commonly observed in patients in a hospice program. Methods: All over 26 patients participated in the acupuncture trial, receiving a course of weekly treatments that ranged from 1 to 14 weeks. The average number of treatments was five. The Edmonton Symptom Assessment Scale (ESAS) was used to assess the severity of pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and dyspnea. A two-tailed, paired t test was applied to the data to compare symptom scores pre- versus post-acupuncture treatment. Settings/Participants: Patients enrolled in All Care Hospice's home care program were given the option to receive acupuncture to supplement usual care offered by the hospice team. Treatment was provided by licensed acupuncturists in the patient's place of residence. Results: Seven out of nine symptoms were significantly (P < .001) improved with acupuncture, the exceptions being drowsiness and appetite. Although the ESAS scale demonstrated a reduction in symptom severity post-treatment for both drowsiness and appetite, this reduction was not found to be significant. Conclusion: Acupuncture was found to be effective for the reduction and relief of symptoms that commonly affect patient QOL. Acupuncture effectively reduced symptoms of pain, tiredness, nausea, depression, anxiety, and shortness of breath, and enhanced feelings of well-being. More research is required to assess the long-term benefits and symptom reduction of acupuncture in a palliative care setting.
C1 [Romeo, Melissa J.; Parton, Barbara; Conboy, Lisa] New England Sch Acupuncture, Newton, MA 02458 USA.
   [Parton, Barbara; Russo, Rachel A.; Hays, Lewis S.] All Care Hosp, Lynn, MA USA.
   [Parton, Barbara] Tufts Med Ctr, Boston, MA USA.
   [Hays, Lewis S.] Tufts Univ, Sch Med, Boston, MA 02111 USA.
   [Conboy, Lisa] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
C3 Tufts Medical Center; Tufts University; Harvard University; Harvard University Medical Affiliates; Beth Israel Deaconess Medical Center
RP Romeo, MJ (corresponding author), New England Sch Acupuncture, 150 Calif St, Newton, MA 02458 USA.
EM mromeo@nesa.edu
CR Abernethy Amy P, 2008, J PAIN PALLIAT CARE PHARMACOTHER, V22, P145
   Ben-Aharon I, 2008, J CLIN ONCOL, V26, P2396, DOI 10.1200/JCO.2007.15.5796
   Centers for Medicare and Medicaid Services (CMS), 2008, MED MED PROGR HOSP C, V73, P120
   Chang BH, 2010, J SUBST USE, V15, P390, DOI 10.3109/14659890903580466
   Choi TY, 2012, SUPPORT CARE CANCER, V20, P1147, DOI 10.1007/s00520-012-1432-9
   Dean-Clower E, 2010, INTEGR CANCER THER, V9, P158, DOI 10.1177/1534735409360666
   Dillon M, 1999, PALLIATIVE MED, V13, P253, DOI 10.1191/026921699667999073
   Faily J, 2007, SUPPORT CARE CANCER, V15, P1003, DOI 10.1007/s00520-007-0294-z
   Filshie J, 2001, ACUPUNCT MED, V19, P117
   Filshie J, 1996, PALLIATIVE MED, V10, P145, DOI 10.1177/026921639601000209
   Filshie Jacqueline, 2006, ACUPUNCT MED, V24, P172
   Filshie J, 2011, ACUPUNCT MED, V29, P166, DOI 10.1136/acupmed-2011-010063
   Johnstone PAS, 2002, PALLIATIVE MED, V16, P235, DOI 10.1191/0269216302pm540oa
   Lee H, 2005, EUR J PAIN, V9, P437, DOI 10.1016/j.ejpain.2004.10.004
   Leng G, 1999, PALLIATIVE MED, V13, P163, DOI 10.1191/026921699676243035
   Lewith GT, 2004, CHEST, V125, P1783, DOI 10.1378/chest.125.5.1783
   Lim JTW, 2011, ACUPUNCT MED, V29, P173, DOI 10.1136/aim.2011.004044
   Mansky PJ, 2006, CANCER J, V12, P425, DOI 10.1097/00130404-200609000-00011
   Nystrom E, 2008, ACUPUNCT MED, V26, P27, DOI 10.1136/aim.26.1.27
   Pan CX, 2000, J PAIN SYMPTOM MANAG, V20, P374, DOI 10.1016/S0885-3924(00)00190-1
   Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518
   Schulman-Green D, 2010, J PALLIAT MED, V13, P155, DOI 10.1089/jpm.2009.0245
   Sellick S M, 1998, CANCER PREV CONTROL, V2, P7
   Spiller Juliet, 2007, ACUPUNCT MED, V25, P109
   Standish LJ, 2008, AM J HOSP PALLIAT ME, V25, P298, DOI 10.1177/1049909108315916
   Vickers Andrew J, 2005, BMC PALLIAT CARE, V4, P5, DOI 10.1186/1472-684X-4-5
   Zappa SB, 2003, J NURS CARE QUAL, V18, P22, DOI 10.1097/00001786-200301000-00004
NR 27
TC 14
Z9 20
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1550-8307
EI 1878-7541
J9 EXPLORE-NY
JI Explore-J Sci. Heal.
PD SEP-OCT 15
PY 2015
VL 11
IS 5
BP 357
EP 362
DI 10.1016/j.explore.2015.06.001
PG 6
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CQ7JT
UT WOS:000360780500004
PM 26254221
DA 2026-01-16
ER

PT J
AU Greenlee, H
   Crew, KD
   Capodice, J
   Awad, D
   Jeffres, A
   Unger, JM
   Lew, DL
   Hansen, LK
   Meyskens, FL Jr
   Wade, JL 3rd
   Hershman, DL
AF Greenlee, Heather
   Crew, Katherine D
   Capodice, Jillian
   Awad, Danielle
   Jeffres, Anne
   Unger, Joseph M
   Lew, Danika L
   Hansen, Lisa K
   Meyskens, Frank L Jr
   Wade, James L 3rd
   Hershman, Dawn L
TI Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce
SO Journal of acupuncture and meridian studies
LA English
DT Journal Article
DE acupuncture; aromatase inhibitor; breast cancer; clinical trial; multisite; randomized controlled trial
AB Robust methods are needed to efficiently conduct large, multisite, randomized,  controlled clinical trials of acupuncture protocols. The Southwest Oncology Group  (SWOG) S1200 trial is a randomized, controlled (i.e., sham-controlled and  waitlist-controlled) trial of a standardized acupuncture protocol for treating  aromatase inhibitor (AI)-associated arthralgias in early-stage breast cancer  patients (n = 228). The primary objective of this study was to determine whether  true acupuncture administered twice weekly for 6 weeks, as compared to sham  acupuncture or a waitlist control, reduced AI-associated joint pain at 6 weeks as  assessed by patient reports. The study was conducted at 11 institutions across  the United States. The true acupuncture protocol was developed using a  consensus-based process. The true acupuncture and the sham acupuncture protocols  each consisted of 12 sessions administered for 6 weeks, followed by one weekly  session for 6 weeks. The true acupuncture protocol used standardized protocol  points, and the standardized acupoints were tailored to a patient's joint  symptoms. The similarly standardized sham acupuncture protocol utilized  superficial needling of nonacupoints. Standardized methods were developed to  train and monitor acupuncturists and included online and in-person training,  study manuals, monthly phone calls, and remote quality assurance monitoring  throughout the study period. The research staff similarly received online and  in-person training and monthly phone calls.
C1 Columbia University Medical Center, New York, USA. 
   Columbia University Medical Center, New York, USA.
   Mount Sinai Medical Center, New York, USA.
   Columbia University Medical Center, New York, USA.
   Columbia University Medical Center, New York, USA.
   SWOG Statistical Center/Fred Hutchinson Cancer Research Center, Seattle, USA.
   SWOG Statistical Center/Fred Hutchinson Cancer Research Center, Seattle, USA.
   Legacy Health System, Portland, USA.
   University of California at Irvine, Orange, USA.
   Cancer Care Specialists of Central Illinois/Heartland NCORP, Decatur, USA.
   Columbia University Medical Center, New York, USA.
EM hg2120@columbia.edu
NR 0
TC 0
SN 2093-815
EI 2005-290
J9 J Acupunct Meridian Stud
PD JUN 24
PY 2015
VL 8
IS 3
BP 152
EP 8
DI 10.1016/j.jams.2015.03.006
PG -144
WC Aromatase Inhibitors; adverse effects; Arthralgia; etiology; Breast Neoplasms; drug therapy; Female; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; standards
UT PubMed:26100070
PM 26100070
DA 2015-06-24
ER

PT J
AU Chen, K
   Li, C
AF Chen, Kaijun
   Li, Caili
TI [Acupuncture combined with medication for ulcerative colitis with damp-heat
SO Zhongguo zhen jiu = Chinese acupuncture & moxibustion
LA chi
DT Journal Article
AB OBJECTIVE: To explore the effects and mechanism of acupuncture at Zusanli (ST 36)  combined with oral administration of Gexia Zhuyu decoction on damp-heat  ulcerative colitis at active phase. METHODS: One hundred and twenty cases of  damp-heat ulcerative colitis at active phase, by using random draw method, were  divided into an observation group and a control group, 60 cases in each one.  Patients in the control group were treated with basic treatment combined with  oral administration of Gexia Zhuyu decoction. Based on this, patients in the  observation group were additionally treated with acupuncture at Zusanli (ST 36).  The treatment was given both for 14 days. The efficacy, each symptom score, serum  interleukin-1beta (IL-1beta), interleukin-6 (IL-6) and tumor necrosis  factor-alpha (TNF-alpha) were observed. RESULTS: (1) After treatment, the total  effective rate was 98.3% (59/60) in the observation group, which was  significantly higher than 86.7% (52/60) in the control group (P<0.05). ( The  improvement rates of ulceration, edema, erosion and polyp in the observation  group were obviously higher than those in the control group (all P<0.05). (3)  After treatment, the symptom scores of diarrhea, bloody purulent stool, abdominal  pain, tenesmus as well as inflammatory factors of IL-1beta, IL-6 and TNF-alpha  were all improved compared with those before treatment in the two groups (all  P<0.05); the differences between the observation, group and control group were  statistically significant (all P<0.05). (4) During the 3-month follow up visit,  the recurrence rate was 1.7% (1/59) in the observation group, which was  significantly lower than 11.5% (6/52) in the control group (P<0.05). CONCLUSION:  The Gexia Zhuyu decoction combined with acupuncture at Zusanli (ST 36) could  effectively improve efficacy, reduce recurrence rate, relieve clinical symptoms  and prompt recovery of mucous membrane in patients with damp-heat ulcerative  colitis at active phase, which is related with reducing the expression of  inflammation.
NR 0
TC 0
SN 
EI 0255-293
J9 Zhongguo Zhen Jiu
PD AUG 11
PY 2015
VL 35
IS 5
BP 435
EP 8
DI 
PG -427
WC Acupuncture Points; Acupuncture Therapy; Adult; Aged; Colitis, Ulcerative; drug therapy; Combined Modality Therapy; Drugs, Chinese Herbal; administration & dosage; Humans; Interleukin-1beta; genetics; Interleukin-6; genetics; Male; Middle Aged; Tumor Necrosis Factor-alpha; genetics; Young Adult
UT PubMed:26255512
PM 26255512
DA 2015-08-11
ER

PT J
AU Nielsen, S
   Campbell, G
   Peacock, A
   Smith, K
   Bruno, R
   Hall, W
   Cohen, M
   Degenhardt, L
AF Nielsen, Suzanne
   Campbell, Gabrielle
   Peacock, Amy
   Smith, Kimberly
   Bruno, Raimondo
   Hall, Wayne
   Cohen, Milton
   Degenhardt, Louisa
TI Health service utilisation by people living with chronic non-cancer pain:
SO Australian health review : a publication of the Australian Hospital Association
LA English
DT Journal Article
AB Objective The aims of the present study were to describe the use, and barriers to  the use, of non-medication pain therapies and to identify the demographic and  clinical correlates of different non-opioid pain treatments. Methods The study  was performed on a cohort (n=1514) of people prescribed pharmaceutical opioids  for chronic non-cancer pain (CNCP). Participants reported lifetime and past month  use of healthcare services, mental and physical health, pain characteristics,  current oral morphine equivalent daily doses and financial and access barriers to  healthcare services. Results Participants reported the use of non-opioid pain  treatments, both before and after commencing opioid therapy. Services accessed  most in the past month were complementary and alternative medicines (CAMs; 41%),  physiotherapy (16%) and medical and/or pain specialists (15%). Higher opioid dose  was associated with increased financial and access barriers to non-opioid  treatment. Multivariate analyses indicated being younger, female and having  private health insurance were the factors most commonly associated with accessing  non-opioid treatments. Conclusions Patients on long-term opioid therapy report  using multiple types of pain treatments. High rates of CAM use are concerning  given limited evidence of efficacy for some therapies and the low-income status  of most people with CNCP. Financial and insurance barriers highlight the  importance of considering how different types of treatments are paid for and  subsidised. What is known about the topic? Given concerns regarding long-term  efficacy, adverse side-effects and risk of misuse and dependence, prescribing  guidelines recommend caution in prescribing pharmaceutical opioids in cases of  CNCP, typically advising a multidisciplinary approach to treatment. There is a  range of evidence supporting different (non-drug) treatment approaches for CNCP  to reduce pain severity and increase functioning. However, little is known about  the non-opioid treatments used among those with CNCP and the demographic and  clinical characteristics that may be associated with the use of different types  of treatments. Understanding the use of non-drug therapy among people with CNCP  is crucial given the potential to improve pain control for these patients. What  does this paper add? The present study found that a wide range of non-opioid  treatments was accessed by the study sample, both before and after commencing  opioids, indicating that in this sample opioids were not the sole strategy used  for pain management. The most common treatment (other than opioids) was CAM,  reported by two-fifths of the sample. Having private health insurance was  associated with increased use of non-opioid treatments for pain, highlighting the  importance of considering how treatments are paid for and potential financial  barriers to effective treatments. What are the implications for practitioners?  Patients' beliefs and financial barriers may affect the uptake of different  treatments. Many patients may be using complementary and alternative approaches  with limited evidence to support their use, highlighting the need for clinicians  to discuss with patients the range of prescribed and non-prescribed treatments  they are accessing and to help them understand the benefits and risks of  treatments that have not been tested sufficiently, or have inconsistent evidence,  as to their efficacy in improving pain outcomes.
C1 National Drug and Alcohol Research Centre, UNSW, 22-32 King Street, Randwick, NSW 2031, Australia. Email:.
   National Drug and Alcohol Research Centre, UNSW, 22-32 King Street, Randwick, NSW 2031, Australia. Email:.
   School of Medicine, University of Tasmania, Private Bag 30, Hobart, Tas. 7001, Australia. Email:.
   National Drug and Alcohol Research Centre, UNSW, 22-32 King Street, Randwick, NSW 2031, Australia. Email:.
   National Drug and Alcohol Research Centre, UNSW, 22-32 King Street, Randwick, NSW 2031, Australia. Email:.
   Centre for Youth Substance Abuse Research, University of Queensland, Australia. Email.
   St Vincent's Clinical School, UNSW Medicine, Level 5 deLacy Building, St Vincent's Hospital, Victoria Street, Darlinghurst, NSW 2010, Australia. Email.
   National Drug and Alcohol Research Centre, UNSW, 22-32 King Street, Randwick, NSW 2031, Australia. Email:.
NR 0
TC 0
SN 
EI 0156-578
J9 Aust Health Rev
PD NOV 26
PY 2015
VL 40
IS 5
BP 490
EP 499
DI 10.1071/AH15047
PG 9
WC Acupuncture Therapy; Aged; Analgesics, Opioid; therapeutic use; Australia; Chronic Pain; therapy; Complementary Therapies; Drug Utilization; Female; Health Services; statistics & numerical data; Humans; Interviews as Topic; Male; Manipulation, Chiropractic; Middle Aged; Pain Management; methods; Pain Measurement; Physical Therapy Modalities; Practice Patterns, Physicians'; statistics & numerical data; Prospective Studies; Treatment Outcome
UT PubMed:26599263
PM 26599263
DA 2015-11-26
ER

PT J
AU Yeh, CH
   Chien, LC
   Lin, WC
   Bovbjerg, DH
   van, Londen GJ
AF Yeh, Chao Hsing
   Chien, Lung-Chang
   Lin, Wei-Chun
   Bovbjerg, Dana Howard
   van Londen, G J
TI Pilot Randomized Controlled Trial of Auricular Point Acupressure to Manage
SO Cancer nursing
LA English
DT Journal Article
AB BACKGROUND: Current management for a symptom cluster of pain, fatigue, and  disturbed sleep in breast cancer patients has limited effects. OBJECTIVE: The  purposes of this prospective, randomized controlled pilot study were to (1)  assess the feasibility and tolerability of auricular point acupressure (APA)  intervention to manage pain, fatigue, and sleep disturbance in breast cancer  patients and (2) provide an initial appraisal of effect size as compared with a  control intervention. METHODS: Thirty-one participants were randomized into  either an active APA group (n = 16) or a control APA group (n = 15), which  included the sham APA treatment not related to the symptoms. All participants  received the APA once a week for 4 weeks. Self-report measures were obtained at  baseline, weekly during intervention, at end of intervention, and at a 1-month  follow-up. RESULTS: For the 4-week of APA treatment, the retention rate was 88%  for the active APA group and 73% for the control APA group. After 4 weeks of APA,  participants in the active APA treatment had reported a reduction of 71% in pain,  44% in fatigue, 31% in sleep disturbance, and 61% in interference with daily  activities. The control APA group experienced some moderate reduction in these  symptoms. CONCLUSION: Given that this was a pilot study with a small sample size,  results must be interpreted with caution. IMPLICATIONS FOR PRACTICE: Our results  suggest that APA may provide an inexpensive and effective complementary approach  for the management of symptom clusters for breast cancer patients, and further  study is warranted.
C1 Author Affiliations: School of Nursing, University of Pittsburgh, Pennsylvania (Drs Yeh and Lin)
   Department of Biostatistics, University of Texas, San Antonio(Dr Chien)
   Biobehavioral Oncology Program, University of Pittsburgh,Pennsylvania (Dr Bovbjerg)
   and Division of Hematology/Oncology, Department ofMedicine, University of Pittsburgh Medical Center, Pennsylvania (Dr van Londen).
NR 0
TC 0
SN 1538-980
EI 
J9 Cancer Nurs
PD SEP 22
PY 2015
VL 39
IS 5
BP 402
EP 10
DI 10.1097/NCC.0000000000000303
PG -392
WC Acupuncture, Ear; methods; Adult; Aged; Aged, 80 and over; Breast Neoplasms; complications; Fatigue; etiology; Female; Humans; Middle Aged; Pain Management; methods; Pilot Projects; Placebo Effect; Sleep
UT PubMed:26390073
PM 26390073
DA 2015-09-22
ER

PT J
AU Cheng, XL
   Liu, HQ
   Wang, Q
   Huo, JG
   Wang, XN
   Cao, P
AF Cheng, Xiao L.
   Liu, Hong Q.
   Wang, Qi
   Huo, Jie G.
   Wang, Xiao N.
   Cao, Peng
TI Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE chemotherapy-induced peripheral neurotoxicity; complementary and alternative medicine; herbal medicine; acupuncture; Pathogenesis
ID oxaliplatin-related neurotoxicity; neuropathic pain; alcoholic neuropathy; diabetic-neuropathy; drug transporters; paclitaxel; cancer; vincristine; curcumin; extract
AB Chemotherapy-induced peripheral neurotoxicity (CIPN) is a severe and dose-limiting side effect of antineoplastic drugs. It can cause sensory, motor and autonomic system dysfunction, and ultimately force patients to discontinue chemotherapy. Until now, little is understood about CIPN and no consistent caring standard is available. Since CIPN is a multifactorial disease, the clinical efficacy of single pharmacological drugs is disappointing, prompting patients to seek alternative treatment options. Complementary and alternative medicines (CAMs), especially herbal medicines, are well known for their multifaceted implications and widely used in human health care. Up to date, several phytochemicals, plant extractions, and herbal formulas have been evaluated for their potential therapeutic benefit of preventing the onset and progression of CIPN in experimental models. Clinical acupuncture has also been shown to improve CIPN symptoms. In this review, we will give an outline of our current knowledge regrading the advanced research of CIPN, the role of CAMs in alleviating CIPN and possible lacunae in research that needs to be addressed.
C1 [Cheng, Xiao L.; Liu, Hong Q.; Huo, Jie G.; Wang, Xiao N.; Cao, Peng] Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Jiangsu, Peoples R China.
   [Cheng, Xiao L.; Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China.
   [Wang, Qi] Jiangsu Shenlong Pharmaceut Co Ltd, Yancheng, Peoples R China.
C3 Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine
RP Cao, P (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Jiangsu, Peoples R China.
EM pcao79@yahoo.com
FU National Natural Science Foundation of China [81403092, 81473377, 81274150, 81573665]; Foundation for Distinguished Young Scholars of Jiangsu Province [BK20140049]
CR Abad ANamvaran Abbas, 2011, CHINESE JOURNAL OF NATURAL MEDICINES, V9, P126, DOI 10.3724/SP.J.1009.2011.00126
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Al Moundhri MS, 2013, J MED TOXICOL, V9, P25, DOI 10.1007/s13181-012-0239-x
   Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008
   Ameyaw EO, 2014, PHARMACOGN RES, V6, P172, DOI 10.4103/0974-8490.129041
   Anand U, 2010, MOL PAIN, V6, P0, DOI 10.1186/1744-8069-6-82
   Andoh Tsugunobu, 2014, J TRADIT COMPLEMENT MED, V4, P293, DOI 10.4103/2225-4110.128906
   Argyriou AA, 2014, CANCER MANAG RES, V6, P135, DOI 10.2147/CMAR.S44261
   Argyriou AA, 2013, CANCER-AM CANCER SOC, V119, P3570, DOI 10.1002/cncr.28234
   Ataie A, 2010, PHARMACOL BIOCHEM BE, V96, P378, DOI 10.1016/j.pbb.2010.06.009
   Attia HN, 2012, BEHAV PHARMACOL, V23, P153, DOI 10.1097/FBP.0b013e3283512c00
   Azevedo MI, 2013, MOL PAIN, V9, P0, DOI 10.1186/1744-8069-9-53
   Bahar MK, 2013, ADV HIGH ENERGY PHYS, V2013, P0, DOI 10.1155/2013/814985
   Bennett GJ, 2011, EUR J NEUROSCI, V33, P1667, DOI 10.1111/j.1460-9568.2011.07652.x
   Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030
   Broyl A, 2010, LANCET ONCOL, V11, P1057, DOI 10.1016/S1470-2045(10)70206-0
   Carozzi VA, 2015, NEUROSCI LETT, V596, P90, DOI 10.1016/j.neulet.2014.10.014
   Cassileth BR, 2007, CHEST, V132, P340S, DOI 10.1378/chest.07-1389
   Cavaletti G, 2014, ANTICANCER RES, V34, P483
   Cavaletti G, 2011, ONCOLOGIST, V16, P1667, DOI 10.1634/theoncologist.2011-0343
   Ceresa C, 2011, CURR MED CHEM, V18, P329, DOI 10.2174/092986711794839160
   Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610
   Dean-Clower E, 2010, INTEGR CANCER THER, V9, P158, DOI 10.1177/1534735409360666
   Fidanboylu M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025212
   Flatters SJL, 2006, NEUROSCI LETT, V397, P219, DOI 10.1016/j.neulet.2005.12.013
   Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029
   Florea Ana-Maria, 2011, CANCERS (BASEL), V3, P1351, DOI 10.3390/cancers3011351
   Gamelin L, 2008, J CLIN ONCOL, V26, P1188, DOI 10.1200/JCO.2007.15.3767
   Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029
   Gauchan P, 2009, BIOL PHARM BULL, V32, P732, DOI 10.1248/bpb.32.732
   Gobran NS, 2013, CHINESE-GERMAN J CLIN ONCOL, V12, P232, DOI 10.1007/S10330-013-1161-7
   Goswami C, 2012, J NEUROCHEM, V123, P1, DOI 10.1111/j.1471-4159.2012.07892.x
   Han YQ, 2013, FRONT PHARMACOL, V4, P0, DOI 10.3389/fphar.2013.00156
   Hara T, 2013, PAIN, V154, P882, DOI 10.1016/j.pain.2013.02.023
   Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914
   Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x
   Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019
   Kandhare AD, 2012, NEUROSCI LETT, V511, P18, DOI 10.1016/j.neulet.2012.01.019
   Kaur G, 2010, J BRACHIAL PLEX PERI, V5, P0, DOI 10.1186/1749-7221-5-3
   Kim HK, 2010, ANESTHESIOLOGY, V112, P432, DOI 10.1097/ALN.0b013e3181ca31bd
   Ko J, 2002, J BIOCHEM MOL BIOL, V35, P420
   Kono T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep200
   Leal AD, 2014, CANCER-AM CANCER SOC, V120, P1890, DOI 10.1002/cncr.28654
   Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012
   Lee JS, 2012, BMC COMPLEM ALTERN M, V12, P0, DOI 10.1186/1472-6882-12-124
   Litscher G, 2002, LASER MED SCI, V17, P19, DOI 10.1007/s10103-002-8262-9
   Liu YF, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/541217
   Loprinzi CL, 2014, J CLIN ONCOL, V32, P997, DOI 10.1200/JCO.2013.52.0536
   Mangiacavalli S, 2010, BRIT J HAEMATOL, V149, P916, DOI 10.1111/j.1365-2141.2010.08138.x
   Mannelli LD, 2012, J PAIN, V13, P276, DOI 10.1016/j.jpain.2011.11.009
   Melli G, 2008, EXP NEUROL, V214, P276, DOI 10.1016/j.expneurol.2008.08.013
   Mendonça LM, 2013, NEUROTOXICOLOGY, V34, P205, DOI 10.1016/j.neuro.2012.09.011
   Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004
   Mizuno K, 2014, J PHARMACOL SCI, V125, P91, DOI 10.1254/jphs.13244FP
   Nativi C, 2013, SCI REP-UK, V3, P0, DOI 10.1038/srep02005
   Negi G, 2011, CURR NEUROVASC RES, V8, P294, DOI 10.2174/156720211798120972
   Nishioka M, 2011, INT J CLIN ONCOL, V16, P322, DOI 10.1007/s10147-010-0183-1
   Öztürk G, 2004, TOXICOL APPL PHARM, V196, P169, DOI 10.1016/j.taap.2003.12.006
   Park HJ, 2012, ANESTH ANALG, V115, P1228, DOI 10.1213/ANE.0b013e318262e170
   Park JH, 2010, BRAIN RES, V1322, P24, DOI 10.1016/j.brainres.2010.02.001
   Podratz JL, 2011, NEUROBIOL DIS, V41, P661, DOI 10.1016/j.nbd.2010.11.017
   Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3
   Quartu M, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/180428
   Nieto FR, 2008, PAIN, V137, P520, DOI 10.1016/j.pain.2007.10.012
   Raygude Kiran S, 2012, INFLAMMOPHARMACOLOGY, V20, P331, DOI 10.1007/s10787-012-0122-z
   Salat K, 2013, CURR MED CHEM, V20, P1409, DOI 10.2174/09298673113209990107
   Sandireddy R, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/674987
   Schäfers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052
   Schroeder S, 2012, ACUPUNCT MED, V30, P4, DOI 10.1136/acupmed-2011-010034
   Shabani M, 2012, NEUROTOXICOLOGY, V33, P1314, DOI 10.1016/j.neuro.2012.08.004
   Silva JRT, 2011, J PAIN, V12, P51, DOI 10.1016/j.jpain.2010.04.008
   Sittl R, 2012, P NATL ACAD SCI USA, V109, P6704, DOI 10.1073/pnas.1118058109
   Sprowl JA, 2013, P NATL ACAD SCI USA, V110, P11199, DOI 10.1073/pnas.1305321110
   Ta LE, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054161
   Ta LE, 2010, MOL PAIN, V6, P0, DOI 10.1186/1744-8069-6-15
   Thiagarajan VRK, 2013, TOXICOL IND HEALTH, V29, P3, DOI 10.1177/0748233711432573
   Uno T, 2005, DIABETES RES CLIN PR, V69, P129, DOI 10.1016/j.diabres.2004.11.017
   Ushio S, 2012, EUR J CANCER, V48, P1407, DOI 10.1016/j.ejca.2011.08.009
   Wagner K, 2011, J AGR FOOD CHEM, V59, P2816, DOI 10.1021/jf102559q
   Wang Hong-tao, 2011, ZHONGHUA XUE YE XUE ZA ZHI, V32, P107
   Wang JR, 2008, BIOL PHARM BULL, V31, P643, DOI 10.1248/bpb.31.643
   Wang YK, 2013, SCI REP-UK, V3, P0, DOI 10.1038/srep01864
   Waseem M, 2016, PROTOPLASMA, V253, P417, DOI 10.1007/s00709-015-0821-6
   Webster RG, 2005, BRIT J PHARMACOL, V146, P1027, DOI 10.1038/sj.bjp.0706407
   Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011
   Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018
   Xiao WH, 2012, PAIN, V153, P704, DOI 10.1016/j.pain.2011.12.011
   Xu Wei-Ru, 2010, ZHONGGUO ZHEN JIU, V30, P457
   Yamamoto Tomoya, 2009, GAN TO KAGAKU RYOHO, V36, P89
   Yerra VG, 2013, REDOX BIOL, V1, P394, DOI 10.1016/j.redox.2013.07.005
   Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006
   Zhang YY, 2014, BASIC RES CARDIOL, V109, P0, DOI 10.1007/s00395-014-0407-z
   Zheng H, 2012, EXP NEUROL, V238, P225, DOI 10.1016/j.expneurol.2012.08.023
NR 93
TC 29
Z9 36
U1 0
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
EI 
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD OCT 23
PY 2015
VL 6
IS 
BP 
EP 
DI 10.3389/fphar.2015.00234
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CX9UO
UT WOS:000366051400002
PM 26557088
DA 2026-01-16
ER

PT J
AU He, CJ
   Wang, T
   Gu, YF
   Tian, QH
   Zhou, B
   Wu, CG
AF He, Chengjian
   Wang, Tao
   Gu, Yifeng
   Tian, Qinghua
   Zhou, Bi
   Wu, Chungen
TI Unusual case of pyogenic spondylodiscitis, vertebral osteomyelitis and bilateral psoas abscesses after acupuncture: diagnosis and treatment with interventional management
SO ACUPUNCTURE IN MEDICINE
LA English
DT Article
DE INFECTIOUS DISEASES; PAIN MANAGEMENT
AB Background We report, for the first time, a case of pyogenic spondylodiscitis combined with vertebral osteomyelitis and bilateral psoas abscesses after acupuncture. Case history A 60-year-old man was diagnosed with rectal cancer, and radical rectectomy and permanent colostomy were carried out. However, 3years after the surgery the patient complained of pain in the lower back, and the symptoms worsened after seven sessions of acupuncture. Technetium 99m-labelled methylene diphosphonate (Tc-99m-MDP) bone scintigraphy (BS) revealed abnormal uptake of Tc-99m-MDP in the L4 and L5 vertebrae. He was admitted to our hospital because of suspected bone metastases from rectal cancer. He was diagnosed with infection based on a history of acupuncture and the findings of enhanced MRI and CT. Percutaneous lumbar discectomy (PLD), external drainage and irrigation using antibiotics were carried out to treat the L4-5 disc. Pathological analyses and bacterial culture of the resected disc confirmed infection with group C streptococcus. Postoperative antibiotic treatment resulted in significant pain relief on the third day and gradual complete relief. Considerable improvement was seen on CT and MRI at follow-up. Conclusions We consider it highly likely that this patient's infection was caused by acupuncture. In patients with malignancy, abnormal uptake of Tc-99m-MDP in BS may signify bone metastasis but can also be observed in bone infections. PLD can be used to resect diseased discs to relieve pain quickly and to prevent herniation of lumbar discs. After PLD, external drainage can be employed for abscess drainage, decompression and perfusion of antibiotics. PLD may serve as an alternative to open surgery for pyogenic spondylodiscitis.
C1 [He, Chengjian; Wang, Tao; Gu, Yifeng; Tian, Qinghua; Zhou, Bi; Wu, Chungen] Shanghai Jiao Tong Univ, Dept Diagnost & Intervent Radiol, Affiliated Peoples Hosp 6, Shanghai 200233, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University
RP Wu, CG (corresponding author), Shanghai Jiao Tong Univ, Dept Diagnost & Intervent Radiol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Shanghai, Peoples R China.
EM wcgshly@163.com
CR GARCIA AA, 1994, WESTERN J MED, V161, P90
   Ha GY, 1999, J CLIN MICROBIOL, V37, P1227, DOI 10.1128/JCM.37.4.1227-1228.1999
   Matsumura Y, 1998, J ORAL MAXIL SURG, V56, P495, DOI 10.1016/S0278-2391(98)90721-2
   Peuker E, 2001, ACUPUNCT MED, V19, P103
   Rampes H, 1995, ACUPUNCT MED, V13, P26, DOI 10.1136/aim.13.1.26
   Walsh B, 2001, ACUPUNCT MED, V19, P109
   Wiwanitkit V, 2003, COMPLEMENT THER MED, V11, P272, DOI 10.1016/S0965-2299(03)00141-9
   Woo PCY, 2001, NEW ENGL J MED, V345, P842, DOI 10.1056/NEJM200109133451119
NR 8
TC 8
Z9 12
U1 0
U2 12
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0964-5284
EI 1759-9873
J9 ACUPUNCT MED
JI Acupunct. Med.
PD APR 15
PY 2015
VL 33
IS 2
BP 154
EP 157
DI 10.1136/acupmed-2014-010717
PG 4
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CF4NQ
UT WOS:000352526800011
PM 25795295
DA 2026-01-16
ER

PT J
AU Johnson, JR
   Crespin, DJ
   Griffin, KH
   Finch, MD
   Dusek, JA
AF Johnson, Jill R
   Crespin, Daniel J
   Griffin, Kristen H
   Finch, Michael D
   Dusek, Jeffery A
TI Effects of integrative medicine on pain and anxiety among oncology inpatients.
SO Journal of the National Cancer Institute. Monographs
LA English
DT Journal Article
AB BACKGROUND: Few studies have investigated the effectiveness of integrative  medicine (IM) therapies on pain and anxiety among oncology inpatients. METHODS:  Retrospective data obtained from electronic medical records identified patients  with an oncology International Classification of Diseases-9 code who were  admitted to a large Midwestern hospital between July 1, 2009 and December 31,  2012. Outcomes were change in patient-reported pain and anxiety, rated before and  after individual IM treatment sessions, using a numeric scale (0-10). RESULTS: Of  10948 hospital admissions over the study period, 1833 (17%) included IM therapy.  Older patients had reduced odds of receiving any IM therapy (odds ratio [OR]:  0.97, 95% confidence interval [95% CI] = 0.96 to 0.98) and females had 63% (OR:  1.63, 95% CI = 1.38 to 1.92) higher odds of receiving any IM therapy compared  with males. Moderate (OR: 1.97, 95% CI = 1.61 to 2.41), major (OR: 3.54, 95% CI =  2.88 to 4.35), and extreme (OR: 5.96, 95% CI = 4.71 to 7.56) illness severity  were significantly associated with higher odds of receiving IM therapy compared  with admissions of minor illness severity. After receiving IM therapy, patients  averaged a 46.9% (95% CI = 45.1% to 48.6%, P <.001) reduction in pain and a 56.1%  (95% CI = 54.3% to 58.0%, P <.001) reduction in anxiety. Bodywork and traditional  Chinese Medicine therapies were most effective for reducing pain, while no  significant differences among therapies for reducing anxiety were observed.  CONCLUSIONS: IM services to oncology inpatients resulted in substantial decreases  in pain and anxiety. Observational studies using electronic medical records  provide unique information about real-world utilization of IM. Future studies are  warranted and should explore potential synergy of opioid analgesics and IM  therapy for pain control.
C1 Integrative Health Research Center, Penny George Institute for Health and Healing, Allina Health, Minneapolis, MN (JRJ, KHG, JAD)
   Division of HealthPolicy and Management, University of Minnesota School of Public Health,Minneapolis, MN (DJC)
   Medical Industry Leadership Institute, Carlson School ofManagement, University of Minnesota, Minneapolis, MN (MDF).Jill.Johnson3@allina.com.
   Integrative Health Research Center, Penny George Institute for Health and Healing, Allina Health, Minneapolis, MN (JRJ, KHG, JAD)
   Division of HealthPolicy and Management, University of Minnesota School of Public Health,Minneapolis, MN (DJC)
   Medical Industry Leadership Institute, Carlson School ofManagement, University of Minnesota, Minneapolis, MN (MDF).
   Integrative Health Research Center, Penny George Institute for Health and Healing, Allina Health, Minneapolis, MN (JRJ, KHG, JAD)
   Division of HealthPolicy and Management, University of Minnesota School of Public Health,Minneapolis, MN (DJC)
   Medical Industry Leadership Institute, Carlson School ofManagement, University of Minnesota, Minneapolis, MN (MDF).
   Integrative Health Research Center, Penny George Institute for Health and Healing, Allina Health, Minneapolis, MN (JRJ, KHG, JAD)
   Division of HealthPolicy and Management, University of Minnesota School of Public Health,Minneapolis, MN (DJC)
   Medical Industry Leadership Institute, Carlson School ofManagement, University of Minnesota, Minneapolis, MN (MDF).
   Integrative Health Research Center, Penny George Institute for Health and Healing, Allina Health, Minneapolis, MN (JRJ, KHG, JAD)
   Division of HealthPolicy and Management, University of Minnesota School of Public Health,Minneapolis, MN (DJC)
   Medical Industry Leadership Institute, Carlson School ofManagement, University of Minnesota, Minneapolis, MN (MDF).
NR 0
TC 0
SN 1745-661
EI 1052-677
J9 J Natl Cancer Inst Monogr
PD MAR 10
PY 2015
VL 2014
IS 50
BP 330
EP 7
DI 10.1093/jncimonographs/lgu030
PG -323
WC Acupressure; Acupuncture Therapy; Adult; Age Factors; Aged; Anxiety; therapy; Complementary Therapies; statistics & numerical data; Female; Humans; Inpatients; psychology; Integrative Medicine; Male; Massage; Middle Aged; Neoplasms; complications; Pain; etiology; Pain Management; methods; Retrospective Studies; Severity of Illness Index; Sex Factors
UT PubMed:25749600
PM 25749600
DA 2015-03-10
ER

PT J
AU Mallory, MJ
   Croghan, KA
   Sandhu, NP
   Lemaine, V
   Degnim, AC
   Bauer, BA
   Cha, SS
   Croghan, IT
AF Mallory, Molly J
   Croghan, Katrina A
   Sandhu, Nicole P
   Lemaine, Valerie
   Degnim, Amy C
   Bauer, Brent A
   Cha, Stephen S
   Croghan, Ivana T
TI Acupuncture in the postoperative setting for breast cancer patients: a
SO The American journal of Chinese medicine
LA English
DT Journal Article
DE Acupuncture; Breast Cancer; Breast Reconstruction; Feasibility; Mastectomy; Postsurgical; Quality of Life
AB Acupuncture is used to treat a variety of symptoms and conditions associated with  cancer and cancer treatments. The present study was performed to evaluate the  feasibility of providing acupuncture in the hospital setting for breast cancer  patients and to evaluate the short-term effect of acupuncture on stress, anxiety,  and pain. This was an open label study conducted at Mayo Clinic Hospital,  Methodist and Saint Marys Campus, Rochester, Minnesota. A total of 20 adult  breast cancer patients undergoing mastectomy and/or breast reconstruction were  recruited and offered daily acupuncture intervention beginning postoperative day  1 and continuing for the duration of the hospital stay. Outcome measures included  the Symptom Visual Analog Scale (VAS) and Satisfaction Question and  Was-it-Worth-it (WIWI) Questionnaire. It was found that acupuncture is a feasible  option for postoperative breast cancer patients. In addition, it can  significantly decrease the levels of anxiety (p = 0.0065), tension/muscular  discomfort (p < 0.001) and pain (p = 0.023). The association between acupuncture  and relaxation was found to be statistically borderline (p = 0.053). This  feasibility study showed that acupuncture can be integrated into a busy  postsurgical clinical practice. These results also suggest that acupuncture may  be an important intervention in the postoperative setting for breast cancer  patients.
C1 Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
NR 0
TC 0
SN 1793-685
EI 
J9 Am J Chin Med
PD FEB 17
PY 2015
VL 43
IS 1
BP 45
EP 56
DI 10.1142/S0192415X15500032
PG 11
WC Acupuncture; Adult; Anxiety; therapy; Breast Neoplasms; psychology; Feasibility Studies; Female; Humans; Mastectomy; Middle Aged; Pain, Postoperative; therapy; Postoperative Care; Quality of Life; Plastic Surgery Procedures; Stress, Psychological; therapy; Treatment Outcome
UT PubMed:25682785
PM 25682785
DA 2015-02-17
ER

PT J
AU Bae, K
   Yoo, HS
   Lamoury, G
   Boyle, F
   Rosenthal, DS
   Oh, B
AF Bae, Kyeore
   Yoo, Hwa-Seung
   Lamoury, Gillian
   Boyle, Frances
   Rosenthal, David S
   Oh, Byeongsang
TI Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review.
SO Integrative cancer therapies
LA English
DT Journal Article
DE acupuncture; aromatase inhibitors; arthralgia; breast cancer; joint pain; pain management
AB BACKGROUND: Aromatase inhibitors (AIs) are commonly used as adjunctive hormone  treatment for early breast cancer patients. The major side effect of AIs is  arthralgia, which affects adherence. Previous reviews suggested that acupuncture  is effective in the management of cancer-related pain. The aim of this review is  to evaluate the effects of acupuncture on arthralgia caused by AIs. METHODS: This  article examined randomized controlled trials (RCTs) measuring the effects of  acupuncture on joint symptoms caused by AIs within 8 medical databases till May  2014. The quality of the articles was evaluated according to the Cochrane risk of  bias (ROB) tool. RESULTS: Four RCTs were identified in medical journals. Two  studies were conducted with manual acupuncture and 2 studies were  electroacupuncture. The range of sample size was between 32 and 67. One RCT  showed significant improvement in the acupuncture group compared with the sham  control group and another RCT showed a statistical difference between the  electroacupuncture and waitlist group. The other 2 studies showed no statistical  differences between control and acupuncture groups. Two studies conducted blood  analysis to elucidate the mechanism of efficacy of acupuncture for arthralgia.  The 2 positive studies had a lower ROB and 2 studies had a high ROB. CONCLUSIONS:  The systematic review suggests that acupuncture has potential benefits to improve  arthralgia caused by AIs. However, further trials of adequate sample size,  appropriate control group, and longer follow-up are necessary to investigate the  efficacy of acupuncture in AI-induced arthralgia.
C1 Royal North Shore Hospital, Sydney Medical School, Sydney, New South Wales, Australia East-West Cancer Center, Dunsan Korean Medicine Hospital of DaejeonUniversity, Daejeon, Korea kyeorebae@gmail.com.
   East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University, Daejeon, Korea.
   Royal North Shore Hospital, Sydney Medical School, Sydney, New South Wales, Australia Mater Hospital, Sydney Medical School, Sydney, New South Wales,Australia.
   Mater Hospital, Sydney Medical School, Sydney, New South Wales, Australia.
   Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
   Royal North Shore Hospital, Sydney Medical School, Sydney, New South Wales, Australia Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
NR 0
TC 0
SN 1552-695
EI 
J9 Integr Cancer Ther
PD JUL 30
PY 2015
VL 14
IS 6
BP 496
EP 502
DI 10.1177/1534735415596573
PG 6
WC Acupuncture Therapy; methods; Aromatase Inhibitors; adverse effects; Arthralgia; chemically induced; Breast Neoplasms; drug therapy; Female; Humans; Randomized Controlled Trials as Topic
UT PubMed:26220605
PM 26220605
DA 2015-07-30
ER

PT J
AU Yeh
   Chien, L
   Glick, R
   van Londen, G
   Bovbjerg, D
AF Yeh
   Chien, L.
   Glick, R.
   van Londen, G.
   Bovbjerg, D.
TI Auricular point acupressure to manage symptom clusters of pain, fatigue, and disturbed sleep in breast cancer patients
SO JOURNAL OF PAIN
LA English
DT Meeting Abstract
C1 [Yeh; Chien, L.; Glick, R.; van Londen, G.; Bovbjerg, D.] Univ Pittsburgh, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh
NR 0
TC 1
Z9 1
U1 0
U2 18
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1526-5900
EI 
J9 J PAIN
JI J. Pain
PD APR 15
PY 2015
VL 16
IS 4
BP S110
EP S110
DI 10.1016/j.jpain.2015.01.459
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CF7PK
UT WOS:000352748600439
DA 2026-01-16
ER

PT J
AU Gamus, D
AF Gamus, Dorit
TI [Advances in research of complementary and integrative medicine: a review of
SO Harefuah
LA heb
DT Review
AB This article assesses the evidence for effectiveness, adverse effects and  cost-effectiveness of complementary therapies, as reflected in publications in  high impact factor medical journals during the years 2012-2014. The search  detected 13 randomized controlled studies (RCTs) and 14 meta-analyses, which  collectively assessed results of 191 RCTs involving the participation of several  thousand patients. Pain was the major focus of acupuncture research in both  clinical and fMRI studies, which demonstrated that the effect of acupuncture is  beyond the placebo effect. In addition, RCTs supported the use of acupuncture as  an adjunctive therapy in chronic obstructive pulmonary disease and in moderate to  severe depression. A promising trend was reported for the ameliorating effect of  acupuncture in gout. Spinal manipulations may be helpful in cervical pain and  yoga may be a useful treatment option for chronic neck pain, chronic low back  pain and for pain-related disability. Beneficial effects of adding hypnosis and  massage therapy to the treatment of fibromyalgia patients were also documented.  Tai-chi may reduce balance impairment in mild-to-moderate Parkinson's disease and  improve symptoms in patients with osteoarthritis. Products containing cranberry  are associated with protective effects in some subgroups of patients with  recurrent urinary tract infections. Chinese herbs may assist in glycemic control  of diabetes patients and improve survival rate of patients with non-small cell  lung cancer. Some of the complementary therapies were found to be cost-effective.  Physicians should be aware of the possible adverse effects of these treatments  and of possible drug-herb interactions. Further larger scale trials are  justified.
NR 0
TC 0
SN 
EI 0017-776
J9 Harefuah
PD MAR 24
PY 2015
VL 154
IS 1
BP 9
EP 15, 70
DI 
PG 1
WC Complementary Therapies; adverse effects; Cost-Benefit Analysis; Humans; Integrative Medicine; methods; Randomized Controlled Trials as Topic
UT PubMed:25796668
PM 25796668
DA 2015-03-24
ER

PT J
AU Paley, CA
   Johnson, MI
   Tashani, OA
   Bagnall, AM
AF Paley, Carole A
   Johnson, Mark I
   Tashani, Osama A
   Bagnall, Anne-Marie
TI Acupuncture for cancer pain in adults.
SO The Cochrane database of systematic reviews
LA English
DT Journal Article
AB BACKGROUND: Forty per cent of individuals with early or intermediate stage cancer  and 90% with advanced cancer have moderate to severe pain and up to 70% of  patients with cancer pain do not receive adequate pain relief. It has been  claimed that acupuncture has a role in management of cancer pain and guidelines  exist for treatment of cancer pain with acupuncture. This is an updated version  of a Cochrane Review published in Issue 1, 2011, on acupuncture for cancer pain  in adults. OBJECTIVES: To evaluate efficacy of acupuncture for relief of  cancer-related pain in adults. SEARCH METHODS: For this update CENTRAL, MEDLINE,  EMBASE, PsycINFO, AMED, and SPORTDiscus were searched up to July 2015 including  non-English language papers. SELECTION CRITERIA: Randomised controlled trials  (RCTs) that evaluated any type of invasive acupuncture for pain directly related  to cancer in adults aged 18 years or over. DATA COLLECTION AND ANALYSIS: We  planned to pool data to provide an overall measure of effect and to calculate the  number needed to treat to benefit, but this was not possible due to  heterogeneity. Two review authors (CP, OT) independently extracted data adding it  to data extraction sheets. Data sheets were compared and discussed with a third  review author (MJ) who acted as arbiter. Data analysis was conducted by CP, OT  and MJ. MAIN RESULTS: We included five RCTs (285 participants). Three studies  were included in the original review and two more in the update. The authors of  the included studies reported benefits of acupuncture in managing pancreatic  cancer pain; no difference between real and sham electroacupuncture for pain  associated with ovarian cancer; benefits of acupuncture over conventional  medication for late stage unspecified cancer; benefits for auricular (ear)  acupuncture over placebo for chronic neuropathic pain related to cancer; and no  differences between conventional analgesia and acupuncture within the first 10  days of treatment for stomach carcinoma. All studies had a high risk of bias from  inadequate sample size and a low risk of bias associated with random sequence  generation. Only three studies had low risk of bias associated with incomplete  outcome data, while two studies had low risk of bias associated with allocation  concealment and one study had low risk of bias associated with inadequate  blinding. The heterogeneity of methodologies, cancer populations and techniques  used in the included studies precluded pooling of data and therefore  meta-analysis was not carried out. A subgroup analysis on acupuncture for  cancer-induced bone pain was not conducted because none of the studies made any  reference to bone pain. Studies either reported that there were no adverse events  as a result of treatment, or did not report adverse events at all. AUTHORS'  CONCLUSIONS: There is insufficient evidence to judge whether acupuncture is  effective in treating cancer pain in adults.
C1 Research & Development Department, Airedale NHS Foundation Trust, Airedale General Hospital, Steeton, Keighley, West Yorkshire, UK, BD20 6TD.
NR 0
TC 0
SN 1469-493
EI 
J9 Cochrane Database Syst Rev
PD OCT 16
PY 2015
VL 2015
IS 10
BP CD007753
EP CD007753
DI 10.1002/14651858.CD007753.pub3
PG 1
WC Acupuncture Therapy; methods; Acupuncture, Ear; methods; Adult; Humans; Neoplasms; complications; Pain; etiology; Pain Management; methods; Pain Measurement; Randomized Controlled Trials as Topic
UT PubMed:26468973
PM 26468973
DA 2015-10-16
ER

PT J
AU Dhingra, L
   Ahmed, E
   Shin, J
   Scharaga, E
   Magun, M
AF Dhingra, Lara
   Ahmed, Ebtesam
   Shin, Jae
   Scharaga, Elyssa
   Magun, Maximilian
TI Cognitive Effects and Sedation
SO PAIN MEDICINE
LA English
DT Review
DE Opioid Therapy; Chronic Pain; Adverse Events; Cognitive Impairment; Psychomotor Dysfunction; Sedation
ID opioid-induced sedation; chronic noncancer pain; low-back-pain; nonmalignant pain; release morphine; management; cancer; performance; analgesics; delirium
AB ObjectiveCognitive effects and sedation (CES) are prevalent in chronic nonmalignant pain populations receiving long-term opioid therapy and are among the most common reasons patients discontinue opioid use. In this narrative review, we describe the phenomenology, epidemiology, mechanisms, assessment, and management of opioid-related CES. DesignWe reviewed the empirical and theoretical literature on CES in opioid-treated populations with chronic pain. Data on long-term opioid therapy (3 months in duration) in chronic nonmalignant pain patients were sought. ResultsThe phenomenology of CES includes: inattention, concentration difficulties, memory deficits, psychomotor dysfunction, perceptual distortions, and executive dysfunction and somnolence, sleep disorders, and lethargy. Deficits may be caused by unrelieved pain or opioid therapy alone, or from a combination of these and other factors. Mechanisms include central nervous system effects, for example, direct toxic effects on neurons resulting in decreased consciousness; direct effects on processing and reaction resulting in cognitive or psychomotor impairment, and inhibitory effects on cholinergic activity. Pharmacological management approaches may include opioid dose reduction and rotation or psychostimulant use. Nonpharmacological approaches may include cognitive-behavioral therapy, mindfulness-based stress reduction, acupuncture, exercise, and yoga. ConclusionsThe most prevalent CES include: memory deficits (73-81%), sleep disturbance (35-57%), and fatigue (10%). At its most severe, extreme cognitive dysfunction can result in frank delirium and decreased alertness can result in coma. Emotional distress, sleep disorders, and other comorbidities and treatments can worsen CES, particularly among the elderly. Conclusions about the neuropsychological domains affected by opioids are limited due to the heterogeneity of studies and methodological issues.
C1 [Dhingra, Lara; Ahmed, Ebtesam] MJHS Inst Innovat Palliat Care, New York, NY 10006 USA.
   [Ahmed, Ebtesam; Magun, Maximilian] St Johns Univ, Coll Pharm & Hlth Sci, New York, NY USA.
   [Shin, Jae] Calif Pacific Med Ctr, Div Hepatol, San Francisco, CA USA.
   [Scharaga, Elyssa] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA.
C3 St. John's University; California Pacific Medical Center; Yeshiva University
RP Dhingra, L (corresponding author), MJHS Inst Innovat Palliat Care, 39 Broadway,3rd Floor, New York, NY 10006 USA.
EM LDhingra@mjhs.org
FU American Cancer Society [117416-RSGT-09-201-01-PC]; Pfizer's Office of Independent Grants for Learning and Change [8408357]; Cystic Fibrosis Foundation Therapeutics, Inc. [PORTEN13AO]
CR Unknown -, 2013, CLIN GERIATR, V0, P0
   Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008
   Dagtekin O, 2007, ANESTH ANALG, V105, P1442, DOI 10.1213/01.ane.0000281078.65585.1e
   Dimsdale JE, 2007, J CLIN SLEEP MED, V3, P33
   Dworkin RH, 2010, MAYO CLIN PROC, V85, PS3, DOI 10.4065/mcp.2009.0649
   Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356
   Ersek Mary, 2004, PAIN MANAG NURS, V5, P75, DOI 10.1016/j.pmn.2003.11.002
   Fredheim OMS, 2006, PALLIATIVE MED, V20, P35, DOI 10.1191/0269216306pm1099oa
   Gagnon B, 2005, J PSYCHIATR NEUROSCI, V30, P100
   Gallagher R, 2007, CAN FAM PHYSICIAN, V53, P426
   Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358
   Jarzyna D, 2011, PAIN MANAG NURS, V12, P118, DOI 10.1016/j.pmn.2011.06.008
   Jorge LL, 2009, EUR J PHYS REHAB MED, V45, P469
   Kendall SE, 2010, PAIN, V150, P225, DOI 10.1016/j.pain.2010.05.012
   Knotkova H, 2009, J PAIN SYMPTOM MANAG, V38, P426, DOI 10.1016/j.jpainsymman.2009.06.001
   Kurita GP, 2012, ACTA ANAESTH SCAND, V56, P1257, DOI 10.1111/j.1399-6576.2012.02760.x
   Lavretsky Helen, 2009, AGING HEALTH, V5, P61, DOI 10.2217/1745509X.5.1.61
   Lawlor PG, 2002, CANCER-AM CANCER SOC, V94, P1836, DOI 10.1002/cncr.10389
   Leung L, 2015, BMJ OPEN, V5, P0, DOI 10.1136/bmjopen-2015-007650
   Liu XH, 2014, ACTA NEUROPSYCHIATR, V26, P195, DOI 10.1017/neu.2013.47
   Mailis-Gagnon A, 2012, CLIN J PAIN, V28, P542, DOI 10.1097/AJP.0b013e3182385332
   Mandala Mario, 2006, THER CLIN RISK MANAG, V2, P447, DOI 10.2147/tcrm.2006.2.4.447
   Mao JR, 2002, J NEUROSCI, V22, P7650
   McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6
   McNicol E, 2003, J PAIN, V4, P231, DOI 10.1016/S1526-5900(03)00556-X
   Mercadante S, 2001, J PAIN SYMPTOM MANAG, V21, P144, DOI 10.1016/S0885-3924(00)00228-1
   Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002
   Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76
   Nisbet AT, 2009, PAIN MANAG NURS, V10, P154, DOI 10.1016/j.pmn.2009.03.001
   Noble M, 2008, J PAIN SYMPTOM MANAG, V35, P214, DOI 10.1016/j.jpainsymman.2007.03.015
   ONeil CK, 2012, AM J GERIATR PHARMAC, V10, P331, DOI 10.1016/j.amjopharm.2012.09.004
   Pasero C, 2007, AM J NURS, V107, P52, DOI 10.1097/00000446-200702000-00023
   Puustinen J, 2011, BMC GERIATR, V11, P0, DOI 10.1186/1471-2318-11-70
   Raja SN, 2002, NEUROLOGY, V59, P1015, DOI 10.1212/WNL.59.7.1015
   Reissig JE, 2005, ANN PHARMACOTHER, V39, P727, DOI 10.1345/aph.1E309
   Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041
   Sabatowski R, 2014, PAIN THER, V3, P17, DOI 10.1007/s40122-014-0025-3
   Schiltenwolf M, 2014, PAIN PHYSICIAN, V17, P9
   Slatkin NE, 2001, J PAIN SYMPTOM MANAG, V21, P425, DOI 10.1016/S0885-3924(01)00270-6
   Slatkin Neal E, 2003, J SUPPORT ONCOL, V1, P53
   Smith HS, 2014, J PAIN RES, V7, P589, DOI 10.2147/JPR.S55782
   Smith Howard S, 2007, ANESTHESIOL CLIN, V25, P809, DOI 10.1016/j.anclin.2007.07.005
   Stone P, 2011, PALLIATIVE MED, V25, P431, DOI 10.1177/0269216310380763
   Swegle JM, 2006, AM FAM PHYSICIAN, V74, P1347
   Tassain V, 2003, PAIN, V104, P389, DOI 10.1016/S0304-3959(03)00047-2
   Wang D, 2007, SLEEP MED REV, V11, P35, DOI 10.1016/j.smrv.2006.03.006
   Webster L, 2003, PAIN MED, V4, P135, DOI 10.1046/j.1526-4637.2003.03014.x
   Wheeler M, 2002, J PAIN, V3, P159, DOI 10.1054/jpai.2002.123652
   Won A, 2006, J GERONTOL A-BIOL, V61, P165, DOI 10.1093/gerona/61.2.165
   Young J, 2007, BMJ-BRIT MED J, V334, P842, DOI 10.1136/bmj.39169.706574.AD
   Yue HJ, 2010, MED CLIN N AM, V94, P435, DOI 10.1016/j.mcna.2010.02.007
NR 52
TC 41
Z9 46
U1 0
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1526-2375
EI 1526-4637
J9 PAIN MED
JI Pain Med.
PD OCT 15
PY 2015
VL 16
IS 
BP S37
EP S43
DI 10.1111/pme.12912
PG 7
WC Anesthesiology; Medicine, General & Internal
SC Anesthesiology; General & Internal Medicine
GA CT7AB
UT WOS:000362964300008
PM 26461075
DA 2026-01-16
ER

PT J
AU Patel, JN
   Miller, K
   Symanowski, JT
   Edelen, C
AF Patel, Jai Narendra
   Miller, Katherine
   Symanowski, James Thomas
   Edelen, Connie
TI Efficacy of acupuncture (ACU) therapy for cancer-related pain management in oncology patients (pts)
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Meeting Abstract
C1 Levine Canc Inst, Charlotte, NC USA.
   Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA.
   Carolinas Palliat Care, Levine Canc Inst, Charlotte, NC USA.
C3 Carolinas HealthCare System
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN 0732-183X
EI 1527-7755
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD OCT 10
PY 2015
VL 33
IS 29
BP 
EP 
DI 10.1200/jco.2015.33.29_suppl.196
PG 1
WC Oncology
SC Oncology
GA DO9LD
UT WOS:000378107000191
DA 2026-01-16
ER

PT J
AU Du, J
   Fang, J
   Chen, Y
   Wu, S
   Liang, Y
   Fang, J
AF Du, Junying
   Fang, Junfan
   Chen, Yitian
   Wu, Saifei
   Liang, Yi
   Fang, Jianqiao
TI [Parametric optimization of electroacupuncture against bone-cancer pain in rats
SO Zhongguo zhen jiu = Chinese acupuncture & moxibustion
LA chi
DT Journal Article
AB OBJECTIVE: To observe the intervention of electroacupuncture (EA) with different  current frequencies and treatment frequencies on pain thresholt in rats with  bone-cancer pain, so as to optimize treatment parameters of EA against bone  cancer pain; and by measuring gene expression of opioid receptor and precursor in  different tissues to preliminarily explore the possible mechanism of EA against  bone cancer pain. METHODS: Ninety healthy female SD rats were randomly divided  into a control group, a model group, EA groups (6 subgroups according to  different frequencies) and a sham EA group, ten rats in each one. Rats in the  control group were injected with 10 µL of amicrobic phosphate buffer solution  (PBS) into tibial cavity; rats in the remaining groups were injected with Walker  256 cancer cells to establish model of bone-cancer pain. No treatment was given  to rats in the control group and model group; rats in the EA groups were treated  with EA at bilateral "Housanli" (ST 36) and "Genduan" with 3 different current  frequencies (2 Hz, 100 Hz and 2 Hz/100 Hz), once a day and once every other day,  30 min per treatment (1mA for 15 min, 2 mA for 15 min); rats in the sham EA group  were treated with identical acupoints as the EA group, but the acupoints were  needled subcutaneously and EA was connected with power off. All the treatment was  given for 14 days. Dynamic plantar aesthesiometer was applied to measure the paw  withdrawal thresholds (PWTs) of the affected side before the model establishment,  6d, 8d, 10d, 12d, 14d, 16d, 18d, and 20d after model establishment. The mRNA  expressions of µ-opioid receptor (MOR), κ-opioid receptor (KOR), δ-opioid  receptor (DOR), proopiomelanocortin (POMC) and prodynorphin (PDYN) in dorsal root  ganglion (DRG) and lumbar spinal cord dorsal horn (SCDH) of L4-L6 of the affected  side were detected by PCR method. RESULTS: There were no differences in PWTs  among all groups before model establishment (P>0. 05). Each time point after  model establishment, PWTs in model group were obviously lower than those in the  control group (all P<0. 01). Compared with the model group, PWTs in each EA  subgroup were all increased (all P<0.05), but the differences at different time  points were not significant among EA subgroups (P>0.05). The mRNA expressions of  MOR, KOR, POMC, and PDYN in L4-L6 DRG in the 2 Hz/100 Hz II group were  significantly higher than those in model group (P<0. 05, P<0. 01), while the mRNA  expressions of MOR, KOR, DOR, POMC and PDYN in SCDH were not different compared  with the model group (P>0. 05). CONCLUSION: EA treatment has obvious analgesic  effect on bone-cancer pain, however, its effect is not related with current  frequency and treating frequency. EA against bone-cancer pain may be related with  increasing the mRNA expression of some peripheral opioid receptors and precursor.
NR 0
TC 0
SN 
EI 0255-293
J9 Zhongguo Zhen Jiu
PD APR 10
PY 2015
VL 35
IS 2
BP 161
EP 8
DI 
PG -153
WC Acupuncture Analgesia; instrumentation; Acupuncture Points; Animals; Bone Neoplasms; complications; Electroacupuncture; instrumentation; Enkephalins; metabolism; Female; Ganglia, Spinal; metabolism; Humans; Pain; etiology; Pain Management; instrumentation; Protein Precursors; metabolism; Rats; Rats, Sprague-Dawley; Receptors, Opioid; genetics
UT PubMed:25854026
PM 25854026
DA 2015-04-10
ER

PT J
AU Romeo, MJ
   Parton, B
   Russo, RA
   Hays, LS
   Conboy, L
AF Romeo, Melissa J
   Parton, Barbara
   Russo, Rachel A
   Hays, Lewis S
   Conboy, Lisa
TI Acupuncture to Treat the Symptoms of Patients in a Palliative Care Setting.
SO Explore (New York, N.Y.)
LA English
DT Journal Article
DE acupuncture; anxiety; hospice; pain; palliative; well-being
AB INTRODUCTION: Patients enrolled in hospice and palliative care programs  experience a vast array of symptoms requiring the expertise of a  multidisciplinary team to address. Acupuncture can be an effective addition to a  hospice team whose goal is maximum comfort and quality of life (QOL). The  objective of this project was to examine the effectiveness of acupuncture to  relieve symptoms commonly observed in patients in a hospice program. METHODS: All  over 26 patients participated in the acupuncture trial, receiving a course of  weekly treatments that ranged from 1 to 14 weeks. The average number of  treatments was five. The Edmonton Symptom Assessment Scale (ESAS) was used to  assess the severity of pain, tiredness, nausea, depression, anxiety, drowsiness,  appetite, well-being, and dyspnea. A two-tailed, paired t test was applied to the  data to compare symptom scores pre- versus post-acupuncture treatment.  SETTINGS/PARTICIPANTS: Patients enrolled in All Care Hospice's home care program  were given the option to receive acupuncture to supplement usual care offered by  the hospice team. Treatment was provided by licensed acupuncturists in the  patient's place of residence. RESULTS: Seven out of nine symptoms were  significantly (P < .001) improved with acupuncture, the exceptions being  drowsiness and appetite. Although the ESAS scale demonstrated a reduction in  symptom severity post-treatment for both drowsiness and appetite, this reduction  was not found to be significant. CONCLUSION: Acupuncture was found to be  effective for the reduction and relief of symptoms that commonly affect patient  QOL. Acupuncture effectively reduced symptoms of pain, tiredness, nausea,  depression, anxiety, and shortness of breath, and enhanced feelings of  well-being. More research is required to assess the long-term benefits and  symptom reduction of acupuncture in a palliative care setting.
C1 New England School of Acupuncture, 150 California St., Newton, MA 02458. 
   New England School of Acupuncture, 150 California St., Newton, MA 02458
   All Care Hospice, Lynn, MA
   Tufts Medical Center, Boston, MA.
   All Care Hospice, Lynn, MA.
   All Care Hospice, Lynn, MA
   Tufts University School of Medicine, Boston, MA.
   New England School of Acupuncture, 150 California St., Newton, MA 02458
   Beth Israel Deaconess Medical Center, Boston, MA.
EM mromeo@nesa.edu
NR 0
TC 0
SN 1878-754
EI 
J9 Explore (NY)
PD AUG 9
PY 2015
VL 11
IS 5
BP 357
EP 62
DI 10.1016/j.explore.2015.06.001
PG -295
WC Acupuncture Therapy; Anxiety; etiology; Appetite; Depression; etiology; Dyspnea; etiology; Fatigue; etiology; Hospices; Humans; Nausea; etiology; Neoplasms; complications; Pain; etiology; Pain Management; Palliative Care; Quality of Life; Severity of Illness Index
UT PubMed:26254221
PM 26254221
DA 2015-08-09
ER

PT J
AU Irwin, ML
   Cartmel, B
   Gross, CP
   Ercolano, E
   Li, FY
   Yao, XP
   Fiellin, M
   Capozza, S
   Rothbard, M
   Zhou, Y
   Harrigan, M
   Sanft, T
   Schmitz, K
   Neogi, T
   Hershman, D
   Ligibel, J
AF Irwin, Melinda L.
   Cartmel, Brenda
   Gross, Cary P.
   Ercolano, Elizabeth
   Li, Fangyong
   Yao, Xiaopan
   Fiellin, Martha
   Capozza, Scott
   Rothbard, Marianna
   Zhou, Yang
   Harrigan, Maura
   Sanft, Tara
   Schmitz, Kathryn
   Neogi, Tuhina
   Hershman, Dawn
   Ligibel, Jennifer
TI Randomized Exercise Trial of Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Article
ID postmenopausal women; physical-activity; joint symptoms; clinical-practice; therapy; outcm; acupuncture; tamoxifen; pain
AB Purpose Arthralgia occurs in up to 50% of breast cancer survivors treated with aromatase inhibitors (AIs) and is the most common reason for poor AI adherence. We conducted, in 121 breast cancer survivors receiving an AI and reporting arthralgia, a yearlong randomized trial of the impact of exercise versus usual care on arthralgia severity. Patients and Methods Eligibility criteria included receiving an AI for at least 6 months, reporting >= 3 of 10 for worst joint pain on the Brief Pain Inventory (BPI), and reporting < 90 minutes per week of aerobic exercise and no strength training. Participants were randomly assigned to exercise (150 minutes per week of aerobic exercise and supervised strength training twice per week) or usual care. The BPI, Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index, and Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire were completed at baseline and at 3, 6, 9, and 12 months. Intervention effects were evaluated using mixed-model repeated measures analysis, with change at 12 months as the primary end point. Results Over 12 months, women randomly assigned to exercise (n = 61) attended 70% (+/- standard deviation [SD], 28%) of resistance training sessions and increased their exercise by 159 (+/- SD, 136) minutes per week. Worst joint pain scores decreased by 1.6 points (29%) at 12 months among women randomly assigned to exercise versus a 0.2-point increase (3%) among those receiving usual care (n = 60; P < .001). Pain severity and interference, as well as DASH and WOMAC pain scores, also decreased significantly at 12 months in women randomly assigned to exercise, compared with increases for those receiving usual care (all P < .001). Conclusion Exercise led to improvement in AI-induced arthralgia in previously inactive breast cancer survivors. (C) 2014 by American Society of Clinical Oncology
C1 [Irwin, Melinda L.; Cartmel, Brenda; Gross, Cary P.; Ercolano, Elizabeth; Li, Fangyong; Yao, Xiaopan; Fiellin, Martha; Capozza, Scott; Rothbard, Marianna; Zhou, Yang; Harrigan, Maura; Sanft, Tara] Yale Univ, New Haven, CT 06520 USA.
   [Irwin, Melinda L.; Cartmel, Brenda; Gross, Cary P.; Ercolano, Elizabeth; Li, Fangyong; Yao, Xiaopan; Zhou, Yang; Sanft, Tara] Yale Canc Ctr, New Haven, CT USA.
   [Schmitz, Kathryn] Univ Penn, Philadelphia, PA 19104 USA.
   [Neogi, Tuhina] Boston Univ, Sch Med, Boston, MA 02118 USA.
   [Ligibel, Jennifer] Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Hershman, Dawn] Columbia Univ, New York, NY USA.
C3 Yale University; Yale University; Yale New Haven Hospital; University of Pennsylvania; Boston University; Harvard University; Harvard University Medical Affiliates; Dana-Farber Cancer Institute; Columbia University
RP Irwin, ML (corresponding author), Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, POB 208034, New Haven, CT 06520 USA.
EM melinda.irwin@yale.edu
FU National Cancer Institute [R01 CA132931]; Breast Cancer Research Foundation; Yale Cancer Center [P30 CA016359]; Clinical and Translational Science Award from the National Center for Advancing Translational Science, a component of the National Institutes of Health [UL1 TR000142]; National Cancer Institute [P30CA016359] Funding Source: NIH RePORTER
CR Unknown -, 2011, THE DASH AND QUICKDASH OUTCOME MEASURE USERS MANUAL, V0, P0
   Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207
   BELLAMY N, 1988, J RHEUMATOL, V15, P1833
   BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163
   Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082
   Chlebowski RT, 2009, J CLIN ONCOL, V27, P4032, DOI 10.1200/JCO.2009.23.3270
   Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081
   Clarke M, 2006, ANN ONCOL, V17, PX59, DOI 10.1093/annonc/mdl238
   Cleeland CS, 1994, ANNALS ACADEMY OF MEDICINE SINGAPORE, V23, P129
   Crew KD, 2007, J CLIN ONCOL, V25, P3877, DOI 10.1200/JCO.2007.10.7573
   Crew KD, 2010, J CLIN ONCOL, V28, P1154, DOI 10.1200/JCO.2009.23.4708
   Fallowfield LJ, 2006, J CLIN ONCOL, V24, P910, DOI 10.1200/JCO.2005.03.3654
   Fitzmaurice GM, 2011, APPL LONGITUDINAL AN, V0, P122
   Galantino ML, 2013, ALTERN THER HEALTH M, V19, P38
   Galantino ML, 2012, INTEGR CANCER THER, V11, P313, DOI 10.1177/1534735411413270
   Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054
   Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312
   Greenlee H, 2013, SUPPORT CARE CANCER, V21, P1077, DOI 10.1007/s00520-012-1628-z
   Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64
   Henry NL, 2008, BREAST CANCER RES TR, V111, P365, DOI 10.1007/s10549-007-9774-6
   Hershman DL, 2011, BREAST CANCER RES TR, V126, P529, DOI 10.1007/s10549-010-1132-4
   Jones MD, 2014, MED SCI SPORT EXER, V46, P1640, DOI 10.1249/MSS.0000000000000273
   Khan QJ, 2010, BREAST CANCER RES TR, V119, P111, DOI 10.1007/s10549-009-0495-x
   KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401
   Mao JJ, 2014, EUR J CANCER, V50, P267, DOI 10.1016/j.ejca.2013.09.022
   Mao JJ, 2009, CANCER, V115, P3631, DOI 10.1002/cncr.24419
   Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5
   Oh B, 2013, ACUPUNCT MED, V31, P264, DOI 10.1136/acupmed-2012-010309
   Peel AB, 2014, J AM HEART ASSOC, V3, P0, DOI 10.1161/JAHA.113.000432
   Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112
   Schmitz KH, 2009, NEW ENGL J MED, V361, P664, DOI 10.1056/NEJMoa0810118
   Sestak I, 2008, LANCET ONCOL, V9, P866, DOI 10.1016/S1470-2045(08)70182-7
   Thomas KS, 2002, BMJ-BRIT MED J, V325, P752, DOI 10.1136/bmj.325.7367.752
NR 33
TC 234
Z9 262
U1 0
U2 50
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN 0732-183X
EI 1527-7755
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD APR 1
PY 2015
VL 33
IS 10
BP 1104
EP 1111
DI 10.1200/JCO.2014.57.1547
PG 8
WC Oncology
SC Oncology
GA CK2QZ
UT WOS:000356057900006
PM 25452437
DA 2026-01-16
ER

PT J
AU Paley, CA
   Johnson, MI
   Tashani, OA
   Bagnall, AM
AF Paley, Carole A.
   Johnson, Mark I.
   Tashani, Osama A.
   Bagnall, Anne-Marie
TI Acupuncture for cancer pain in adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Pain Management; Acupuncture Therapy [*methods]; Acupuncture, Ear [methods]; Neoplasms [*complications]; Pain [etiology]; Pain Measurement; Randomized Controlled Trials as Topic; Adult; Humans
ID palliative care; auricular acupuncture; bone pain; management; electroacupuncture; osteoarthritis; chemotherapy; metaanalysis; sham
AB Background Forty per cent of individuals with early or intermediate stage cancer and 90% with advanced cancer have moderate to severe pain and up to 70% of patients with cancer pain do not receive adequate pain relief. It has been claimed that acupuncture has a role in management of cancer pain and guidelines exist for treatment of cancer pain with acupuncture. This is an updated version of a Cochrane Review published in Issue 1, 2011, on acupuncture for cancer pain in adults. Objectives To evaluate efficacy of acupuncture for relief of cancer-related pain in adults. Search methods For this update CENTRAL, MEDLINE, EMBASE, PsycINFO, AMED, and SPORTDiscus were searched up to July 2015 including non-English language papers. Selection criteria Randomised controlled trials (RCTs) that evaluated any type of invasive acupuncture for pain directly related to cancer in adults aged 18 years or over. Data collection and analysis We planned to pool data to provide an overall measure of effect and to calculate the number needed to treat to benefit, but this was not possible due to heterogeneity. Two review authors (CP, OT) independently extracted data adding it to data extraction sheets. Data sheets were compared and discussed with a third review author (MJ) who acted as arbiter. Data analysis was conducted by CP, OT and MJ. Main results We included five RCTs (285 participants). Three studies were included in the original review and two more in the update. The authors of the included studies reported benefits of acupuncture in managing pancreatic cancer pain; no difference between real and sham electroacupuncture for pain associated with ovarian cancer; benefits of acupuncture over conventional medication for late stage unspecified cancer; benefits for auricular (ear) acupuncture over placebo for chronic neuropathic pain related to cancer; and no differences between conventional analgesia and acupuncture within the first 10 days of treatment for stomach carcinoma. All studies had a high risk of bias from inadequate sample size and a low risk of bias associated with random sequence generation. Only three studies had low risk of bias associated with incomplete outcome data, while two studies had low risk of bias associated with allocation concealment and one study had low risk of bias associated with inadequate blinding. The heterogeneity of methodologies, cancer populations and techniques used in the included studies precluded pooling of data and therefore meta-analysis was not carried out. A subgroup analysis on acupuncture for cancer-induced bone pain was not conducted because none of the studies made any reference to bone pain. Studies either reported that there were no adverse events as a result of treatment, or did not report adverse events at all. Authors' conclusions There is insufficient evidence to judge whether acupuncture is effective in treating cancer pain in adults.
C1 [Paley, Carole A.] Airedale NHS Fdn Trust, Res & Dev Dept, Keighley, England.
   [Johnson, Mark I.; Tashani, Osama A.; Bagnall, Anne-Marie] Leeds Beckett Univ, Fac Hlth & Social Sci, Leeds, W Yorkshire, England.
C3 Leeds Beckett University
RP Paley, CA (corresponding author), Airedale Dist Gen Hosp, Airedale NHS Fdn Trust, Dept Res & Dev, Keighley BD20 6TD, W Yorkshire, England.
EM carolepaley2@btinternet.com
FU National Institute for Health Research (NIHR)
CR Alimi D, 2003, J CLIN ONCOL, V21, P4120, DOI 10.1200/JCO.2003.09.011
   Unknown -, 2008, CANC PAIN CLIN PAIN, V0, P0
   AUNG S, 1994, ACUPUNCT MED, V12, P37
   Bardia A, 2006, J CLIN ONCOL, V24, P5457, DOI 10.1200/JCO.2006.08.3725
   Bjordal JM, 2007, BMC MUSCULOSKEL DIS, V8, P0, DOI 10.1186/1471-2474-8-51
   Brainin-Mattos J, 2006, PAIN, V122, P174, DOI 10.1016/j.pain.2006.01.032
   Cata JP, 2006, MINERVA ANESTESIOL, V72, P151
   Chao LF, 2009, BREAST CANCER RES TR, V118, P255, DOI 10.1007/s10549-009-0533-8
   Chen H, 2013, PANCREATOLOGY, V13, P594, DOI 10.1016/j.pan.2013.10.007
   Chen Zhong-jie, 2008, ZHONGGUO ZHEN JIU, V28, P251
   Choi TY, 2012, SUPPORT CARE CANCER, V20, P1147, DOI 10.1007/s00520-012-1432-9
   Claseem A, 2008, ANN INTERN MED, V148, P141, DOI 10.7326/0003-4819-148-2-200801150-00009
   Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210
   Dang W, 1998, J TRADIT CHIN MED, V18, P31
   Davis MA, 2008, J PAIN, V9, P667, DOI 10.1016/j.jpain.2008.03.011
   Derry CJ, 2006, CLIN MED, V6, P381, DOI 10.7861/clinmedicine.6-4-381
   Dillon M, 1999, PALLIATIVE MED, V13, P253, DOI 10.1191/026921699667999073
   Ernst E, 2006, J INTERN MED, V259, P125, DOI 10.1111/j.1365-2796.2005.01584.x
   Ernst E, 2004, PAIN, V109, P203, DOI 10.1016/j.pain.2004.01.028
   Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056
   Everdingen MHJVDBV, 2007, PAIN, V132, P312, DOI 10.1016/j.pain.2007.08.022
   Ezzo J, 2000, PAIN, V86, P217, DOI 10.1016/S0304-3959(99)00304-8
   FILSHIE J, 1990, ACUPUNCT MED, V8, P38
   Filshie Jacqueline, 2006, ACUPUNCT MED, V24, P172
   Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01
   Garcia MK, 2013, J CLIN ONCOL, V31, P952, DOI 10.1200/JCO.2012.43.5818
   Goudas L, 2001, EVID REP TECHNOL ASSESS (SUMM), V0, P1
   Gralow J, 2007, J PAIN SYMPTOM MANAG, V33, P462, DOI 10.1016/j.jpainsymman.2007.01.001
   Green S, 2005, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD005319
   Guo R, 1995, J TRADIT CHIN MED, V15, P262
   Harding C, 2009, BJU INT, V103, P186, DOI 10.1111/j.1464-410X.2008.07884.x
   He D, 2004, PAIN, V109, P299, DOI 10.1016/j.pain.2004.01.018
   Hopwood V, 2004, ACUPUNCTURE PHYSIOTH, V1st, P0
   Johnson Mark I, 2006, ACUPUNCT MED, V24, P71
   Keskinbora K, 2007, J PAIN SYMPTOM MANAG, V34, P183, DOI 10.1016/j.jpainsymman.2006.11.013
   Kwon YD, 2006, RHEUMATOLOGY, V45, P1331, DOI 10.1093/rheumatology/kel207
   Laird B, 2008, EUR J CANCER, V44, P1078, DOI 10.1016/j.ejca.2008.03.022
   Lee H, 2005, EUR J PAIN, V9, P437, DOI 10.1016/j.ejpain.2004.10.004
   Lian WL, 2014, CHIN J INTEGR MED, V20, P136, DOI 10.1007/s11655-013-1439-1
   Lipton Allan, 2004, J SUPPORT ONCOL, V2, P205
   Lu WD, 2012, MED ACUPUNCT, V24, P233, DOI 10.1089/acu.2012.0904
   Lund Irene, 2009, CHIN MED, V4, P1, DOI 10.1186/1749-8546-4-1
   Lundeberg T, 2008, ACUPUNCT MED, V26, P239, DOI 10.1136/aim.26.4.239
   Macdonald G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001930.pub3
   Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014
   Manheimer E, 2007, ANN INTERN MED, V146, P868, DOI 10.7326/0003-4819-146-12-200706190-00008
   Minton O, 2007, J PAIN SYMPTOM MANAG, V33, P115, DOI 10.1016/j.jpainsymman.2006.09.011
   Petrut B, 2008, CURR ONCOL, V15, PS50, DOI 10.3747/co.v15i0.205
   POULAIN P, 1985, B CANCER, V72, P342
   Ripamonti C, 2000, CURR REV PAIN, V4, P187
   Sima L, 2009, J CLIN ONCOL, V27, P0
   Sun Y, 2008, BRIT J ANAESTH, V101, P151, DOI 10.1093/bja/aen146
   The Nordic Cochrane Centre, 2014, REV MAN VERS 5 3, V0, P0
   Towler P, 2013, SUPPORT CARE CANCER, V21, P2913, DOI 10.1007/s00520-013-1882-8
   Trinh KV, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004870.pub3
   Urch CE, 2008, CLIN PAIN MANAGEMENT, V2nd ed., P3
   Vallerand AH, 2007, PAIN, V132, P82, DOI 10.1016/j.pain.2007.01.029
   White A, 2007, RHEUMATOLOGY, V46, P384, DOI 10.1093/rheumatology/kel413
   White A, 2008, ACUPUNCT MED, V26, P111, DOI 10.1136/aim.26.2.111
   XIA Y, 1986, JOURNAL OF TRADITIONAL CHINESE MEDICINE, V6, P23
   Yu G Q, 1992, J TRADIT CHIN MED, V12, P243
   Zhang Ting, 2006, CHIN J INTEGR MED, V12, P180
NR 79
TC 99
Z9 116
U1 4
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PD JUN 15
PY 2015
VL 0
IS 10
BP 
EP 
DI 10.1002/14651858.CD007753.pub3
PG 33
WC Medicine, General & Internal
SC General & Internal Medicine
GA V47DX
UT WOS:000209933600011
PM 26468973
DA 2026-01-16
ER

PT J
AU Song, HJ
   Seo, HJ
   Lee, H
   Son, H
   Choi, SM
   Lee, S
AF Song, Hyun Jin
   Seo, Hyun-Ju
   Lee, Heeyoung
   Son, Heejeong
   Choi, Sun Mi
   Lee, Sanghun
TI Effect of self-acupressure for symptom management: a systematic review.
SO Complementary therapies in medicine
LA English
DT Journal Article
DE Acupressure; Self-administration; Signs and Symptoms
AB OBJECTIVES: To assess the efficacy and safety of self-administered acupressure to  alleviate symptoms of various health problems, including allergic disease,  cancer, respiratory disease, dysmenorrhea, perceived stress, insomnia, and sleep  disturbances. METHODS: We searched core, Korean, Chinese, and Japanese databases,  including Ovid-MEDLINE, Ovid-EMBASE, the Cochrane Central Register of Controlled  Trials (CENTRAL), the Cumulative Index to Nursing and Allied Health Literature  (CINAHL), six representative electronic Korean medical databases, China National  Knowledge Infrastructure (CNKI), and Japan Science and Technology Information  Aggregator (J-STAGE). We included randomized controlled trials (RCTs) and  quasi-RCTs that examined disease-specific effects or symptom relief, adverse  reactions, and quality-of-life (QOL) for self-administered acupressure. Data  collection and assessment of the methodological quality of the included studies  were conducted by two independent reviewers. RESULTS: Eight RCTs and two  quasi-RCTs showed positive effects and safety of self-acupressure therapy in  clinically diverse populations. Quality assessment revealed moderate quality for  the RCTs, with 50% or more of the trials assessed as presenting a low risk of  bias in seven domains. All of the selected 10 studies reported positive effects  for primary outcomes of self-acupressure therapy for symptom management,  including significant improvements in symptom scores in allergic disease, nausea  and vomiting in cancer, symptom scores in respiratory disease, pain symptoms in  dysmenorrhea, and stress/fatigue scores and sleep disturbances in healthy people.  CONCLUSIONS: Our findings suggest that self-administered acupressure shows  promise to alleviate the symptoms of various health problems. Therefore, further  research with larger samples and methodologically well-designed RCTs is required  to establish the efficacy of self-administered acupressure.
C1 School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
   Department of Nursing, College of Medicine, Chosun University, 309 Pilmum-daero, Dong-gu, Gwangju 501-759, South Korea. 
   Public Health Medical Service, Seoul National University Bundang Hospital, Seongnam, South Korea.
   Graduate School of Public Health, Seoul National University, Seoul, South Korea.
   Korea Institute of Oriental Medicine, Daejeon, South Korea.
   Korea Institute of Oriental Medicine, Daejeon, South Korea.
EM shj5th@korea.ac.kr
NR 0
TC 0
SN 1873-696
EI 
J9 Complement Ther Med
PD FEB 1
PY 2015
VL 23
IS 1
BP 68
EP 78
DI 10.1016/j.ctim.2014.11.002
PG 10
WC Acupressure; methods; Disease Management; Humans; Quality of Life; Self Care; methods
UT PubMed:25637155
PM 25637155
DA 2015-02-01
ER

PT J
AU Chien, TJ
   Liu, CY
   Chang, YF
   Fang, CJ
   Hsu, CH
AF Chien, Tsai-Ju
   Liu, Chia-Yu
   Chang, Yi-Fang
   Fang, Ching-Ju
   Hsu, Chung-Hua
TI Acupuncture for treating aromatase inhibitor-related arthralgia in breast cancer:
SO Journal of alternative and complementary medicine (New York, N.Y.)
LA English
DT Journal Article
AB PURPOSE: Acupuncture has been used as a complementary medical treatment for  arthralgia and other types of pain. The objective of this review is to assess the  effectiveness of acupuncture in the treatment of arthralgia in patients with  breast cancer who were treated with aromatase inhibitors (AIs). METHODS: A  literature search was performed, without language restrictions, of 10 databases  from their inception through February 2014. The literature reviewed included  randomized clinical trials (RCTs) and clinical trials that compared real versus  sham acupuncture for the treatment of AI-related musculoskeletal symptoms  (AIMSS). The methodologic quality of these trials was assessed by using the  modified Jadad Quality Scale. Meta-analytic software (RevMan 5.0) was used to  analyze the data. RESULTS: Five To compare the effects of real versus sham  acupuncture, five RCTs were assessed by meta-analysis and quality analysis. Three  of the RCTs reported favorable effects with regard to use of acupuncture in  reducing pain and joint-related symptoms, while the other two RCTs did not. The  meta-analysis showed trends toward reduced pain and stiffness in patients given  acupuncture compared with those who received sham treatment (n=82; pain, mean  difference: -2.07 [95% confidence interval (CI), -4.72 to 0.57]; p=0.12;  stiffness, mean difference: -86.10 [95% CI, -249.11 to 76.92]; p=0.30), although  these differences were not statistically significant. CONCLUSIONS: Acupuncture  has been reported as a safe and promising treatment for AIMSS, but the present  analysis indicated that the effects were not statistically significant. Other  outcome measurements, such as imaging studies, would be worth including in future  studies to further confirm the efficacy of acupuncture in AIMSS.
C1 1 Institute of Traditional Medicine, National Yang-Ming University , Taipei, Taiwan .
NR 0
TC 0
SN 1557-770
EI 1075-553
J9 J Altern Complement Med
PD APR 29
PY 2015
VL 21
IS 5
BP 251
EP 60
DI 10.1089/acm.2014.0083
PG -191
WC Acupuncture Therapy; methods; Aromatase Inhibitors; adverse effects; Arthralgia; chemically induced; Breast Neoplasms; drug therapy; Female; Humans
UT PubMed:25915433
PM 25915433
DA 2015-04-29
ER

PT J
AU Zhang, JQ
   Xue, FS
   Meng, FM
   Li, RP
AF Zhang, Jia Qiang
   Xue, Fu Shan
   Meng, Fan Min
   Li, Rui-Ping
TI Assessing the anaesthetic and analgesic effects of electroacupuncture in patients
SO Acupuncture in medicine : journal of the British Medical Acupuncture Society
LA English
DT Letter
C1 Department of Anesthesiology, Henan Provincial People's Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
   Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic ofChina.
   Department of Anesthesiology, Henan Provincial People's Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
   Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic ofChina.
NR 0
TC 0
SN 1759-987
EI 
J9 Acupunct Med
PD JUL 17
PY 2015
VL 34
IS 1
BP 69
EP 70
DI 10.1136/acupmed-2015-010880
PG 1
WC Acupuncture Analgesia; Anesthetics; administration & dosage; Female; Humans; Male; Pain, Postoperative; therapy; Sufentanil; administration & dosage; Supratentorial Neoplasms; surgery; Transcutaneous Electric Nerve Stimulation
UT PubMed:26177686
PM 26177686
DA 2015-07-17
ER

PT J
AU Javdan, B
   Cassileth, B
AF Javdan, Bahar
   Cassileth, Barrie
TI Acupuncture Research at Memorial Sloan Kettering Cancer Center.
SO Journal of acupuncture and meridian studies
LA English
DT Review
DE acupuncture; cancer; dyspnea; lung cancer; lymphedema; xerostomia
AB Acupuncture may help treat specific cancer-related symptoms. Here, we summarize  our clinical trials that sought to determine acupuncture's role in managing  cancer-related symptoms. Trials have been conducted to determine acupuncture's  ability to mitigate cancer-related symptoms including dyspnea, fatigue,  xerostomia, lymphedema, hot flashes, postoperative ileus, pain and dysfunction  after neck dissection, and postthoracotomy pain. Published studies indicate that  acupuncture versus placebo acupuncture failed to reduce cancer-related dyspnea.  Both true and sham acupuncture alleviated fatigue slightly, but no significant  differences between groups emerged. Compared with sham acupuncture, our research  showed that acupuncture significantly improved saliva production in patients with  xerostomia and significantly reduced lymphedema patients' arm circumference in a  pilot study. However, acupuncture failed to significantly reduce hot flashes and  was no more successful than sham acupuncture in reducing postoperative ileus.  Significant reductions in pain and dysfunction occurred in cancer patients after  neck dissection. In a feasibility study, acupuncture was found to be acceptable  to lung cancer patients and did not interfere with standard postoperative care.  In summary, acupuncture is a potential candidate for the treatment of some  important cancer-related symptoms. Large clinical trials and research to  investigate mechanistic pathways are warranted.
C1 Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA.
   Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA.
EM cassileth@mskcc.org
NR 0
TC 0
SN 2093-815
EI 
J9 J Acupunct Meridian Stud
PD JUN 24
PY 2015
VL 8
IS 3
BP 115
EP 21
DI 10.1016/j.jams.2015.03.005
PG -94
WC Acupuncture Therapy; Biomedical Research; Clinical Trials as Topic; Combined Modality Therapy; adverse effects; Fatigue; etiology; Hot Flashes; etiology; Humans; Lymphedema; etiology; Neoplasms; therapy; New York City; Pain, Postoperative; etiology; Xerostomia; etiology
UT PubMed:26100064
PM 26100064
DA 2015-06-24
ER

PT J
AU Simpson, CA
AF Simpson, Charles A.
TI Complementary Medicine in Chronic Pain Treatment
SO PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA
LA English
DT Article
DE Complementary and alternative medicine; Chronic pain; Therapies; Evidence-based medicine
ID randomized controlled-trials; low-back-pain; alternative medicine; spinal manipulation; ayurvedic medicine; follow-up; acupuncture; therapy; cancer; reliability
AB This article discusses several issues related to therapies that are considered "complementary" or "alternative" to conventional medicine. A definition of "complementary and alternative medicine" (CAM) is considered in the context of the evolving health care field of complementary medicine. A rationale for pain physicians and clinicians to understand these treatments of chronic pain is presented. The challenges of an evidence-based approach to incorporating CAM therapies are explored. Finally, a brief survey of the evidence that supports several widely available and commonly used complementary therapies for chronic pain is provided.
C1 [Simpson, Charles A.] CHP Grp, Clin Affairs, Beaverton, OR USA.
RP Simpson, CA (corresponding author), 3990 Southwest Lafollett Rd, Cornelius, OR 97113 USA.
EM casimpsondc@gmail.com
CR AARP NCCAM, 2010, COMPL ALT MED WHAT P, V0, P0
   Adams J, 2013, HEADACHE, V53, P459, DOI 10.1111/j.1526-4610.2012.02271.x
   Al-Shenqiti AM, 2005, CLIN REHABIL, V19, P482, DOI 10.1191/0269215505cr791oa
   Unknown -, 1997, NIH CONSENS STATEMENT, V15, P1
   Unknown -, 1900, DOI 10.1002/14651858.CD002766, V0, P0
   Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548
   Barnes PM, 2008, NATL HLTH STAT REPOR, V0, P0, DOI DOI 10.1037/E623942009-001
   Bernstein BJ, 2001, ONCOLOGY-NY, V15, P1267
   Bernstein BJ, 2001, ONCOLOGY WILLISTON P, V15, P1283
   Bishop FL, 2010, J ALTERN COMPLEM MED, V16, P175, DOI 10.1089/acm.2009.0292
   Bledsoe Bryan E, 2004, J AM OSTEOPATH ASSOC, V104, P405
   Braverman D L, 1999, PHYS MED REHABIL CLIN N AM, V10, P631
   Braverman DL, 1999, PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, V10, P0
   Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009
   Bronfort G, 2003, J AM CHIRO, V40, P42
   Brunelli B, 2004, J NEUROL SCI, V218, P59, DOI 10.1016/j.jns.2003.10.013
   Carter R, 2002, J FAM PRACTICE, V51, P38
   Chaitow L, 2004, J OSTEOP MED, V7, P33, DOI 10.1016/S1443-8461(04)80007-8
   Chopra A, 2002, MED CLIN N AM, V86, P75, DOI 10.1016/S0025-7125(03)00073-7
   Chou R, 2007, NONPHARMACOLOGIC THE, V0, P0
   Chow RT, 2005, LASER SURG MED, V37, P46, DOI 10.1002/lsm.20193
   Chu Dennis A, 2004, PHYS MED REHABIL CLIN N AM, V15, P773, DOI 10.1016/j.pmr.2004.02.001
   Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1073, DOI 10.1016/j.apmr.2005.01.003
   Coffelt TA, 2013, PEDIATRICS, V132, PE422, DOI 10.1542/peds.2012-1739
   Committee on Advancing Pain Research Care and Education, 2011, REL PAIN AM, V0, P0
   Curtis D, 2010, J BODYW MOV THER, V14, P272, DOI 10.1016/j.jbmt.2010.01.009
   Dagenais Simon, 2005, SPINE J, V5, P310, DOI 10.1016/j.spinee.2004.09.011
   Deyo RA, 2014, J PAIN, V15, P569, DOI 10.1016/j.jpain.2014.03.005
   Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102
   DiNucci EM, 2005, ORTHOP NURS, V24, P259
   Eisenberg D, 1993, NEW ENGL J MED, V328, P426
   Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569
   Ernst E, 1998, CANCER-AM CANCER SOC, V83, P777, DOI 10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O
   Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9
   Fleming Sara, 2007, BMC COMPLEMENT ALTERN MED, V7, P15, DOI 10.1186/1472-6882-7-15
   Fu LM, 2009, J ALTERN COMPLEM MED, V15, P133, DOI 10.1089/acm.2008.0135
   Gagnier Joel, 2011, HERBAL MED LOW BACK, V0, P0
   Green C, 1999, COMPLEMENT THER MED, V7, P199
   Gross A, 2010, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004249.pub3
   Haas M, 2014, BMC COMPLEM ALTERN M, V14, P0, DOI 10.1186/1472-6882-14-16
   Healthcare Analysis & Information Group (HAIG), 2011, 2011 COMPL ALT MED, V0, P0
   Hirsh AT, 2005, CLIN J PAIN, V21, P302, DOI 10.1097/01.ajp.0000113057.92184.90
   Institute of Medicine (US) Committee on the Use of Complementary and Alternative Medicine by the American Public, 2005, COMPL ALT MED US, V0, P8
   Jain Sanjiv, 2004, PHYS MED REHABIL CLIN N AM, V15, P811, DOI 10.1016/j.pmr.2004.04.005
   Jonas WB, 1999, ESSENTIALS COMPLEMEN, V0, P210
   Kristoffersen ES, 2013, J HEADACHE PAIN, V14, P0, DOI 10.1186/1129-2377-14-36
   Kumar S, 2013, INT J GEN MED, V6, P733, DOI 10.2147/IJGM.S50243
   Langevin HM, 2011, EVID-BASED COMPL ALT, V2011, P0, DOI 10.1155/2011/180805
   Linde K, 2001, INT J EPIDEMIOL, V30, P526, DOI 10.1093/ije/30.3.526
   LUM LC, 1975, J PSYCHOSOM RES, V19, P375, DOI 10.1016/0022-3999(75)90017-3
   Lundgren Justin, 2004, PHYS MED REHABIL CLIN N AM, V15, P955, DOI 10.1016/j.pmr.2004.04.003
   Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014
   McCrory D, 2001, EVIDENCE REPORT: BEHAVIORAL AND PHYSICAL TREATMENTS FOR TENSION-TYPE AND CERVICOGENIC HEADACHE, V0, P0
   McMakin C, 1998, TOPICS CLIN CHIRO, V5, P29
   McMakin C, 2004, J BODYW MOV THER, V8, P143, DOI 10.1016/j.jbmt.2003.12.006
   McMakin CR, 2005, J BODYW MOV THER, V9, P169, DOI 10.1016/j.jbmt.2004.12.003
   McPartland John M, 2004, JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, V104, P244
   Mehling WE, 2005, ALTERN THER HEALTH M, V11, P44, DOI 10.1111/j.1365-263X.2005.00605.x
   Molassiotis A, 2005, ANN ONCOL, V16, P655, DOI 10.1093/annonc/mdi110
   Moran RW, 2001, J MANIP PHYSIOL THER, V24, P183
   Muller R, 2005, J MANIP PHYSIOL THER, V28, P3, DOI 10.1016/j.jmpt.2004.12.004
   NIH National Cancer Institute, 2014, NIH PUBLICATION, V14-6287, P0
   OConnell NE, 2014, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD008208.pub3
   Oschman J, 2003, ENERGY MEDICINE IN THERAPEUTICS AND HUMAN PERFORMANCE, V0, P0
   Park JB, 2005, SEMIN ARTHRITIS RHEU, V34, P705, DOI 10.1016/j.semarthrit.2004.11.005
   Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202
   Rosen JE, 2010, 14 INT THYR C PAR SE, V0, P0
   Rosenberg EI, 2008, PAIN MED, V9, P1065, DOI 10.1111/j.1526-4637.2008.00477.x
   Rubinstein SM, 2013, COCHRANE DB SYST REV, V0, P0
   Sawyer J, 1998, AORN J, V67, P674, DOI 10.1016/S0001-2092(06)62838-X
   Schutzler L, 2014, INTERNAL HLTH LOCUS, V0, P0
   Shekelle PG, 2005, ANN INTERN MED, V142, P1042, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00003
   SHEKELLE PG, 1992, ANN INTERN MED, V117, P590, DOI 10.7326/0003-4819-117-7-590
   Simon D, 2007, COCHRANE DB SYST REV, V0, P0
   Sirois FM, 2008, BMC COMPLEM ALTERN M, V8, P0, DOI 10.1186/1472-6882-8-16
   Starr P, 1982, SOCIAL TRANSFORMATIO, V0, P0
   SULLIVAN MD, 1993, J MED PHILOS, V18, P213, DOI 10.1093/jmp/18.2.213
   TRAVEL JG, 1983, MYOFASCIAL PAIN DYSF, V1, P0
   Trigkilidas D, 2010, ANN ROY COLL SURG, V92, P595, DOI 10.1308/003588410X12699663904196
   Trinh K, 2007, SPINE, V32, P236, DOI 10.1097/01.brs.0000252100.61002.d4
   Weeks J, 2012, INTEGRATOR BLOG 0329, V0, P0
   Wells M, 2007, CANCER NURS, V30, P45, DOI 10.1097/00002820-200701000-00008
   Wells RE, 2011, HEADACHE, V51, P1087, DOI 10.1111/j.1526-4610.2011.01917.x
   Whitten Christine E, 2005, PERM J, V9, P41
   Wolsko PM, 2004, ALTERN THER HEALTH M, V10, P36
   Woodman JP, 2012, INT J CLIN PRACT, V66, P98, DOI 10.1111/j.1742-1241.2011.02817.x
   Ypusefi-Nooraie R, 2008, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD005107.pub4
   Yuan J, 2008, SPINE, V33, PE887, DOI 10.1097/BRS.0b013e318186b276
NR 91
TC 7
Z9 10
U1 1
U2 27
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1047-9651
EI 1558-1381
J9 PHYS MED REH CLIN N
JI Phys. Med. Rehabil. Clin. N. Am.
PD MAY 15
PY 2015
VL 26
IS 2
BP 321
EP +
DI 10.1016/j.pmr.2014.12.005
PG 28
WC Rehabilitation
SC Rehabilitation
GA CJ3AV
UT WOS:000355356700013
PM 25952068
DA 2026-01-16
ER

PT J
AU He, C
   Wang, T
   Gu, Y
   Tian, Q
   Zhou, B
   Wu, C
AF He, Chengjian
   Wang, Tao
   Gu, Yifeng
   Tian, Qinghua
   Zhou, Bi
   Wu, Chungen
TI Unusual case of pyogenic spondylodiscitis, vertebral osteomyelitis and bilateral
SO Acupuncture in medicine : journal of the British Medical Acupuncture Society
LA English
DT Journal Article
DE INFECTIOUS DISEASES; PAIN MANAGEMENT
AB BACKGROUND: We report, for the first time, a case of pyogenic spondylodiscitis  combined with vertebral osteomyelitis and bilateral psoas abscesses after  acupuncture. CASE HISTORY: A 60-year-old man was diagnosed with rectal cancer,  and radical rectectomy and permanent colostomy were carried out. However, 3 years  after the surgery the patient complained of pain in the lower back, and the  symptoms worsened after seven sessions of acupuncture. Technetium 99m-labelled  methylene diphosphonate ((99m)Tc-MDP) bone scintigraphy (BS) revealed abnormal  uptake of (99m)Tc-MDP in the L4 and L5 vertebrae. He was admitted to our hospital  because of suspected bone metastases from rectal cancer. He was diagnosed with  infection based on a history of acupuncture and the findings of enhanced MRI and  CT. Percutaneous lumbar discectomy (PLD), external drainage and irrigation using  antibiotics were carried out to treat the L4-5 disc. Pathological analyses and  bacterial culture of the resected disc confirmed infection with group C  streptococcus. Postoperative antibiotic treatment resulted in significant pain  relief on the third day and gradual complete relief. Considerable improvement was  seen on CT and MRI at follow-up. CONCLUSIONS: We consider it highly likely that  this patient's infection was caused by acupuncture. In patients with malignancy,  abnormal uptake of (99m)Tc-MDP in BS may signify bone metastasis but can also be  observed in bone infections. PLD can be used to resect diseased discs to relieve  pain quickly and to prevent herniation of lumbar discs. After PLD, external  drainage can be employed for abscess drainage, decompression and perfusion of  antibiotics. PLD may serve as an alternative to open surgery for pyogenic  spondylodiscitis.
C1 Department of Diagnostic and Interventional Radiology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
   Department of Diagnostic and Interventional Radiology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
   Department of Diagnostic and Interventional Radiology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
   Department of Diagnostic and Interventional Radiology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
   Department of Diagnostic and Interventional Radiology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
   Department of Diagnostic and Interventional Radiology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
NR 0
TC 0
SN 1759-987
EI 
J9 Acupunct Med
PD MAR 22
PY 2015
VL 33
IS 2
BP 154
EP 7
DI 10.1136/acupmed-2014-010717
PG -147
WC Acupuncture Therapy; adverse effects; Discitis; diagnostic imaging; Humans; Lumbar Vertebrae; diagnostic imaging; Male; Middle Aged; Osteomyelitis; diagnostic imaging; Psoas Abscess; diagnostic imaging; Radiography; Tomography, Emission-Computed
UT PubMed:25795295
PM 25795295
DA 2015-03-22
ER

PT J
AU Tao, WW
   Luo, X
   Cui, B
   Liang, DP
   Wang, CL
   Duan, YY
   Li, XF
   Zhou, SY
   Zhao, MJ
   Li, Y
   He, YM
   Wang, SW
   Kelley, KW
   Jiang, P
   Liu, QT
AF Tao, Weiwei
   Luo, Xi
   Cui, Bai
   Liang, Dapeng
   Wang, Chunli
   Duan, Yangyang
   Li, Xiaofen
   Zhou, Shiyu
   Zhao, Mingjie
   Li, Yi
   He, Yumin
   Wang, Shaowu
   Kelley, Keith W.
   Jiang, Ping
   Liu, Quentin
TI Practice of traditional Chinese medicine for psycho-behavioral intervention improves quality of life in cancer patients: A systematic review and meta-analysis
SO ONCOTARGET
LA English
DT Article
DE traditional Chinese medicine; psycho-behavioral interventions; quality of life; cancer; meta-analysis
ID randomized controlled-trial; breast-cancer; tai-chi; colorectal-cancer; health; symptoms; fatigue; acupuncture; depression; management
AB Background: Cancer patients suffer from diverse symptoms, including depression, anxiety, pain, and fatigue and lower quality of life (QoL) during disease progression. This study aimed to evaluate the benefits of Traditional Chinese Medicine psycho-behavioral interventions (TCM PBIs) on improving QoL by meta-analysis. Methods: Electronic literature databases (PubMed, CNKI, VIP, and Wanfang) were searched for randomized, controlled trials conducted in China. The primary intervention was TCM PBIs. The main outcome was health-related QoL (HR QoL) post-treatment. We applied standard meta analytic techniques to analyze data from papers that reached acceptable criteria. Results: The six TCM PBIs analyzed were acupuncture, Chinese massage, Traditional Chinese Medicine five elements musical intervention (TCM FEMI), Traditional Chinese Medicine dietary supplement (TCM DS), Qigong and Tai Chi. Although both TCM PBIs and non-TCM PBIs reduced functional impairments in cancer patients and led to pain relief, depression remission, reduced time to flatulence following surgery and sleep improvement, TCM PBIs showed more beneficial effects as assessed by reducing both fatigue and gastrointestinal distress. In particular, acupuncture relieved fatigue, reduced diarrhea and decreased time to flatulence after surgery in cancer patients, while therapeutic Chinese massage reduced time to flatulence and time to peristaltic sound. Conclusion: These findings demonstrate the efficacy of TCM PBIs in improving QoL in cancer patients and establish that TCM PBIs represent beneficial adjunctive therapies for cancer patients.
C1 [Tao, Weiwei; Luo, Xi; Cui, Bai; Liang, Dapeng; Wang, Chunli; Liu, Quentin] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China.
   [Tao, Weiwei; Luo, Xi; Cui, Bai; Liang, Dapeng; Wang, Chunli; Liu, Quentin] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou, Guangdong, Peoples R China.
   [Tao, Weiwei] Dalian Med Univ, Coll Nursing, Dalian, Peoples R China.
   [Duan, Yangyang; Wang, Shaowu] Dalian Med Univ, Dept Radiol, Affiliated Hosp 2, Dalian, Peoples R China.
   [Li, Xiaofen] Dalian Med Univ, Sch Publ Hlth, Dalian, Peoples R China.
   [Zhou, Shiyu] Dalian Med Univ, Dept Psychol, Dalian, Peoples R China.
   [Zhao, Mingjie] Dalian Med Univ Magazine, Dalian, Peoples R China.
   [Li, Yi] Dalian Med Univ, Sch Art, Dalian, Peoples R China.
   [He, Yumin] Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China.
   [Kelley, Keith W.] Coll ACES, Dept Anim Sci, Integrat Immunol & Behav Program, Urbana, IL USA.
   [Kelley, Keith W.] Univ Illinois, Coll Med, Dept Pathol, Urbana, IL USA.
   [Jiang, Ping] Dalian Med Univ, Grad Sch, Dalian, Peoples R China.
C3 Dalian Medical University; Sun Yat Sen University; State Key Lab Oncology South China; Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University; Shanghai University of Traditional Chinese Medicine; University of Illinois System; University of Illinois Urbana-Champaign; Dalian Medical University
RP Liu, QT (corresponding author), Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China.
EM wsw_2003@163.com; kwkelley@illinois.edu; dywx.2009@163.com; liuqiang@dlmedu.edu.cn
FU China Central Budget Recruitment Program of High-Level Overseas Talent [GDW 201221022066]; National Basic Research Program of China (973 Program) [2012CB967000]; Program for Changjiang Scholars and Innovative Research Team in Universities [ITR 13049]; NIH [RO1 SUB UT00000712]; National Natural Science Foundation of China (NNSF) [81130040, 81201686];  [NSF 2014029102]
CR Ahlberg K, 2003, LANCET, V362, P640, DOI 10.1016/S0140-6736(03)14186-4
   Andersen BL, 2007, BRAIN BEHAV IMMUN, V21, P953, DOI 10.1016/j.bbi.2007.03.005
   王运良, 2012, 中华物理医学与康复杂志 CHINESE JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, V34, P64
   Unknown -, 2013, CHIN NURS RES, V0, P0
   Balk Judith, 2009, J SOC INTEGR ONCOL, V7, P4
   Blesch K S, 1991, ONCOL NURS FORUM, V18, P81
   Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743
   Bower JE, 2011, J CLIN ONCOL, V29, P3517, DOI 10.1200/JCO.2011.36.1154
   Bradt J, 2011, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD006911
   Bruera E, 2010, J CLIN ONCOL, V28, P3671, DOI 10.1200/JCO.2010.29.8984
   Campo RA, 2013, INTEGR CANCER THER, V12, P464, DOI 10.1177/1534735413485418
   Chen Z, 2013, CANCER-AM CANCER SOC, V119, P1690, DOI 10.1002/cncr.27904
   Chung JH, 2013, WORLD J MENS HEALTH, V31, P157, DOI 10.5534/wjmh.2013.31.2.157
   Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P4333, DOI 10.1002/cncr.28376
   Dahlquist Lynnda M, 2002, J PEDIATR ONCOL NURS, V19, P22, DOI 10.1053/jpon.2002.30009
   Dean-Clower E, 2010, INTEGR CANCER THER, V9, P158, DOI 10.1177/1534735409360666
   deGramont A, 1997, J CLIN ONCOL, V15, P808, DOI 10.1200/JCO.1997.15.2.808
   Deng G, 2013, SUPPORT CARE CANCER, V21, P1735, DOI 10.1007/s00520-013-1720-z
   Epplein M, 2011, J CLIN ONCOL, V29, P406, DOI 10.1200/JCO.2010.30.6951
   Eremin O, 2009, BREAST, V18, P17, DOI 10.1016/j.breast.2008.09.002
   Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724
   Freise H, 2011, BRIT J ANAESTH, V107, P859, DOI 10.1093/bja/aer339
   Giese-Davis J, 2011, J CLIN ONCOL, V29, P413, DOI 10.1200/JCO.2010.28.4455
   HANSEL TT, 1991, CLIN EXP IMMUNOL, V86, P271
   Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667
   Henderson V, 2012, BREAST CANCER RES TR, V131, P99, DOI 10.1007/s10549-011-1738-1
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Ho YH, 1996, DIS COLON RECTUM, V39, P307, DOI 10.1007/BF02049473
   Hollingworth W, 2013, J CLIN ONCOL, V31, P3631, DOI 10.1200/JCO.2012.48.3040
   Irwin MR, 2008, SLEEP, V31, P1001
   Janelsins MC, 2011, CLIN BREAST CANCER, V11, P161, DOI 10.1016/j.clbc.2011.03.013
   Jeon Soon-Yang, 2005, TAEHAN KANHO HAKHOE CHI, V35, P135
   Johnston MF, 2011, BMC COMPLEM ALTERN M, V11, P0, DOI 10.1186/1472-6882-11-49
   Krischer MM, 2007, J CLIN ONCOL, V25, P4657, DOI 10.1200/JCO.2006.09.0126
   Lämås K, 2009, INT J NURS STUD, V46, P759, DOI 10.1016/j.ijnurstu.2009.01.007
   Lang EV, 2000, LANCET, V355, P1486, DOI 10.1016/S0140-6736(00)02162-0
   Lavretsky H, 2011, AM J GERIAT PSYCHIAT, V19, P839, DOI 10.1097/JGP.0b013e31820ee9ef
   LECROY CW, 1992, SOC WORK, V37, P225
   Legge MF, 1999, IEEE ENG MED BIOL, V18, P80, DOI 10.1109/51.752983
   Li ZY, 2012, ZHONGGUO SHIYAN FANG, V18, P332
   Meric-Bernstam F, 2013, J CLIN ONCOL, V31, P1849, DOI 10.1200/JCO.2012.45.3043
   Mielenz T, 2006, HEALTH QUAL LIFE OUT, V4, P0, DOI 10.1186/1477-7525-4-66
   Mishra SI, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD007566.pub2
   Nolan RP, 2010, HYPERTENSION, V55, P1033, DOI 10.1161/HYPERTENSIONAHA.109.146233
   Osborn RL, 2006, INT J PSYCHIAT MED, V36, P13, DOI 10.2190/EUFN-RV1K-Y3TR-FK0L
   Paskett ED, 2008, CANCER-AM CANCER SOC, V113, P3222, DOI 10.1002/cncr.23891
   [强万敏 QIANG Wanmin], 2011, 中华护理杂志 CHINESE JOURNAL OF NURSING, V46, P537
   Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493
   Sniezek DP, 2013, MED ACUPUNCT, V25, P164, DOI 10.1089/acu.2012.0900
   Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678
   Theodoropoulos GE, 2013, TECH COLOPROCTOL, V17, P525, DOI 10.1007/s10151-013-1008-9
   van der Meulen IC, 2013, ONCOLOGIST, V18, P336, DOI 10.1634/theoncologist.2012-0299
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Wadler S, 1998, J CLIN ONCOL, V16, P3169, DOI 10.1200/JCO.1998.16.9.3169
   Walker EM, 2010, J CLIN ONCOL, V28, P634, DOI 10.1200/JCO.2009.23.5150
   Weis J, 2011, EXPERT REV PHARM OUT, V11, P441, DOI 10.1586/erp.11.44
   [项春雁 XIANG Chunyan], 2006, 中华护理杂志 CHINESE JOURNAL OF NURSING, V41, P969
   Yan X, 2006, INT J BIOCHEM CELL B, V38, P2102, DOI 10.1016/j.biocel.2006.06.002
   Yeh ML, 2006, CANCER NURS, V29, P149, DOI 10.1097/00002820-200603000-00012
   Yu JF, 2002, CHIN J NURS, V37, P799
   Zeng YC, 2014, COMPLEMENT THER MED, V22, P173, DOI 10.1016/j.ctim.2013.11.010
   Zhang J, 2012, J ALTERN COMPLEM MED, V18, P994, DOI 10.1089/acm.2011.0514
NR 70
TC 69
Z9 79
U1 4
U2 73
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD NOV 24
PY 2015
VL 6
IS 37
BP 39725
EP 39739
DI 10.18632/oncotarget.5388
PG 15
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA CY0RW
UT WOS:000366114400032
PM 26498685
DA 2026-01-16
ER

PT J
AU Fiorini, FR
   Santoro, R
   Cristofaro, G
   Buongiorno, A
   Mannelli, G
   Picconi, M
   Gallo, O
AF Fiorini, F R
   Santoro, R
   Cristofaro, G
   Buongiorno, A
   Mannelli, G
   Picconi, M
   Gallo, O
TI Potential use of acupuncture in the treatment of first bite syndrome.
SO American journal of otolaryngology
LA English
DT Journal Article
AB OBJECTIVES: First bite syndrome (FBS) is an early postoperative pain syndrome  characterized by the sudden onset of pain in the parotid region at the first bite  of each meal. The etiology is not certain, hence a standardized therapy does not  exist. METHODS: A 50-year old woman referred to us complaining of a swelling in  the right parotid region. Fine-needle aspiration biopsy (FNAB) was diagnostic for  pleomorphus adenoma of the deep lobe of the parotid gland. A 50-year old man  presented with a mass in the right side of the neck, FNAB was diagnostic for  parapharyngeal space neurinoma. The first patient was submitted to total  parotidectomy with facial nerve preservation, the second to extracapsular  dissection of the tumor. A week after surgery both patients developed FBS. A  qualitative/quantitative description of pain was obtained by means of a  self-coded questionnaire. The score ranges from 8 to 44, corresponding to the  lowest and the highest discomfort possible, respectively. Acupuncture was used to  treat these 2 patients. The treatment protocol comprised 6 sessions, one per  week, lasting 30 minutes each. RESULTS: Our questionnaire was administered before  and after treatment and the score dropped from 33 to 25 in the female, from 30 to  15 in the male patient. CONCLUSION: FBS is a complication of upper cervical  surgery with a high morbidity rate. We describe the first two cases of FBS that  were successfully treated with acupuncture in our ENT department. We believe that  this procedure may represent a valid therapeutic alternative in the future.
C1 First Clinic of Otorhinolaryngology, Deparment of Surgery and Translational Medicine, University of Florence, Italy. 
   First Clinic of Otorhinolaryngology, Deparment of Surgery and Translational Medicine, University of Florence, Italy.
   First Clinic of Otorhinolaryngology, Deparment of Surgery and Translational Medicine, University of Florence, Italy.
   First Clinic of Otorhinolaryngology, Deparment of Surgery and Translational Medicine, University of Florence, Italy.
   First Clinic of Otorhinolaryngology, Deparment of Surgery and Translational Medicine, University of Florence, Italy.
   "Sinergie" private practice and "Panakeia", School of Naturopathy, Florence, Italy.
   First Clinic of Otorhinolaryngology, Deparment of Surgery and Translational Medicine, University of Florence, Italy.
EM rancescaromanafiorini@gmail.com
NR 0
TC 0
SN 1532-818
EI 
J9 Am J Otolaryngol
PD MAR 19
PY 2015
VL 36
IS 3
BP 484
EP 7
DI 10.1016/j.amjoto.2015.01.023
PG -477
WC Acupuncture Therapy; Adenoma, Pleomorphic; surgery; Female; Humans; Male; Mastication; Middle Aged; Neurilemmoma; surgery; Pain; diagnosis; Parotid Neoplasms; surgery; Postoperative Complications; Syndrome
UT PubMed:25783766
PM 25783766
DA 2015-03-19
ER

PT J
AU Li, H
   Shang, XJ
   Dong, QR
AF Li, Huan
   Shang, Xiao-Jun
   Dong, Qi-Rong
TI Effects of transcutaneous electrical nerve stimulation on rats with the third lumbar vertebrae transverse process syndrome
SO ACUPUNCTURE IN MEDICINE
LA English
DT Article
ID pain; model; frequency; inflammation; suppression; receptor; therapy
AB Objective To investigate the analgesic and anti-inflammatory effects of transcutaneous electrical nerve stimulation (TENS) at local or distant acupuncture points in a rat model of the third lumbar vertebrae transverse process syndrome. Methods Forty Sprague-Dawley rats were randomly divided into control, model, model plus local acupuncture point stimulation at BL23 (model+LAS) and model plus distant acupuncture point stimulation at ST36 (model+DAS) groups. All rats except controls underwent surgical third lumbar vertebrae transverse process syndrome modelling on day 2. Thereafter, rats in the model+LAS and model+DAS groups were treated daily with TENS for a total of six treatments (2/100 Hz, 30 min/day) from day 16 to day 29. Thermal pain thresholds were measured once a week during treatment and were continued until day 57, when local muscle tissue was sampled for RTPCR and histopathological examination after haematoxylin and eosin staining. mRNA expression of interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF-alpha) and inducible nitric oxide synthase (iNOS) was determined. Results Thermal pain thresholds of all model rats decreased relative to the control group. Both LAS and DAS significantly increased the thermal pain threshold at all but one point during the treatment period. Histopathological assessment revealed that the local muscle tissues around the third lumbar vertebrae transverse process recovered to some degree in both the model+LAS and model+DAS groups; however, LAS appeared to have a greater effect. mRNA expression of IL-1 beta, TNF-alpha and iNOS in the local muscle tissues was increased after modelling and attenuated in both model+LAS and model+DAS groups. The beneficial effect was greater after LAS than after DAS. Conclusions TENS at both local (BL23) and distant (ST36) acupuncture points had a pain-relieving effect in rats with the third lumbar vertebrae transverse process syndrome, and LAS appeared to have greater anti-inflammatory and analgesic effects than DAS.
C1 [Li, Huan; Dong, Qi-Rong] Suzhou Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China.
   [Li, Huan; Shang, Xiao-Jun] Suzhou Univ, Peoples Hosp Changzhou 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China.
   [Li, Huan; Shang, Xiao-Jun] Suzhou Univ, Affiliated Hosp 3, Suzhou, Jiangsu, Peoples R China.
RP Dong, QR (corresponding author), Suzhou Univ, Affiliated Hosp 2, Dept Orthopaed, 1005 Sanxiang Rd, Suzhou, Jiangsu, Peoples R China.
EM qrdong0512@126.com
CR Alves DP, 2013, NITRIC OXIDE-BIOL CH, V28, P8, DOI 10.1016/j.niox.2012.09.001
   Bo L, 2013, J ACUPUNCT TUINA SCI, V2, P113
   Maciel LYD, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/485043
   Gao YH, 2013, NEUROCHEM RES, V38, P1467, DOI 10.1007/s11064-013-1047-7
   Gim GT, 2011, BRAIN RES BULL, V86, P403, DOI 10.1016/j.brainresbull.2011.09.010
   Gonçalves DO, 2011, BRAZ J MED BIOL RES, V44, P173, DOI 10.1590/S0100-879X2011007500001
   Guo Chang-Qing, 2012, ZHONGGUO ZHEN JIU, V32, P617
   Guo CQ, 2014, J TRADIT CHIN MED, V34, P194, DOI 10.1016/S0254-6272(14)60078-9
   Kim HW, 2008, BRAIN RES BULL, V75, P698, DOI 10.1016/j.brainresbull.2007.11.015
   LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004
   Li C, 2011, J ACUPUNCT TUINA SCI, V9, P73
   Li HY, 2010, ALTERN THER HEALTH M, V16, P38
   Lima LV, 2015, EUR J PAIN, V19, P369, DOI 10.1002/ejp.555
   Noma N, 2013, J DENT RES, V92, P456, DOI 10.1177/0022034513483770
   Özaktay AC, 2002, EUR SPINE J, V11, P467, DOI 10.1007/s00586-002-0430-x
   Park C, 2015, ANAESTHESIA, V70, P434, DOI 10.1111/anae.12933
   Qiao JL, 2011, J TRADIT CHIN MED, V31, P83, DOI 10.1016/S0254-6272(11)60018-6
   Shih CM, 2009, ANESTH ANALG, V108, P1303, DOI 10.1213/ane.0b013e318193e919
   Sun Chang-le, 2011, ZHONGGUO GU SHANG, V24, P828
   Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011
   Tucker DL, 2015, J CLIN PATHOL, V68, P479, DOI 10.1136/jclinpath-2015-202908
   Vallinga MS, 2015, J SEX MED, V12, P228, DOI 10.1111/jsm.12740
   [王健瑞 Wang Jianrui], 2003, 中华物理医学与康复杂志 CHINESE JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, V25, P394
   Wang S, 1999, J TRADIT CHIN MED, V19, P190
   Wang Yong-zhi, 2009, ZHONGGUO GU SHANG, V22, P438
   Wen You-Liang, 2012, ZHONGGUO ZHEN JIU, V32, P345
   Xiang XH, 2014, J NEUROSCI RES, V92, P555, DOI 10.1002/jnr.23351
   Yamazaki H, 2014, J ORTHOP RES, V32, P286, DOI 10.1002/jor.22486
   Zeng C, 2015, OSTEOARTHR CARTILAGE, V23, P189, DOI 10.1016/j.joca.2014.11.014
NR 29
TC 8
Z9 10
U1 1
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0964-5284
EI 1759-9873
J9 ACUPUNCT MED
JI Acupunct. Med.
PD OCT 15
PY 2015
VL 33
IS 5
BP 400
EP 405
DI 10.1136/acupmed-2014-010752
PG 6
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CW4XM
UT WOS:000364999900010
PM 26104377
DA 2026-01-16
ER

PT J
AU Bae, K
   Yoo, HS
   Lamoury, G
   Boyle, F
   Rosenthal, DS
   Oh, B
AF Bae, Kyeore
   Yoo, Hwa-Seung
   Lamoury, Gillian
   Boyle, Frances
   Rosenthal, David S.
   Oh, Byeongsang
TI Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review
SO INTEGRATIVE CANCER THERAPIES
LA English
DT Review
DE acupuncture; breast cancer; aromatase inhibitors; arthralgia; joint pain; pain management
ID early breast-cancer; adjuvant endocrine therapy; joint symptoms; risk-factors; musculoskeletal symptoms; randomized-trials; american society; pain; women; management
AB Background. Aromatase inhibitors (AIs) are commonly used as adjunctive hormone treatment for early breast cancer patients. The major side effect of AIs is arthralgia, which affects adherence. Previous reviews suggested that acupuncture is effective in the management of cancer-related pain. The aim of this review is to evaluate the effects of acupuncture on arthralgia caused by AIs. Methods. This article examined randomized controlled trials (RCTs) measuring the effects of acupuncture on joint symptoms caused by AIs within 8 medical databases till May 2014. The quality of the articles was evaluated according to the Cochrane risk of bias (ROB) tool. Results. Four RCTs were identified in medical journals. Two studies were conducted with manual acupuncture and 2 studies were electroacupuncture. The range of sample size was between 32 and 67. One RCT showed significant improvement in the acupuncture group compared with the sham control group and another RCT showed a statistical difference between the electroacupuncture and waitlist group. The other 2 studies showed no statistical differences between control and acupuncture groups. Two studies conducted blood analysis to elucidate the mechanism of efficacy of acupuncture for arthralgia. The 2 positive studies had a lower ROB and 2 studies had a high ROB. Conclusions. The systematic review suggests that acupuncture has potential benefits to improve arthralgia caused by AIs. However, further trials of adequate sample size, appropriate control group, and longer follow-up are necessary to investigate the efficacy of acupuncture in AI-induced arthralgia.
C1 [Bae, Kyeore; Lamoury, Gillian; Oh, Byeongsang] Royal N Shore Hosp, Sydney Med Sch, Sydney, NSW, Australia.
   [Bae, Kyeore; Yoo, Hwa-Seung] Daejeon Univ, Dunsan Korean Med Hosp, East West Canc Ctr, Taejon, South Korea.
   [Lamoury, Gillian; Boyle, Frances] Mater Hosp, Sydney Med Sch, Sydney, NSW, Australia.
   [Rosenthal, David S.; Oh, Byeongsang] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.
C3 Royal North Shore Hospital; University of Sydney; Daejeon University; University of Sydney; Harvard University; Harvard Medical School; Harvard University Medical Affiliates; Dana-Farber Cancer Institute
RP Bae, K (corresponding author), Daejeon Univ, Dunsan Korean Med Hosp, East West Canc Ctr, Taejon, South Korea.
EM kyeorebae@gmail.com
CR Unknown -, 2014, ALL MULT CAR SYDN AU, V0, P0
   Appleyard I, 2014, EUR J INTEGR MED, V6, P234, DOI 10.1016/j.eujim.2014.03.004
   Bao T, 2013, BREAST CANCER RES TR, V138, P167, DOI 10.1007/s10549-013-2427-z
   Bao YJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/170396
   Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008
   Burstein HJ, 2014, J CLIN ONCOL, V32, P2255, DOI 10.1200/JCO.2013.54.2258
   Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082
   Chien Tsai-Ju, 2013, J TRADIT COMPLEMENT MED, V3, P234, DOI 10.4103/2225-4110.119733
   Chim K, 2013, BMC CANCER, V13, P0, DOI 10.1186/1471-2407-13-401
   Choi TY, 2012, SUPPORT CARE CANCER, V20, P1147, DOI 10.1007/s00520-012-1432-9
   Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207
   Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814
   Coleman RE, 2008, CANCER TREAT REV, V34, P275, DOI 10.1016/j.ctrv.2007.10.004
   Crew KD, 2007, J CLIN ONCOL, V25, P3877, DOI 10.1200/JCO.2007.10.7573
   Crew KD, 2010, J CLIN ONCOL, V28, P1154, DOI 10.1200/JCO.2009.23.4708
   Din OS, 2010, BREAST CANCER RES TR, V120, P525, DOI 10.1007/s10549-010-0757-7
   Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606
   Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9
   Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0
   Fuhrman BJ, 2012, J NATL CANCER I, V104, P326, DOI 10.1093/jnci/djr531
   Gaillard S, 2011, BREAST CANCER RES, V13, P0, DOI 10.1186/bcr2818
   Garcia MK, 2014, CURR ONCOL REP, V16, P0, DOI 10.1007/s11912-014-0418-9
   Garcia MK, 2013, J CLIN ONCOL, V31, P952, DOI 10.1200/JCO.2012.43.5818
   Gibson L, 2009, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003370.pub3
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017
   Henry NL, 2008, BREAST CANCER RES TR, V111, P365, DOI 10.1007/s10549-007-9774-6
   Hind D, 2007, HEALTH TECHNOL ASSES, V11, P1
   Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6
   Koog YH, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020679
   Laroche F, 2014, J PAIN, V15, P293, DOI 10.1016/j.jpain.2013.11.004
   Lee H, 2005, EUR J PAIN, V9, P437, DOI 10.1016/j.ejpain.2004.10.004
   Lu WD, 2013, CURR PAIN HEADACHE R, V17, P0, DOI 10.1007/s11916-013-0321-3
   Lu WD, 2010, CURR TREAT OPTION ON, V11, P141, DOI 10.1007/s11864-010-0126-0
   Lundeberg T, 2008, ACUPUNCT MED, V26, P239, DOI 10.1136/aim.26.4.239
   Macdonald G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001930.pub3
   Mao JJ, 2014, EUR J CANCER, V50, P267, DOI 10.1016/j.ejca.2013.09.022
   Mao JJ, 2009, CANCER, V115, P3631, DOI 10.1002/cncr.24419
   Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356
   ORegan D, 2010, AUTON NEUROSCI-BASIC, V157, P96, DOI 10.1016/j.autneu.2010.05.001
   Oh B, 2013, ACUPUNCT MED, V31, P264, DOI 10.1136/acupmed-2012-010309
   Paley CA, 2011, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD007753.pub2
   Peng Hao, 2010, ZHONG XI YI JIE HE XUE BAO, V8, P501
   Rocha-Cadman X, 2012, PALLIAT SUPPORT CARE, V10, P225, DOI 10.1017/S1478951512000636
   Savovic J, 2014, SYST REV-LONDON, V3, P0, DOI 10.1186/2046-4053-3-37
   Sestak I, 2008, LANCET ONCOL, V9, P866, DOI 10.1016/S1470-2045(08)70182-7
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Towler P, 2013, SUPPORT CARE CANCER, V21, P2913, DOI 10.1007/s00520-013-1882-8
   Wolfe F, 2005, J RHEUMATOL, V32, P583
   Younus J, 2010, CURR ONCOL, V17, P87
NR 51
TC 33
Z9 34
U1 0
U2 27
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1534-7354
EI 1552-695X
J9 INTEGR CANCER THER
JI Integr. Cancer Ther.
PD NOV 15
PY 2015
VL 14
IS 6
BP 496
EP 502
DI 10.1177/1534735415596573
PG 7
WC Oncology; Integrative & Complementary Medicine
SC Oncology; Integrative & Complementary Medicine
GA CT8JW
UT WOS:000363063200001
PM 26220605
DA 2026-01-16
ER

